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Variations in gene expression are the basis of differences in cell and tissue function, 
response to DNA damaging agents, susceptibility to genetic disease, and cellular 
differentiation.  The purpose of this dissertation research was to characterize variation in 
basal gene expression among adult mouse tissues for selected stress response, DNA 
repair and damage control genes and to utilize variation in temporal gene expression 
patterns to identify candidate genes associated with germ cell differentiation from mitosis 
through meiosis in the prepubertal mouse testis.  To accomplish these goals, high 
throughput analyses of gene expression were performed using custom cDNA and random 
oligonucleotide microarrays.  cDNA microarray technology was optimized by evaluating 
the effects of multiple hybridization and image analysis methodologies on the magnitude 
of background-subtracted hybridization signal intensities.  The results showed that 
hybridizing lower probe quantities in a buffer developed at Lawrence Livermore National 
Laboratory to tryptone-blocked microarrays improved signal intensities.  In addition, the 
error in expression ratio measurements was significantly reduced when microarray 
images were preprocessed.  A custom cDNA microarray comprised of 417 genes and 
enriched for stress response, DNA repair, and damage control genes was used to 
investigate basal gene expression differences among adult mouse testis, brain, liver, 
spleen, and heart.  Genes with functions related to stress response exhibited the most 
variation in expression among tissues whereas DNA repair-associated gene expression 
varied the least.  Random oligonucleotide microarrays comprised of ~10,000 genes were 
used to profile changes in gene expression during the first wave of spermatogenesis in the 
prepubertal mouse testis.  Approximately 550 genes were differentially expressed as male 
germ cells differentiated from spermatogonia to primary spermatocytes.  These findings 
suggest that the 313 unannotated sequences and 178 genes with known functions in other 
biological pathways have spermatogenesis-associated roles.  This dissertation research 
showed that microarrays are a useful tool for quantitating the expression of large numbers 
of genes in parallel under normal physiological conditions and during differentiation.  It 
has also provided candidate genes for future investigations of the molecular mechanisms 
underlying (1) tissue-specific DNA damage response and genetic disease susceptibility 
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Every cell contains the complete genetic code for an organism, yet cell 
morphologies and functions are biologically diverse.  The morphological, biochemical, 
and physiological diversity of cells within an organism is attributable to differences in 
their history of gene expression during differentiation (Strachan and Read, 1999).  The 
profile of genes transcribed in a differentiated cell includes (a) genes whose expression is 
specific and required for a given cell type, (b) genes that are essential for general cell 
functions and are expressed in all cell types, and (c) genes that have tissue-specific 
functions but low levels of transcription are observed in all cell types (referred to as 
illegitimate expression; Strachan and Read, 1999).  Understanding the variation in gene 
expression patterns among cells and tissues under normal physiological conditions and 
abnormal conditions (e.g., in response to genotoxic agents) is important for understanding 
cellular differentiation and function. 
In 1961 Jacob and Monod reported that the expression of groups of genes in the 
bacterial operon is strictly coordinated.  Expression studies up to the 1990s were typically 
limited to analyzing one or a small number of genes using techniques such as cell or 
tissue in situ hybridization, northern blot, RNA dot blot, etc.  These low throughput 
investigations provided only limited insight on the molecular events underlying 
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individual biological processes (e.g., cellular differentiation, cell cycle, DNA repair, etc.).  
However, these techniques are not able to simultaneously analyze the expression of the 
many genes involved in any complex biological process.  The advent of new molecular 
capabilities, such as automated PCR, together with the exponential increase of publicly 
accessible genome sequence information has facilitated the development of high 
throughput methods for gene expression analysis (i.e., serial analysis of gene expression 
or SAGE, expression microarrays, and mRNA differential display).  Through the use of 
these genome-scale techniques, it is possible to analyze the expression of several 
thousand genes in parallel.  
SAGE and mRNA differential display are used to determine which sequences are 
differentially represented between two samples.  This information is then used to 
determine gene identities using other molecular techniques (i.e., DNA sequencing) and 
bioinformatics approaches (e.g., pairwise comparisons of each newly determined 
sequence with the non-redundant sequence database available through the National 
Center for Biotechnology Information).  Microarrays, on the other hand, analyze the 
differential expression of a set of known genes and/or unannotated sequences that are 
selected a priori.  Expression microarrays can be customized to include only specific 
genes of interest.  It is feasible to build custom microarrays to simultaneously study the 
expression of all genes involved in a given biological process (e.g., cell cycle, apoptosis, 
DNA repair, etc.).  Alternatively, expression microarrays may contain random sets of 
genes that represent a variety of biological pathways.  These random microarrays are 
useful for discovering new genes associated with a biological process or tissue pathology. 
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A particularly promising application of both types of expression microarrays is 
the high throughput investigation of a broad range of biological questions in model 
organisms, such as the mouse.  Microarray-based studies of tissues from model 
organisms promise to provide valuable insight on differential gene expression (a) under 
normal physiological conditions, (b) during development, (c) following exposure to 
genotoxic agents, and (d) during carcinogenesis.  Although a genome-wide 
characterization of basal gene expression levels is necessary for a thorough understanding 
of the molecular mechanisms underlying tissue-specific differences in differentiation, 
response to DNA damaging conditions, and genetic disease susceptibility, the high 
throughput analysis of tissue-specific differences in basal gene expression has not been 
reported.  Several laboratories, however, have started to examine global changes in gene 
expression in the mouse following exposure to genotoxic agents such as ionizing 
radiation (Amundson et al., 2001) and phencyclidine (Toyooka et al., 2002).  Expression 
microarrays are also being utilized to profile transcriptional changes associated with 
various types of cancer (e.g., prostate cancer: Ho and Lau, 2002; breast cancer: Jiang et 
al., 2002; colon cancer: Zou et al., 2002; etc.). 
Using expression microarrays, it is possible to obtain a more comprehensive 
evaluation of the sequential molecular changes that are correlated with cellular 
differentiation during development. The prepubertal mouse is an excellent model for 
studying the modulations in expression profiles that are associated with germ cell 
differentiation through the mitotic and meiotic phases of spermatogenesis.  A 
characterization of gene expression across critical timepoints during spermatogenesis is 
essential for understanding the molecular mechanisms of meiosis (e.g., transition from 
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spermatogonial mitosis to meiosis: Wolfes et al., 1989; synaptonemal complex assembly: 
Allen et al., 1996; meiotic cell division: Koji et al., 1992; etc.).  Furthermore, a detailed 
characterization of the normal baseline events may help us understand the genetic causes 
of male infertility (e.g., meiotic arrest of primary spermatocytes: Bailis et al., 2000; 
genetic causes for infertility previously characterized as idiopathic), and the induction 
and transmission of mutations to offspring following paternal exposure to genotoxic 
agents (e.g., ethylnitrosourea: Russell et al., 1979; cyclophosphamide; Schimenti et al., 




The objectives of this dissertation research were to characterize the differential 
basal expression of stress response, damage control, and DNA repair genes among 
healthy mouse tissues and investigate differential gene expression during the 
differentiation of spermatogonia into meiotic cells.  Our approach utilized both custom 
cDNA microarrays and random oligonucleotide microarrays that contain known genes 
with diverse biological functions (including stress response, DNA repair, apoptosis, cell 
cycle, cellular differentiation, etc.) as well as unannotated sequences that may represent 
novel genes. 
The custom cDNA microarray technology used in the basal gene expression 
studies (Chapter 3) was first optimized for the accurate quantitation of expression ratios 
by evaluating different hybridization and image analysis techniques.  Various microarray 
hybridization strategies were investigated to increase signal intensity and reduce 
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background while maintaining hybridization specificity, including studies of the effects 
of (a) fluorescent probe quantity, (b) hybridization buffer composition, and (c) selection 
of slide blocking reagent.  To provide accurate quantitation of hybridization signals, the 
microarray image capture system was calibrated by hybridizing a dilution series to the 
microarray and evaluating the following methods: (a) target spot segmentation, (b) 
quantitation, (c) background subtraction, (d) preprocessing, and (e) normalization.  This 
work helped determine the optimal experimental conditions for accurately evaluating 
differential gene expression in subsequent biological studies. 
 The first biological objective of this dissertation research was to investigate the 
differential expression of stress response, damage control, and DNA repair genes among 
healthy adult mouse tissues using the optimized custom cDNA microarrays (Chapter 3).  
After assessing its reproducibility and precision, the cDNA microarray technology was 
used to (a) compare and contrast gene expression profiles among testis, brain, liver, 
spleen, and heart and (b) evaluate the differential tissue expression of genes with respect 
to their functions in different biological pathways.  Microarray expression ratio 
measurements were compared with northern blot expression ratio measurements for 
selected genes in order to validate the microarray data.  By characterizing in vivo 
differences in the baseline expression of stress response, damage control, and/or DNA 
repair-associated genes, this research provides insight on tissue-specific differences in the 
basal levels of cellular resources immediately available for responding to and processing 
DNA damage. 
 The second biological objective of this dissertation research was to investigate the 
temporal changes in gene expression that are associated with progressive stages of 
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cellular differentiation in the seminiferous tubules as germ cells proceed from mitotic 
spermatogonia to meiotic pachytene spermatocytes (Chapter 4).  Random expression 
microarrays, which contain a diverse representation of known (annotated) genes and 
unannotated sequences, were used to establish gene expression profiles at specific times 
in this differentiation pathway (during spermatogonial mitosis, at the onset of meiosis, 
during mid-prophase of meiosis I (MI), and in the adult mouse to compare the first wave 
of spermatogenesis with full spermatogenesis).  These profiles were compared in order to 
identify both annotated and novel genes whose expression was coordinately up- or down-
regulated as germ cells differentiated through spermatogenesis.  This specific research 
provides insight on the molecular mechanisms responsible for the onset and progression 
of meiosis and may also contribute to our understanding of the genetic causes of male 
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This chapter reviews the development and application of expression microarray 
technology (Section 2.1), discusses the optimization of cDNA microarray hybridizations 
for improved background-subtracted signal intensities (Section 2.2), and examines the 
effects of image acquisition and analysis on expression ratio measurements (Section 2.3).  
After determining the best methods for accurately quantitating expression ratios from 
fluorescent cDNA microarrays visualized using a white light image capture system, this 
research will be applied to the study of differential basal gene expression levels among 










2.1 Fluorescent expression microarray technology review 
 
2.1.1 Introduction 
Historically, gene expression studies have involved analyzing the expression of 
one gene, or a small number of genes, at a time.  Over the past decade, the rapid 
incorporation of genome sequence information into publicly available databases, such as 
the National Center for Biotechnology Information’s (NCBI) Entrez Nucleotide Query 
(http://www.ncbi.nlm.nih.gov/Entrez/nucleotide.html) has facilitated the development of 
a new generation of high throughput methods for studying gene expression on a genome-
wide scale, including serial analysis of gene expression (SAGE), PCR-based technologies 
(e.g., mRNA differential display), and expression microarrays. SAGE and the PCR-based 
technologies first identify transcripts that are differentially represented between 
experimental groups (i.e., cell or tissue samples) and then rely on downstream methods 
for gene identification and expression ratio quantitation. Microarrays quantitate the 
expression for up to tens of thousands of annotated genes or unannotated sequences that 
have been selected a priori for representation on the array. 
To analyze gene expression using microarrays (transcript profiling), RNA is 
extracted from cells or tissue samples, fluorescently or radioactively labeled, and 
hybridized to a solid support that has been spotted with DNA (complementary DNA or 
oligonucleotide sequences) representing the genes of interest.  Images of the hybridized 
array are captured, by either a white light system or a laser scanner, and the spot 
intensities are measured and then compared between samples in order to obtain gene 
expression ratios.  Detailed descriptions of (a) the types of expression microarrays, (b) 
 12
probe generation, hybridization, and visualization, and (c) microarray data acquisition 
and analysis are contained in sections 2.1.2, 2.1.3, and 2.1.4, respectively. 
The first microarray-based experiments were described by Schena et al. (1995) 
who applied complementary DNA (cDNA) microarray technology to the study of 
differential expression among 45 Arabidopsis genes.  Using a dual color fluorescence in 
situ hybridization scheme, Arabidopsis mRNA was reverse transcribed in the presence of 
either fluorescein or lissamine and was hybridized to a microarray comprised of 96 
targets (replicate spotting of 45 Arabidopsis cDNAs and 3 negative control cDNAs).  
This study showed that (1) fluorescently labeled probes could be hybridized to 
immobilized target cDNA with high specificity and (2) the differential expression of 
multiple genes could be quantitated in parallel, even for genes with low abundance 
transcripts. 
Since their development in the mid-1990s, microarrays have become an 
increasingly popular tool for the analysis of differential gene expression.  From January 
2001 to January 2002 alone, over 900 microarray-related articles were indexed in 
PubMed, the database for biomedical literature sponsored by NCBI 
(http://www.ncbi.nlm.nih.gov/ entrez/query.fcgi?db=PubMed).  This technology has been 
used to address a broad range of research questions, including those related to (a) cancer 
(Khan et al., 1999) and other genetic diseases (e.g., Fragile X syndrome: Brown et al., 
2001; Type 1 diabetes: Eaves et al., 2002); (b) host-pathogen interactions (e.g., 
comparative analysis of respiratory pathogens: Diehn and Relman, 2001; Yersinia 
enterocolitica infection: Sauvonnet et al., 2002); (c) environmental and/or occupational 
exposures (Bartosiewicz et al., 2001); (d) development (Tanaka et al., 2000); (e) aging 
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(Weindruch et al., 2001); (f) behavior (Dent et al., 2001); (g) reproduction (e.g., Liu et 
al., 2001); and (h) pharmacology (e.g., therapeutic response: Chang et al., 2002; drug 
metabolism: Gerhold et al., 2001; drug discovery: Debouck and Goodfellow, 1999).  
Because this technology is easily adapted for studying any organism for which genome 
sequence information is available, it has been used to profile expression in diverse 
organisms including prokaryotes such as Escherichia coli (Oh and Liao, 2000), 
Pseudomonas aeruginosa (Ichikawa et al., 2000), and Staphylococcus aureus (Dunman et 
al., 2001) as well as lower eukaryotic organisms (e.g., Saccharomyces cerevisiae: 
Spellman et al., 1998).  Expression microarrays have also been widely applied to the 
study of higher eukaryotes, including plants (e.g., Arabidopsis: Seki et al., 2001; loblolly 
pine: Whetten et al., 2001) and animals (e.g., mouse: Rockett et al., 2001; rat: Guo et al., 
2000; and human: Schena et al., 1996). 
 
 
2.1.2 Types of expression microarrays 
Based on the type of “target” nucleotide sequence that is immobilized on the solid 
support (i.e., glass microscope slide or onto a nylon filter supported by a glass slide), 
there are two broad classifications of expression microarrays: cDNA or oligonucleotide.  
cDNA microarrays are generated by immobilizing expressed sequence tag (EST)-derived 
cDNA clones that are usually ~100 bp to 2 kb in size.  Oligonucleotide microarrays are 
generated by immobilizing or synthesizing identified nucleotide sequences of 
approximately 25-100 bp in length that are unique to the transcript for the gene of 
interest. 
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cDNA and oligonucleotide microarrays are both generated by robotically arraying 
DNA sequences that represent the genes of interest directly onto the solid support.  
However, oligonucleotide microarrays have also been constructed by synthesizing DNA 
sequences directly on the solid support through processes such as photolithography (e.g., 
Affymetrix Expression Microarrays, Affymetrix, Inc., Santa Clara, CA). 
 
 
2.1.3 Probe generation, hybridization, and image capture 
Although specific protocols differ among laboratories, the overall experimental 
approaches for probe generation, hybridization, and visualization are generally very 
similar and include isolation of total RNA or mRNA, cDNA synthesis with fluorescent 
dye or radioactive label incorporation, hybridization (including pre-hybridization slide 
blocking, probe binding, and post-hybridization washes), and image capture.  Figures 1 
and 2 are schematic representations of the probe generation, hybridization, and 
visualization protocols used in our laboratory for the cDNA microarray study in Chapter 
3  and the Affymetrix oligonucleotide microarray study in Chapter 4, respectively. 
 
Probe generation 
To generate probes for hybridization to the microarray, either total RNA or 
mRNA is isolated from cells or tissues and subsequently labeled with fluorophore-
conjugated or radioactively-labeled dNTPs.  Commonly, total RNA is isolated using 
guanidine isothiocyanate and phenol, and mRNA is isolated using an oligo-dT cellulose 
column [the polyA(+) tails of the mRNA bind to the oligo-dTs].  Microarray probes are 
 15
 
Figure 2.1.1.  Experimental 
outline for cDNA microarray 
hybridizations.  (A) Total 
RNA or mRNA is isolated 
from the cell or tissue source 
of interest.  (B) Oligo-(dT) 
and an RNase H- reverse 
transcriptase are used to 
incorporate fluorophore-
conjugated dUTPs into 1st
strand cDNA.  (C) The two 
pools of labeled cDNA are co-
hybridized onto the 
microarray.  (D) Images of the 
hybridized array are captured 
using a white light imaging 
system. 
Co-hybridization to cDNA microarray  
Isolation of reference 
sample total RNA or mRNA
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Figure 2.1.2.  Experimental outline for Affymetrix oligonucleotide microarray 
hybridizations.  (A) Total RNA or mRNA is isolated from the cell or tissue source of interest.  
(B) T7-(dT)24 oligomer and an Rnase H- reverse transcriptase are used to generate 1st strand 
cDNA.  DNA polymerase I and DNA ligase are used in the presence of RNase H for 2nd
strand cDNA synthesis.  (C) T7 RNA polymerase is used to transcribe RNA in vitro while 
simultaneously incorporating biotin labeled UTPs and CTPs.  (D) Transcribed RNA is 
fragmented in a magnesium acetate/ potassium acetate buffer.  (E) Fragmented sequences are 
hybridized to the Affymetrix oligonucleotide expression arrays, and the hybridized sequences 
are stained with a streptavidin-phycoerythrin conjugate.  (F) Images of the hybridized array 
are captured using a laser scanner. 
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labeled by incorporating fluorophore-conjugated dUTPs or dCTPs during either reverse 
transcription or nick translation.  (Although radioactive labels have been used for nylon-
based microarrays, most commercial and non-commercial microarray systems involve the 
hybridization of fluorescently labeled probes to glass slides.  Therefore, this review 
focuses primarily on fluorescent microarray hybridizations.) 
Probe generation techniques vary depending on the cell- or tissue-type or size of 
the tissue sample.  Total RNA is usually isolated from smaller samples in order to prevent 
the loss of mRNA.  In addition the isolated RNA may need to be linearly amplified 
through in vitro transcription in order to obtain enough RNA for hybridization to the 
microarray.  The type of array being hybridized (cDNA or oligonucleotide) also 
contributes to variation in probe generation techniques between laboratories.  For 
oligonucleotide microarrays, the probes must be fragmented prior to hybridization, but 
this step is not necessary for cDNA microarray hybridizations.  Also, the characteristics 
of the microarray imaging system (e.g., wavelengths of the excitation and emission 
filters) must be matched to the type of fluorophore to be incorporated into the probe. 
 
Hybridization 
Typically, all microarray probe hybridization protocols include: a slide blocking 
procedure (which reduces non-specific binding of the fluorescently labeled probe mixture 
to areas outside of the arrayed spots); use of a special hybridization buffer; and post-
hybridization washing techniques to further reduce non-specific probe binding. 
Several reagents have been found to prevent the non-specific binding of the 
probes to the glass slide during in situ hybridizations (e.g., ammonium hydroxide, bovine 
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serum albumin, tryptone, acetic anhydride, etc.).  In our experience, selection of the 
appropriate blocking reagent for microarray experiments depends upon the system used 
for image capture because the magnitude of the background intensity is directly affected 
by the combination of blocking reagent, excitation source (i.e., white light or laser), and 
excitation/emission filters. 
Microarray hybridization stringency is determined by the combination of 
hybridization buffer, the length of time for hybridization, and hybridization temperature.  
More specifically, the composition of the hybridization buffer directly affects the length 
of time and temperature of the hybridization.  The presence of large polymers (e.g., 
dextran sulfate) in the buffer increases the rate of reassociation and therefore decreases 
the length of time necessary for hybridization.  The environmental temperature required 
for hybridization is also affected by whether or not the buffer contains formamide.  The 
presence of formamide increases the effective hybridization temperature, (calculated as 
the environmental temperature + 0.4-0.6 times the % formamide), and, therefore, is 
usually determined prior to hybridization in order to maintain the correct level of 
hybridization stringency (i.e., allows the probe to hybridize, but prevents non-specific 
probe hybridization).  Additional information on the optimization of fluorescent cDNA 
microarray hybridizations is contained in Section 2.2. 
Post-hybridization washes usually involve using sodium phosphate buffers (i.e., 
PN), saline sodium citrate (SSC), and/or DNase-free water to remove excess probe and 
non-specific probe hybridization. In general, we have found it preferable to have high 
stringency hybridizations so that less rigorous washing procedures (which may affect the 
intensity of the fluorescently-labeled probe and, therefore, also lower the dynamic range 
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and ultimately affect expression ratio quantitation) are required.  The concentrations of 
the wash solutions as well as the temperature of the washes are inversely dependent upon 
the stringency of the hybridization (i.e., the higher the hybridization stringency, the lower 
the wash stringency and vice versa). 
 
Image capture 
 Following hybridization, the fluorescent microarray images are visualized using 
either a white light system or a laser scanner.  White light systems are easily adapted for 
imaging a broad range of fluorophores,  including those detected in the UV bandwidth.  
However, laser scanners are most commonly used for image capture because they avoid 
data analysis problems associated with non-uniform illumination.  In addition, laser 
scanners are able to provide better resolution than the white light systems (~5 µm vs. 
~15µm). 
Our white light image capture system (Figure 1D; Kegelmeyer et al., 2001) 
utilizes light (400 nm – 600 nm) from a source such as a Xenon arc lamp.  The light is 
usually scrambled through a fiber optic cable and passed through excitation and emission 
filters appropriate for the fluorophore used to label the probe.  The emitted light is 
captured by a scientific grade CCD camera connected to a personal computer (PC).  The 
PC controls the camera and collects the microarray images for analysis.  Integration time 
and gain can be adjusted by the user during image capture in order to maximize the signal 
without pixel saturation. 
Laser image capture systems sequentially scan hybridized arrays with focused gas 
lasers (Application note from Packard Bioscience Company, Meriden, CT; 
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http://www.packardbioscience.com/reference_matl/827.asp).  Briefly, the laser is 
reflected from a beamsplitter through an objective lens and onto the microarray.  The 
resulting fluorescence is converted into parallel beams that travel back through the 
beamsplitter and through an emission filter to a detector lens.  The detector lens focuses 
the beam onto the detector for image capture. 
 
 
2.1.4 Microarray data acquisition and analysis 
 After capturing the microarray images, data acquisition and analysis software is 
used to extract signal intensity data from the images and generate expression ratios.  A 
large number of microarray data acquisition and analysis software packages are currently 
available (e.g., ImaGene from Biodiscovery, Inc., Marina del Ray, CA and QuantArray 
from Packard Bioscience Company).  Most acquisition and analysis software allows the 
user to select from a variety of parameters including methods for quantitation, color 
correction (for dual color hybridizations), background subtraction, normalization, and 
sample-to-sample or slide-to-slide comparisons.  The selection of specific software varies 
depending upon the type of microarray (cDNA or oligonucleotide), imaging system, and 
computer platforms (i.e., PC, Macintosh, or UNIX) utilized.  Consideration must also be 
given to the type of downstream analysis to be performed so that the formatted 
microarray data can be easily uploaded into bioinformatics databases, such as those for 
hierarchial clustering (e.g., CLUSFAVOR: Peterson, 2002), promoter analysis (e.g., 
PromoterInspector by Genomatix: Scherf et al., 2000), and biological pathway analysis 
(e.g., GenMAPP: Dahlquist et al., 2002).  Furthermore, the design of microarray 
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experiments is critical (i.e., number of experimental groups; number of replicates per 
group; type of data analysis; selection of data to be reported in the literature and/or in 
public databases; and the type of downstream analysis). There are useful 
recommendations given by the Microarray Gene Expression Data Group 
(http://www.mged.org/ or http://industry.ebi.ac.uk/~alan/MicroArray/), which continues 




 Although they have undeniably become a prominent tool in biological research 
since their first description in 1995, expression microarray technology varies greatly 
among laboratories (different: types of microarrays, probe generation and hybridization 
techniques, image capture systems, and data analysis methods) and the field continues to 
mature.  Standards for conducting microarray experiments, as well as analyzing and 
reporting the voluminous data, are constantly being debated and revised.  However, 
because this technology is maturing in concordance with a rapid increase in the amount 
of publicly accessible genome sequence information for both prokaryotic and eukaryotic 
organisms, it is expected that microarray (and related genome-scale technologies) usage 
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2.2 Optimization of two-color fluorescence cDNA microarray 




The major parameters that affect the quantitation and interpretation of gene 
expression from cDNA microarrays are microarray quality, probe preparation, 
hybridization conditions, image capture, and methods of analysis.  This research focused 
on the technological development of microarray hybridization strategies to increase 
signal intensity while decreasing background.  Specifically, gene-specific and tissue 
sample probes were hybridized to cDNA microarrays to evaluate the effects of probe 
quantity (25 µg vs. 50 µg), hybridization buffer (commercial vs. LLNL formulas), and 
slide blocking procedure (ammonium hydroxide vs. tryptone) on hybridization signal 
intensities.  The results show that improved signal intensities were obtained when lower 
probe amounts were hybridized in a buffer comprised of 42% formamide / 2 x SSC / 10% 
dextran sulfate to microarrays blocked with 0.25% tryptone in water.  These conditions 
were applied to the study of differential basal expression levels among mouse tissues 




Maximizing signal to background ratios is critical for obtaining accurate 
measurements of gene expression from cDNA microarrays.  The magnitude of the signal 
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remaining after background subtraction is dependent upon several factors, including the 
quality of (a) the microarray (e.g., no inherent defects in the solid support and no 
degradation of target DNA spots), (b) the probe (e.g., efficient fluorophore incorporation 
and prevention of photobleaching), (c) the hybridization (e.g., correct hybridization 
stringency and blocking of non-specific probe binding), (d) the image capture system 
(e.g., use of fluorophore-appropriate, narrow bandpass excitation and emission filters and 
the ability to measure differences in exposure time between samples), and (e) the data 
acquisition software (e.g., ability to account for: the measured exposure differences, non-
uniform illumination, spectral crosstalk, etc.). 
Two major aspects of microarray fabrication, preparation of the solid support and 
preparation of the target spot cDNA, can affect background and must be controlled to 
obtain accurate gene expression measurements.  To accomplish this in our experiments, 
the glass microscope slides used as the solid supports (a) were rigorously cleaned using 
concentrated acids such as HCL and H2SO4; (b) had a uniform distribution of the 
chemical used for cDNA attachment to the solid support (e.g., poly-L-lysine or 
aminopropyltrimethoxysilane); and (c) were inspected immediately prior to spotting to 
ensure that the area to be arrayed is free of chips or cracks.  Additionally, the cDNA to be 
spotted onto the array was placed in buffers that facilitated cDNA attachment without 
compromising cDNA integrity (e.g., sodium carbonate/bicarbonate) and arrayed under 
environmental conditions (i.e., temperature and humidity) that allowed the spots to dry 
quickly without spreading into neighboring spots. 
Probe quality has a large impact on signal to background ratios and, therefore, 
also on the accurate quantitation of expression.  In our experiments, fluorescently labeled 
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probes were generated by incorporating both unlabeled dNTPs and fluorophore-
conjugated dUTPs or dCTPs during a reverse transcription reaction.  The appropriate 
balance of labeled and unlabeled dNTPs had to be determined, because if too many 
fluorophore-conjugated dNTPs were incorporated in succession, the reverse transcriptase 
could stall and fall off of the transcript.  Irrespective of the dNTP that was selected, the 
fluorophores have a substantial effect on the signal to background ratios.  The most 
common fluorescent dyes currently used for microarray experiments are the Cyanine 
dyes (Cy3 and Cy5) and the Alexa Fluor dyes (Alexa Fluors 488 and 546).  Initially, the 
Cy dyes were used for microarray experiments due to the limited wavelengths available 
for laser scanners.  However, white light imaging systems (and a few recently developed 
laser scanners) are capable of detecting a broad range of fluorophores, including the 
Alexa Fluor dyes.  We found that the Alexa Fluor 488 and 546 dyes (which have 
excitation and emission spectra similar to FITC and Cy3, respectively)  were preferable 
to the Cy dyes because they are brighter, more photostable, and less sensitive to 
alterations in pH.  Also, when used for dual color hybridizations, these Alexa Fluor dyes 
have less spectral overlap with each other compared to Cy3 and Cy5.  Regardless of the 
fluorophore selected, the use of antifades typically provided better signal to background 
ratios because they preserve signal intensity by preventing photobleaching during the 
image capture procedure.  Unfortunately, antifades can only be used when images are 
captured by white light imaging system because laser scanners require dry slides. 
Hybridization strategies (e.g., increasing probe concentration and the rate of DNA 
reassociation by the addition of large polymers such as dextran sulfate and polyethylene 
glycol; Wetmur, 1971) also have a significant impact on signal to background ratios.  
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Stringent hybridization conditions are critical for accurate expression ratio measurements 
because they increase probe binding while reducing non-specific probe hybridization.  In 
our experiments, stringency was optimized by matching the probe hybridization buffer 
with hybridization temperature and time conditions.  This required the use of the proper 
combinations of formamide (which increases the effective hybridization temperature; 
Miesfeld, 1999) and salt concentration (which stabilizes the hybridized probe; Strachan 
and Read, 1999) for a given hybridization temperature and time. 
To obtain accurate gene expression information from microarray images using a 
white light image capture system, we ensured that the excitation and emission filters had 
narrow, non-overlapping bandpasses (to circumvent/reduce spectral cross-talk) with 
wavelengths that were suitable for the excitation and emission spectra of the fluorophore 
used in probe labeling.  For additional information, see Section 2.3 “Accurate 
quantitation of fluorescence microarrays”.  Improvements to background-subtracted 
signal intensities were also made in our experiments by correcting for camera dark noise, 
non-uniform illumination, spectral cross-talk, and integration time differences.  In 
addition, the selection of segmentation and quantitation methods was dependent upon the 
target spot shapes and the array grid layout (i.e., horizontal x vertical number of spots and 
their position within each row and column) as well as the area hybridized on individual 
spots (e.g., accurate measurements for irregularly shaped spots or spots that only 
hybridize along the edges).  The selection of data acquisition software that included 
flexible background subtraction methods for hybridizations with either high or low 
background was also important for accurately measuring expression ratios.  (See Section 
2.3.). 
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As described above, there are many parameters (and combinations of these 
parameters) that may affect the magnitude of background-subtracted microarray signal 
intensities.  The purpose of this research was to develop cDNA microarray hybridization 
protocols that increased signal to background ratios by concurrently improving signal 
intensity and reducing background intensity.  Probe quantity, hybridization buffer, and 
microarray slide blocking procedures were evaluated for hybridizations of gene-specific 
(simple) and/or tissue sample (complex) probes. 
 
 
2.2.3 Materials and Methods 
cDNA microarray preparation 
Two custom cDNA microarrays were spotted: the microarray used for gene-
specific hybridizations was comprised of 72 genes (322 target spots) and the microarray 
used for the tissue sample hybridizations was comprised of 53 genes (252 target spots).  
For each gene, one to four cDNA clones were obtained from the I.M.A.G.E. Consortium 
at LLNL.  Up to five lambda phage and bacterial sequences served as controls.  Clones 
were PCR-amplified with 5'-C6 amino-modified vector-specific primers, purified on 
Qiagen purification columns (Qiagen Inc., Valencia, CA), ethanol precipitated, and 
resuspended in 0.1M sodium carbonate/bicarbonate (pH = 10.2) for spotting onto the 
microarray slides.   
The glass slides used for arraying were cleaned for 30 min. in 1:1 concentrated 
hydrochloric acid:methanol, soaked overnight in concentrated sulfuric acid, and washed 
10 x 10 min. in room temperature water and 1 x 10 min. in boiling water.  Slides were 
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then submerged in 1% 3-aminopropyltrimethoxysilane (Sigma, St. Louis, MO) / 95% 
acetone/ water for 2 min., washed 10 x 5 min. in acetone, and heated at 110°C for 45 min. 
(Guo et al., 1994).  Silane-coated slides were submerged in 0.2% 1,4-phenylene 
diisothiocyanate (Sigma), 10% pyridine (Sigma) and dimethylformamide (Aldrich, 
Milwaukee, WI) for 2 hours, washed in methanol (2 x 10 min.) and acetone (2 x 10 min.), 
and air-dried.  Target spots for both the gene-specific (simple) and tissue sample 
(complex) hybridizations were robotically arrayed (Norgren Systems, Palo Alto, CA) in 
duplicate with a 250 µm center-to-center distance. 
 
Probe generation 
Gene-specific (simple) probes were generated for each of the following genes: 
Cdc2, Eif-4c, Lig1, Tp53, and Xrcc1.  A cDNA clone representing each gene was 
obtained from the I.M.A.G.E. Consortium at LLNL and was PCR-amplified with gene-
specific primers designed using the Oligo v4.0 primer design software (National 
Biosciences, Inc., Plymouth, MN; Table 2.2.1).  The expected amplicon sizes (range: 
150-470 bp) were verified by electrophoresis on a 2% agarose gel.  The quantity of each 
PCR-product was determined using the GeneQuant spectrophotometer (Amersham 
Pharmacia Biotech, Piscataway, NJ).  To incorporate the fluorescent label (Alexa Fluor 
488-dUTP for Cdc2 and Tp53; Alexa Fluor 546-dUTP for Eif-4c, Lig1, and Xrcc1; 
Molecular Probes Inc., Eugene, OR), 0.5 µg of each product was nick translated using the 
Nick Translation System from Life Technologies (Rockville, MD).  A master mixture 
containing all of the fluorescently labeled genes was prepared and then divided equally, 
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Table 2.2.1. Primers used to amplify cDNA clones for the gene-specific hybridization experiments.        
                     
                     
                     
Gene 





Primers (5'      3') 
  
Estimated amplicon size (bp) 
                      
                Expected    Actual 
                      
Cdc2   Cell division cycle 2   763260   TTTGGAATACCGATACGAGT   470   450 
            CGACCAGCAGACAGGGACAT         
                      
Eif-4c   Elongation initiation factor 4C   959700   AAGAAGTCTGAAGGCCTATG   150   150 
            CAGAGAACTTGGAATGTAGC         
                      
Lig1   Ligase I   605700   ATGCAAGCTGGGAACTGGATT   250   230 
            TGAACCGAGGAAAACGAAGAG         
                      
Tp53   Tumor suppressor protein 53   464741   AAGTGAAGCCCTCCGAGTGT   150   150 
            CCATAGTTGCCCTGGTAAGT         
                      
Xrcc1   X-ray repair complementing defective repair   1022963   GACTGTCACCACATGCGGCG   350   300 
            GGCTGCCTTTGTTCCCTCTG         
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such that each slide was hybridized with ~10 ng of labeled DNA per gene.  The labeled 
probes were co-purified on Qiagen columns (Qiagen, Inc.) and ethanol precipitated. 
Tissue sample (complex) probes were generated by synthesizing first strand 
cDNA from 25-50 µg of adult mouse testis or brain total RNA (Clontech, Inc., Palo Alto, 
CA).  Specifically, testis and brain total RNA were reverse transcribed at 42ºC using an 
oligo-dT primer in the presence of Superscript II reverse transcriptase (Life 
Technologies).  Testis and brain cDNA were labeled during the reverse transcription 
reaction by incorporation of Alexa Fluor 488-dUTPs and Alexa Fluor 546-dUTPs 
(Molecular Probes, Inc.), respectively.  The labeled probes were co-purified on Qiagen 
columns (Qiagen, Inc.) and ethanol precipitated. 
 
Hybridization 
To prevent non-specific probe binding (and thereby reduce background intensity), 
slides were blocked prior to hybridization with ammonium hydroxide (Sigma, St. Louis, 
MO) or tryptone (Difco Laboratories, Detroit, MI).  Slides blocked with ammonium 
hydroxide were incubated at room temperature in 1% NH4OH in water for 10 min., 
washed 3 x 10 min. in double distilled water, and air-dried.  To block with 0.25% or 
0.50% tryptone in water, the slides were submerged in the solution and agitated at 100 
rpm for 1 hour and then immediately denatured.  Regardless of the blocking procedure 
used, slides were denatured for 6 minutes in 70% formamide / 2xSSC / water at 78ºC, 
passed through a 70% / 85% / 100% ethanol series, and air-dried.  An in situ frame 
(Eppendorf, Westbury, NY) was affixed to the slide in order to confine the probe mixture 
over the arrayed area. 
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Table 2.2.2. Experimental design for the gene-specific and tissue sample hybridizations. 
              
Hybridization 





Slide blocking reagent 
              
Gene-specific             
    50 ng   Commercialb   1% NH4OHb 
              
    50 ng   LLNL   1% NH4OH 
              
    50 ng   LLNL   0.50% Tryptone 
              
    50 ng   LLNL   0.25% Tryptone 
              
              
Tissue sample             
    50 µgb   Commercialb   1% NH4OHb 
              
    25 µg   Commercialb   1% NH4OH 
              
    50 µg   LLNL   0.50% Tryptone 
              
    25 µg   LLNL   0.25% Tryptone 
              
              
aGene-specific hybridizations: total quantity of DNA probe; Tissue sample hybridizations: quantity of total  
RNA used for probe generation 
              




The specific combination of probe quantity, hybridization buffer, and slide 
blocking procedure used for each hybridization is shown in Table 2.2.2.  For the gene-
specific hybridizations, each slide was hybridized with 15 µl of probe mixture (10 µl 
hybridization buffer + 1 µl herring sperm DNA + 4 µl labeled probe resuspended in 
double distilled water).  For the tissue-specific hybridizations, each slide was also 
hybridized with 15 µl of probe mixture; however, the detergent SDS was added to 
promote probe movement across the array, and poly (A)+ (Amersham Pharmacia 
Biotech) as well as cot-1 mouse DNA (Life Technologies) were added to increase 
hybridization specificity.  Both hybridization buffers contained formamide and were 
either commercially obtained (Vysis, Inc., Downers Grove, IL) or made at LLNL.  The 
LLNL hybridization buffer was prepared by incubating 4.2 ml of formamide, 1.05 ml of 
20 x SSC, and 1 g of dextran sulfate overnight at 65ºC. Following incubation, water was 
added to bring the hybridization buffer volume to 7 ml.  Probes prepared with the LLNL 
hybridization buffer had a pH = 7.0 and a final concentration of 42% formamide, 2 x 
SSC, and 10% dextran sulfate. 
All hybridization mixtures were denatured at 78°C for 6 min. and snap-cooled on 
ice.  Slides were hybridized for 12 hours in a gently rocking moist chamber at 37°C and 
washed 2 x 2 min. in 42°C water.  Prior to image capture, Vectashield mounting media 






Image capture and analysis 
 Image capture and processing was performed as described by Kegelmeyer et al. 
(2001).  Briefly, images were acquired with a full-field white light imaging system.  
Arrays were exposed to bandpass-filtered excitation light from a Xenon arc lamp.  The 
resulting emitted light was bandpass-filtered and collected by a scientific-grade CCD 
camera.  All images used for the gene-specific experiments were captured using 
comparable integration time and gain settings.  This was also true for the set of tissue 
sample experiments.  Custom algorithms, built within SCIL-Image (Delft, The 
Netherlands), corrected for CCD dark noise, spectral cross-talk, misaligned images and 
integration time variation.  Additional processing algorithms determined the 
“segmentation mask” for each cDNA spot.  The red and green intensities for all spots 
were computed by taking the median of all pixels within the segmentation mask that were 
greater than zero after background subtraction.  Spots covered by debris were eliminated 




Effects of hybridization buffer and slide blocking procedure on signal intensity for gene-
specific (simple probe) hybridizations 
 Five genes, labeled with either Alexa Fluor 488 or Alexa Fluor 546, were co-
hybridized to the 72 gene microarray to evaluate the effects of hybridization buffer and 
slide blocking on the background-subtracted median signal intensities.  Figure 2.2.1 
shows the median background-subtracted signal intensities (± standard error for all target 
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Figure 2.2.1.  Effect of hybridization buffer and slide blocking protocol on background-subtracted microarray signal intensities 
obtained for the gene-specific probes.  The x-axis represents the genes selected for co-hybridization to the cDNA microarray.  
Cdc2 and Tp53 were labeled with Alexa Fluor 488.  Eif-4c, Lig1, and Xrcc1 were labeled with Alexa Fluor 546.  The y-axis 
represents the median background subtracted signal intensity.  Each column represents a different combination of hybridization 
buffer and slide blocking protocol: black – commercial fluorescent probe hybridization buffer and 1% ammonium hydroxide 
blocking reagent; dark gray – LLNL hybridization buffer and 1% ammonium hydroxide blocking reagent; light gray – LLNL 
hybridization buffer and 0.50% tryptone blocking reagent; and white - LLNL hybridization buffer and 0.25% tryptone blocking 

































spots representing the gene of interest) obtained from each hybridization buffer and slide 
blocking combination listed in Table 2.2.2.  The sum of the median intensities (calculated 
as all Alexa Fluor 488 probe intensities + all Alexa Fluor 546 probe intensities per 
hybridization condition) for the commercial buffer / 1% NH4OH, LLNL buffer / 1% 
NH4OH, LLNL buffer / 0.50% tryptone, and LLNL buffer / 0.25% tryptone hybridization 
conditions were approximately 375, 572, 601, and 817, respectively.  Based on the 
average intensity values (average Alexa Fluor 488 vs. average Alexa Fluor 546) within 
each set of hybridization conditions, probes labeled with Alex Fluor 488 had 3.8 to 6.6-
fold higher intensities than those labeled with Alexa Fluor 546. 
 To further compare the effects of hybridization buffer and slide blocking protocol 
on signal intensity, the percent increases in signal intensities, obtained after using 
different hybridization methods, were calculated (Table 2.2.3).  The results showed that, 
irrespective of the blocking reagent utilized, the LLNL hybridization buffer yielded 
signal intensities that were ~41 to 275% higher than those obtained using the commercial 
hybridization buffer.  Next, the effect of slide blocking reagent on signal intensity was 
determined for all slides hybridized using the LLNL buffer.  From these comparisons, it  
was determined that the 0.50% tryptone and 1% NH4OH reagents gave similar results and 
that use of the 0.25% tryptone blocking reagent resulted in signal intensities that were up 
to ~45% higher than those from 0.50% tryptone-blocked slides and up to ~68% higher 
than those from 1% NH4OH-blocked slides.  Furthermore, signal intensities for both of 
the LLNL buffer/tryptone combinations ranged from ~51 to 250% higher than those 
obtained using the commercial buffer / 1% NH4OH hybridization procedure, with the 
exception of Xrcc1.  
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Table 2.2.3. Comparison of background-subtracted signal intensities obtained from gene-specific hybridizations using different combinations of  
                          hybridization buffer and slide blocking reagent.                 
                          




Effect of hybridization bufferb 
  
Effect of slide blocking reagentc 
  
Combined effect of hybridization buffer and slide 
blocking reagent 
    
LLNL vs. Commercial  
  
0.50% tryptone 
vs. 1% NH4OH   
0.25% tryptone 
vs. 1% NH4OH   
0.25% tryptone vs. 
0.50% tryptone   
(LLNL & 0.50% tryptone) vs. 
(Commercial & 1% NH4OH)   
(LLNL & 0.25% tryptone) vs. 
(Commercial & 1% NH4OH) 
                          
Cdc2   41.3   21.4   67.9   38.3   71.5   137.2 
                          
Eif-4c   60.8   NId   20.7   28.8   50.7   94.1 
                          
Lig1   275.4   NId   NId   NId   250.0   204.3 
                          
Tp53   84.0   NId   40.7   45.2   78.3   159.0 
                          
Xrcc1   NId   NId   32.4   41.5   NId   NId 
                          
                          
aPercent increase in the background subtracted signal intensity for condition 1 when compared to condition 2. For example, the signal intensity for Cdc2 increased by 41.3% when 
the LLNL hybridization buffer was used instead of the commercial hybridization buffer. 
 
bSlide blocking reagent: 1% NH4OH                     
                          
cLLNL hybridization buffer. See Materials and Methods for details.                 
                          
dNI = no increase in signal intensity was observed                 
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Effects of probe quantity, hybridization buffer, and slide blocking procedure on signal 
intensity for tissue sample (complex probe) hybridizations 
Mouse tissue samples were labeled with either Alexa Fluor 488 (testis) or Alexa 
Fluor 546 (brain) and co-hybridized to the 53 gene microarray in order to evaluate the 
combined effects of probe quantity, hybridization buffer, and slide blocking protocol on 
the background-subtracted median signal intensities for complex probe hybridizations.  
As shown in Panel A of Figure 2.2.2, probe quantities of 25 µg tended to yield higher 
Alexa Fluor 488 intensities, regardless of the hybridization buffer and slide blocking 
reagent utilized.  However, the same trend was not observed for the Alexa Fluor 546 
labeled probes (Panel B) which generally had the highest intensities when 25 µg of probe 
was hybridized using the LLNL buffer to microarray slides blocked with 0.25% tryptone.  
The remaining three probe quantity / hybridization buffer / slide blocking reagent 
combinations had similar (lower) signal intensities. 
 As shown in Table 2.2.4, the maximum signal intensities obtained for Alexa Fluor 
488 probes ranged from 50.3 for the 50µg / commercial buffer / 1% NH4OH 
hybridization to 237.0 for the 25 µg / LLNL buffer / 0.25% tryptone hybridization.  
Minimum signal intensities, however, were similar across all procedures (range: 9.0 to 
15.5).  In general, hybridizations using 25 µg of probe had higher intensities than the 50 
µg probe hybridizations.  The highest and lowest average signal intensities were observed 
for the 25 µg / commercial buffer / 1% NH4OH hybridization (40.9) and the 50 µg / 
LLNL buffer / 0.50% tryptone hybridization (14.2), respectively.  In fact, the 25 µg / 
commercial buffer / 1% NH4OH protocol had even the highest signal intensity at the 75th 




































Figure 2.2.2.  Distribution of background-
subtracted median signal intensities obtained for 
tissue sample hybridizations performed under 
different conditions. The x-axis represents the 
number of genes evaluated.  The y-axis 
represents the median background subtracted 
signal intensity.  The combinations of probe 
quantity, hybridization buffer, and slide 
blocking protocol are represented as follows: 
blue diamond – 50 µg probe / commercial 
buffer / 1% NH4OH blocking reagent; green 
square – 25 µg probe / commercial buffer / 1% 
NH4OH blocking reagent; yellow triangle – 50 
µg probe / LLNL buffer / 0.25% tryptone 
blocking reagent; and red circle – 25 µg probe / 
LLNL buffer / 0.25% tryptone blocking reagent.  
A.) Distribution of Alexa Fluor 488 intensities.  
B.) Distribution of Alexa Fluor 546 intensities. 
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Table 2.2.4. Characterization of the signal intensities obtained for each Alexa Fluor  
                  
following different tissue sample hybridization protocols.       
                  
    
    Signal intensity distributions 
        
  
  
50 µg / 
commercial / 
NH4OHa   




50 µg / 
LLNL / 
0.50% 
tryptonea   




                  
                  
Alexa Fluor 488                 
                  
Percentile                 
Minimum   10.0   15.5   9.0   14.0 
25th   13.5   19.0   10.5   16.0 
50th   15.0   26.0   12.0   19.0 
75th   20.4   45.8   16.0   27.0 
Maximum   50.3   162.5   39.0   237.0 
                  
Average   19.0   40.9   14.2   27.3 
                  
                  
Alexa Fluor 546                 
                  
Percentile                 
Minimum   6.0   6.0   6.5   11.0 
25th   7.5   9.0   9.0   15.0 
50th   10.0   10.5   12.0   19.0 
75th   14.0   13.5   16.5   33.9 
Maximum   54.0   72.0   136.0   418.0 
                  
Average   12.3   14.3   17.6   36.9 
                  
                  
aProbe quantity / hybridization buffer / slide blocking procedure  
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ranged from 54.0 for the 50µg / commercial buffer / 1% NH4OH hybridization to 418.0 
for the 25 µg / LLNL buffer / 0.25% tryptone hybridization.  The minimum signal 
intensity for the 25 µg / LLNL buffer / 0.25% tryptone hybridization was slightly higher 
(11.0) than the other procedures which resulted in minimum intensities of ~6.0.  The 
highest and lowest average signal intensities were observed for the 25 µg / LLNL buffer / 
0.25% tryptone hybridization (36.9) and the 50µg / commercial buffer / 1% NH4OH 
hybridization (12.3), respectively.  At the 75th percentile, the 25 µg / LLNL buffer / 
0.25% tryptone hybridization had 2.1 to 2.5-fold higher signal intensities compared to the 
other three hybridization protocols. 
Median background-subtracted signal intensities obtained from the different 
hybridization protocols were also evaluated by determining the number of genes with 
signal intensities ≥ 1.5 times the average negative control intensity (Table 2.2.5).  The 
negative control intensities obtained for the Alexa Fluor 546 probes ranged from a low of 
9.5 to a high of 14.1 (data not shown).  The negative control intensities obtained for the 
Alexa Fluor 488 probes were slightly higher and ranged from 10.1 to 18.5 (data not 
shown).  Among the probes labeled with Alexa Fluor 488, the hybridization of 25 µg of 
probe with the commercial buffer to 1% NH4OH-blocked slides resulted in the largest 
number of genes with intensities at least 1.5 times the average negative control intensity 
(25 genes ≥ 1.5; 12 genes ≥ 3.0).  Increasing the probe quantity for this procedure to 50 
µg, however, resulted in the lowest number of genes with signal intensity ratios that were 
at least 1.5 (14 genes ≥ 1.5; 2 genes ≥ 3.0).  Among the Alexa Fluor 546 labeled probes, 
microarrays blocked with 0.25% tryptone and hybridized using 25 µg of probe in the 
LLNL buffer had the highest number of genes with intensities ≥1.5 
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Table 2.2.5. Relationship between the tissue sample hybridization protocol utilized and the  
                  number of genes with signal intensity ratios ≥ 1.5.a 
                  
    Number of genes 
                  
        Signal Intensity Ratio 
  
50 µg / 
Commercial / 
NH4OHb   
25 µg / 
Commercial / 
NH4OH   
50 µg / LLNL 
/ Tryptone 
  
25 µg / LLNL 
/ Tryptone 
                  
Alexa Fluor 488                 
≥ 1.5   14   25   16   16 
≥ 2.0   9   20   6   9 
≥ 2.5   3   14   4   5 
≥ 3.0   2   12   3   3 
                  
Alexa Fluor 546                 
≥ 1.5   13   11   19   23 
≥ 2.0   5   7   9   21 
≥ 2.5   4   5   5   13 
≥ 3.0   2   3   4   11 
                  
Alexa Fluor 488 & 
Alexa Fluor 546                 
≥ 1.5   21   27   21   25 
≥ 2.0   13   22   10   22 
≥ 2.5   6   15   5   13 
≥ 3.0   3   13   4   11 
                  
                  
aCalculated for each gene as: (average gene intensity)/(average negative control intensity)  
                  
bProbe quantity / hybridization buffer / slide blocking procedure  
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times the average negative control intensity (23 genes ≥ 1.5; 11 genes ≥ 3.0), while 
probes hybridized using the commercial buffer and 1% NH4OH blocking reagent had the 
lowest number of genes (11-13 genes ≥ 1.5 and 2-3 genes ≥ 3.0).  When both Alexa 
Fluors were considered together, the number of genes with signal intensity ratios ≥ 1.5 
but less than 2.0 was similar across all procedures (21-27 genes).  However, slides 
hybridized with 25µg of probe, irrespective of the hybridization buffer and blocking 
procedure, had a 2.8 to 4.3-fold increase (over slides hybridized with 50µg of probe) in 




The results of the gene-specific and tissue sample hybridizations show that probe 
quantity, hybridization buffer, and slide blocking procedures all affect background-
subtracted signal intensities, and therefore may also affect accurate microarray expression 
ratio quantitation, especially for genes with low hybridization signal intensities. 
 
Gene-specific probe hybridizations 
 Gene-specific hybridizations were performed to determine the effects of 
hybridization buffer and microarray slide blocking procedure on background-subtracted 
signal intensities.  These simple probes were ideal for comparing the intensities obtained 
for specific genes following different hybridization procedures because the amplicons 
(which do not degrade as readily as the tissue RNA used as the starting material for tissue 
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sample hybridizations) can be simultaneously labeled, combined, and then aliquoted from 
a single master mix for each hybridization.   
 Irrespective of the set of hybridization conditions utilized, Alexa Fluor 546 
intensities were always lower than the Alexa Fluor 488 intensities.  Therefore, these 
differences are most likely the result of intrinsic differences between the fluorophores 
and/or differences between the filter sets used for image capture.  When considering total 
intensities, however, the LLNL buffer / 0.25% tryptone procedure yielded ~2.2-fold 
higher intensity than the method that had been traditionally used in our laboratory 
(commercial buffer/ammonium hydroxide).  In fact, microarray slides hybridized using 
the LLNL hybridization buffer and blocked with 0.25% tryptone generally had the 
highest signal intensities, followed by LLNL buffer / 0.50% tryptone and LLNL buffer / 
1% NH4OH which behaved similarly.  With the exception of the signal detected for 
Xrcc1, the commercial buffer / 1% NH4OH combination gave the lowest background-
subtracted signal intensities.  Overall, the LLNL buffer / 0.25% tryptone protocol 
increased signal intensity ~94% to 204% compared to the signal intensities obtained for 
the commercial buffer / 1% NH4OH protocol previously used in our laboratory. 
 
Tissue sample probe hybridizations 
 Tissue sample hybridizations were performed to determine the combined effects 
of probe quantity, hybridization buffer, and microarray slide blocking procedure on 
background-subtracted signal intensities.  The hybridization conditions traditionally used 
in our laboratory (50 µg probe / commercial buffer / 1% NH4OH) were compared to 
those which used 1/2 the probe quantity and/or a different buffer and blocking reagent.  
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The results showed that decreasing probe quantities only increased the background-
subtracted signal intensities for particular fluorophores.  Unlike the trend toward 
increased signal intensity which was observed for lower quantities of the Alexa Fluor 488 
probe, there were no notable differences in intensities based on the Alexa Fluor 546 
probe quantity alone.  This may suggest that the lower probe amounts resulted in reduced 
background for the Alexa Fluor 488 images (which would increase the magnitude of the 
background-subtracted signal intensity).  A similar effect was probably not observed for 
the Alexa Fluor 546 probes because the background for these images was substantially 
lower than that for the Alexa Fluor 488 images.  Between the two protocols which used 
25 µg of probe, the commercial buffer / ammonium hydroxide combination resulted in 
the highest number of genes with Alexa Fluor 488 signal intensities that were at least 1.5 
times greater than negative control intensities, whereas the LLNL buffer / 0.25% tryptone 
combination resulted in the highest number of genes with Alexa Fluor 546 signal 
intensities that were at least 1.5 times greater than negative control intensities.  However, 
when the results for both Alexa Fluors were considered together, the total number of 
genes with signal intensity ratios of at least 1.5 was similar between the hybridization 
procedures.  This suggests that, like probe quantity, the combination of hybridization 
buffer and slide blocking procedure also affects signal intensity in a fluorophore-
dependent manner.  With respect to the results for Alexa Fluor 488, it is possible that 
ammonium hydroxide is superior to tryptone in masking the autofluorescence of the 
silane-coated microarray.  For Alexa Fluor 546, which tends to have much lower 
background, the LLNL buffer / 0.25% tryptone combination may produce larger signal 
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 Hybridization conditions for the cDNA microarray experiments performed in our 
laboratory previously involved using commercially prepared hybridization buffers to 
hybridize large probe quantities (≥ 50 µg) to slides blocked with ammonium hydroxide.  
The results for both the gene-specific hybridizations (irrespective of fluorophore) and the 
Alexa Fluor 546-labeled tissue sample hybridizations indicated that the largest signal 
intensities were obtained when the LLNL buffer was used in combination with the 0.25% 
tryptone blocking reagent.  However, experience with multiple microarray hybridizations 
has shown that for the white light capture system used in our laboratory, images for the 
Alexa Fluor 546 probes are normally captured using longer integration times and higher 
camera gain settings than those used for the Alexa Fluor 488 probes.  This indicates that 
the Alexa Fluor 546 signal intensities are inherently lower than the Alexa Fluor 488 
intensities.  Because these research findings suggest that microarray experiments 
visualized with this white light image capture system may show improved signal 
intensities by hybridizing lower probe quantities (~ 25 µg) with the in-house 
hybridization buffer (LLNL; 42% formamide / 2 x SSC / 10% dextran sulfate), to 0.25% 
tryptone-blocked slides, this protocol was utilized in our subsequent cDNA microarray 
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2.3 Accurate quantitation of fluorescence microarrays 
 
2.3.1 Abstract 
To more accurately measure fluorescent signals from microarrays, our image 
acquisition and analysis systems were calibrated using groundtruth samples comprised of 
known quantities of gene-specific DNA probes that were labeled with Cy3 and/or FITC 
and hybridized to cDNA targets.  Slides were imaged with a full-field, white light CCD 
imager and analyzed using custom analysis software.  The results obtained with and 
without preprocessing (alignment, color crosstalk compensation, dark field subtraction, 
and integration time) were compared for multiple genes. The accuracy of various image 
processing and analysis techniques (background subtraction, segmentation, quantitation 
and normalization) was also evaluated. This methodology was used to calibrate and 
validate our system for accurate, quantitative measurement of microarrays. The results 
show that preprocessing the images resulted in measurements that were substantially 




Expression microarrays provide a means for monitoring the expression of many 
genes in parallel. Therefore, this technology can provide in-depth understanding of 
biological processes such as DNA repair, cellular differentiation, and development.  
Careful target selection is essential for utilizing custom-built cDNA microarrays to 
address pathway-specific topics. These targets must not only represent the potentially 
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interesting and relevant genes but also minimize sequence homology (and thus cross-
hybridization) among spots. Since subtle differences in gene expression measurements 
can have a large impact on the interpretation of biological data, specificity and 
measurement accuracy are especially important. 
There are many ways to perform the image processing and analysis steps needed 
to derive quantitative information from a microarray image (Brown et al. 2000; Chen et 
al. 1997; Pie’tu et al. 1996). We evaluated a number of different methods for processing 
and analyzing images and showed the effects of preprocessing on quantitation. 
Segmentation, quantitation, background subtraction, preprocessing, and normalization 
were defined as follows: 
 
• Segmentation delineated the extent of each spot, and thus distinguished spots 
from surrounding background. 
 
• Quantitation involved measuring intensities within the spot boundaries 
determined by segmentation. 
 
• Background subtraction was used to remove the effects of autofluorescence 
and other effects that are not due to specific fluorescent hybridization. 
 
• Preprocessing involved characterizing and accounting for the acquisition 
system parameters such as camera dark field, spectral crosstalk, image 
alignment, integration time and camera gain. 
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• Normalization made the measurements from the 2 color channels (e.g. red and 
green) commensurable so they could be sensibly compared or arithmetically 
manipulated relative to one another. It also enabled slide-to-slide 
comparisons. 
 
Each of these processes has optional techniques and implementations. Not only 
are there a number of different possible algorithms for each step, but the optimal 
combinations may also differ from system to system. We used groundtruth to determine 
which techniques and combination of the above options were optimal for correlating 
computed intensities with known probe amounts for our system. However, this 
methodology can be used to calibrate any acquisition and analysis system in order to 
improve measurement accuracy. 
 
 
2.3.3 Materials and Methods 
Generation of amino modified clones 
Expressed sequence tag (EST) clones were obtained from LLNL's I.M.A.G.E. 
Consortium and used as the target cDNA for the microarrays. PCR with sequence-
specific primers verified that each clone represented the correct gene. Two ESTs with an 
insert size ranging from 500 to 1500 base pairs were selected to represent each gene. 
Prior to spotting, inserts from the selected clones were PCR amplified from plasmid 
preparations using 5' C6 amino-modified, vector-specific primers and purified using 
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Qiagen PCR purification columns (Qiagen Inc., Chatsworth, CA). The amplicons were 
precipitated and resuspended for spotting in 0.1M Sodium Carbonate/Bicarbonate 
(pH=10.2) to a final concentration of 2µg/µl. 
 
Slide preparation 
Slides were derivatized according to Guo et al. (1994). Briefly, glass slides were 
coated with 1% 3-aminopropyltrimethoxysilane [Sigma, St. Louis, MO] in 95% 
acetone/water for 2 min., washed 10 times in acetone, and baked at 110°C for 45 min. 
Prior to spotting, the silane was activated by incubating the slides for 2 hours in 0.2% 
1,4-phenylenediisithiocyanate [Sigma, St. Louis, MO], 10% pyridine [Sigma, St. Louis, 
MO] and dimethylformamide [Aldrich, Milwaukee, WI]. Slides were then washed in 
methanol (2x 10 min.) and acetone (2x 10 min.). Slides were air dried and used 




A custom robotic high speed arrayer was used to grid cDNA onto glass 
microscope slides. The gridding system had a 3-axis DC servo driven gantry (GM2340R, 
Glentek, El Segundo, CA). The full travel of the Z-axis was 0.25m with 5µm resolution 
and of the X-and Y-axis (powered by Newport-Klinger MD4 servo motor driver), 2m and 
1m, respectively, with 20µm resolution each. The system controller was a Newport-
KlingerMM2000 card with 3DC modules in an Intel 80486 PC. The spotting tool had 2 
Beryllium-Copper plated pins with a spacing of 4.5mm. The grid density was 4.5 x 4.5 
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mm for each of 2 pins with a center to center spacing of 375 µm. After spotting, the 
slides were humidified in a 37°C incubator for 5 minutes, air dried and stored under 
vacuum at room temperature until hybridization. 
 
Probe labeling 
To create groundtruth over a series of 10 slides, 10 probe mixtures were made 
using clones for the following genes: Globin, Dna-pkcs, Tp53, Rad50, Rad52, and Ku80. 
Each mixture contained both Cy3 and FITC labeled probes for each of the above genes. 
The ratio of the FITC and Cy3 probe amounts shown were expected to correlate with the 
subsequent ratio of intensity measurements.  Globin and Dna-pkcs probes had equal 
proportions across all slides to serve as controls (each was expected to yield a Cy3/FITC 
ratio of 1). Globin was used for normalization. For each of the remaining four genes, the 
probe amount for one dye was held constant while the probe amount for the other dye 
varied, forming a dilution series as shown in Table 2.3.1. Each mixture was hybridized to 
one slide. 
Probes were generated by PCR amplification of the same I.M.A.G.E. clones that 
were spotted onto the array using gene-specific primers. A spectrophotometer was used 
to measure the quantity of each probe. The probe labeling was performed by mixing 
serial dilutions for each gene together per color and afterwards replacing dCTP by Cy3-
dCTP (Amersham Pharmacia Biotech, Piscataway, NJ) or dUTP by FITC-dUTP (dUTP 
(Roche, Indianapolis, IN) using a Nick Translation kit (Life Technologies, Rockville, 
MD) which incorporated labeled nucleotides by using the enzyme DNase I to “nick” the 
DNA and DNA polymerase to replace the excised nucleotides with a mixture of  
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aArrows represent the serial change in the probe amount across the 10 slides. 
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unconjugated and fluorescently-conjugated nucleotides. The Cy3 and FITC labeled probe 




To block non-specific probe binding, slides were incubated for 10 min. in 1% 
NH4OH (Sigma, St. Louis, MO) and washed 3 x 10 minutes in double distilled water 
prior to hybridization. Slides were then denatured for 6 minutes in 70% 
Formamide/2xSSC at 78°C, dehydrated through a 70- 85-100% ethanol series, and air 
dried at room temperature. The probe mixtures hybridized to each slide had similar total 
concentrations. Labeled probes were concentrated using speed vacuum centrifugation and 
resuspended in 5-10 µl hybridization mix containing 70% formamide, 2x SSC, 10% 
dextran sulfate and 1 µl herring DNA. The hybridization mixtures were placed on the 
microarray under a 22x22 mm coverslip, sealed with rubber cement, and denatured at 
72°C for 3 minutes. Hybridization was performed for 24 hours at 37°C in a moist 
chamber, followed by 2 x 10 minute washes at 37°C in 2xSSC. Vectashield mounting 
media (Vector Laboratories Inc., Burlingame, CA) was used to prevent photobleaching of 
the fluorescent dyes.  
 
Image acquisition 
Fluorescent microarray images were acquired with a full-field (15 mm square; 
resolution = 0.015mm/pixel),white light imaging system (Norgren Associates, Palo Alto, 
CA). Light from a 500 watt Xenon light source (400 nm - 600 nm) was scrambled 
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through a fiber optic and passed through a bandpass excitation/emission filter pair before 
reaching a scientific grade CCD camera. The camera was controlled via a PC with a 
MATROX PULSAR digital acquisition and display board. Images were collected onto 
the PC and then transferred to a Unix workstation for analysis. This system was modified 
by adding a second light source (a mercury arc lamp) for UV excitation. The UV 
wavelength allowed the excitation of the nucleic acid stain DAPI (4',6-Diamidino-2-
phenylindole) which assisted in segmentation by delineating all spots, including those 
with weak or absent hybridization signals. 
 
Image analysis 
Custom software was written within the SCIL-Image development platform 
(TNO/TPD, Delft, The Netherlands) for preprocessing, automated background 
subtraction, grid detection, spot detection and quantitation. Custom Perl scripts were used 
to ratio, normalize, summarize and plot data resulting from the image analysis. 
 
 
2.3.4 Image Processing and Analysis Methods 
Preprocessing 
To calibrate the acquisition system, inherent system response characteristics were 
measured and corrected or accounted for in the analysis. For example, all CCD cameras 
have thermal noise even when no light is incident on the CCD. Dark noise, which is noise 
from all sources except photons, was measured and then subtracted from the images 
(Mullikin et al. 1994). Additionally, because the filters in the system do not have perfect 
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bandpass cutoffs and light through the filters is not always parallel, spectral crosstalk 
(FITC signal leaking into the Cy3 channel and vice versa) occurs. All systems should 
also measure and correct for this (Castleman et al. 1996). Image misalignment was also 
corrected, via correlation methods, during preprocessing. Misalignment occurs whenever 
there is a physical shift of the microarray slide between capturing images with different 
filters. Lastly, we corrected for integration time differences between the FITC and Cy3 
images. Although it is feasible to leave this correction until normalization, it is prudent to 
correct for known disparities in a straightforward manner. Then, the factors remaining to 
be corrected by normalization are those for which reliable characterization is not 
available. 
Problems associated with two of the system response characteristics, camera gain 
and non-uniform illumination, were ameliorated even though they are difficult to correct. 
The camera gain is non-linear at higher settings, so gain was held constant during 
acquisition for all images in the same experiment. Non-uniform illumination was difficult 
to correct because of wavelength dependencies (chromatic aberration) and variation of 
the light source over time; therefore, the illumination pattern was optimized for 
uniformity as much as possible during acquisition and was not corrected computationally. 
 
Background subtraction 
Quantitative information was extracted from hybridization signals following 
preprocessing. First, background subtraction was performed in order to account for the 
various sources of fluorescent background, such as autofluorescence inherent to the glass 
slide or other substrate, autofluorescence of the antifade, and the non-specific binding of 
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fluorescent probe to material in the area surrounding the target spots of the array. This 
procedure is different from camera dark field subtraction which accounts for parameters 
inherent to the camera. 
Informal investigations have shown that different substrates have varying levels 
of autofluorescence. For some systems, high quality, polished quartz, such as Corning 
brand slides had a lower contribution to background fluorescence than standard glass 
microscope slides. If background fluorescence was attributable to autofluorescence of the 
substrate, then there was a slowly varying background intensity under the array which 
served as a "DC offset" to the spot signals. (All spot intensities should be above this 
background.) In such a case, background subtraction was a logical and necessary step for 
accurate quantitation of spot signals. 
If background fluorescence was attributable to non-specific binding of the labeled 
probe, then the surrounding signal was only around the spots, because the target DNA 
spotted on the slide prevents the non-specific binding at the spots. In this case, the 
background could have higher intensity than the spots (Figure 2.3.1).  When background 
intensity is higher than target intensity, background subtraction is unwarranted because it 
would result in negatively valued spot intensities.  Therefore, images with this type of 
background were not quantitated and another array was hybridized after applying an 
appropriate blocking procedure to prevent non-specific probe binding. Alternatively, 
spots could be compared to the negative controls (spots that had no probe hybridization) 
to get a relative sense of their brightness, but accurate ratios may be hard to obtain, since 







Figure 2.3.1.  A contrast-enhanced example of a fluorescence microarray image with 
very high background.  The bright white spots indicate hybridized cDNA targets.  Many 
target cDNA spots were not hybridized and appeared darker than the surrounding 
background (as indicated by the black spots within the white background above).  
Therefore, the high background was not additive to the spot intensities, and the 
background intensities should not be subtracted from the target spots.
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After determining which manner of background subtraction was most appropriate 
for a given image, we selected from a number of methods to perform the task (sampling 
pixel intensities near the extremes of the image, sampling just outside of spots, etc.). The 
background subtraction method we employed was an adaptive, non-linear technique 
which continuously sampled the background and created a 2-dimensional, slowly 
changing "sheet" or blanket that followed the low frequency trend of intensity outside of 
the spots. This method, called the lower envelope subtraction (Verbeek, et al. 1988), 
lowered the signal intensities relative to a base value near zero (Figure 2.3.2). 
 
Semi-automated grid placement 
To detect spots with shape and location anomalies, a semi-automated grid 
placement algorithm was utilized which requires an operator to indicate the extent of the 
array and the number of spots present. With this information, the system divided the area 
into self-adjusted, not necessarily uniformly sized, grid squares and each square 
contained one spot.  
 
Three-color segmentation 
Once a grid was overlaid on the array, segmentation methods were used to 
determine which pixels inside a grid square belonged to the spot under investigation and 
which belonged to the background. As expected, segmentation was more difficult for dim 
or non-expressing spots than for bright spots.  To address this problem, a third image of 
the array was acquired after ratio data was obtained for the first two images (Cy3 and 






Figure 2.3.2.  Removal of underlying autofluorescence and subsequent lowering of target spot intensities through background 
subtraction.  The gray-scale microarray images of target spots (right) represent a row of hybridized spots before (top image) and after 
(bottom image) background subtraction.  The graph (left) plots position within the image (x-axis) vs intensity for the corresponding 
position in the image (y-axis). Intensity measurements were made using a six pixel wide horizontal line through the image.  
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slide to mark the location of all DNA target spots. The presence of DAPI stain removed 
any ambiguity about the presence of a valid target DNA when no expression signal was 
observed. It also allowed better determination of the size and shape of the DNA target for 
segmentation.  However, DAPI was not always present in spots with a strong 
hybridization signal. (It is possible that the hybridization of the labeled probes changed 
the properties of the DNA molecule and prevented intercalation of the counterstain.) 
Therefore, images from all 3 dyes (Cy3, FITC, and DAPI) were superimposed and 
aligned in order to obtain the best signal from each spot. This resulting composite image 
was subsequently used for segmentation. 
 
Methods for spot segmentation 
When microarray target spots appear to be very dim, "bagel-shaped", or have 
other irregularities in the absence of counterstain such as DAPI, different segmentation 
methods define different spot areas which in turn affects the intensity measurement.  As 









Figure 2.3.3. Contours of hybridized target spots delineated by different segmentation 
methods.  From left to right these segmentation methods are:  Circle Hough transform, 
Trian threshold, and Hulled Trian. Each of these segmetation methods were evaluated to 
determine which method resulted in ratios of computed intensities closest to the 
groundtruth (i.e., yielded the smallest average error for ratios of known probe quantities. 
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• Circle Hough Transform: Best fit circle was found using an edge detector to 
determine the edges of the spot and then determine their magnitude and 
direction. This information was used to determine the center of the circle that 
best fits the edge information (Verbeek et al. 1998) 
 
• Trian Threshold: An intensity-based histogram was drawn in a grid square 
containing one spot. The low-intensity peak of the histogram (which 
represents background values) was found and a line was fit to the falling slope 
on the right side, forming a triangle (hence the name trian) with the y-axis. 
The clipping level (intensity threshold) was set where this line crosses the x-
axis of the histogram (Ballard et al. 1981). 
 
• Circles + Trian: A logical OR statement was used to combine the results from 
the two methods above. 
 
• Hulled Trian: The morphological convex hull operation was applied to the 
result of the Trian Threshold. 
 
Methods for quantitation of signal intensity 
A number of methods could be used to compute the relative intensities of the red 
and green probe signal for a spot. The differences between the methods lie primarily in 
how well they accurately quantify the signal in the presence of noise or other artifacts. 
We implemented and evaluated a number of methods: 
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• Total Intensity. Summed the intensities of all of the pixels assigned to a spot, 
for each color, and then divided them to get the ratio: 
Σ ΣYi Xi
n n
i=1 i=1  
where Y was the FITC signal, X was the Cy3 signal, i was a pixel in the spot 
and n was the total number of pixels in the segmented region. 
 
• Median. Found the median pixel intensity in each color and took the ratio: 
            (Median of FITC pixel values)/(Median of Cy3 pixel values)  
This method was superior to the total (or averaging) method when there were 
noisy outliers (e.g. a few really bright or dim pixels). It also worked especially 
well when there was a similar number of low and high outliers. 
 
• Pixel-to-pixel mean and average ratios. Divided the intensities of a spot on a 
pixel:pixel basis. Then, calculated the mean or the median of the pixel:pixel 
ratios for the entire spot. This method assumed that the two wavelength 
images were perfectly aligned and that the spot shape was consistent in both 
colors. 
 
• Fit line. Since the pixel:pixel ratios within a spot can vary a lot, especially for 
bagel-shaped spots, another approach was to plot the pixel intensities in one 
wavelength versus another for each pixel and then fit a line to the resulting 
scatterplot. Each pixel was represented by a point on the scatterplot, with the x 
location its intensity in one wavelength and the y location its intensity in 
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another. The slope of the line that passed through the 0 y-intercept represented 
the final ratio. 
 
• Log geometric mean. The log geometric mean of the intensities in a spot is 
10 L, such that  






where Y represented the FITC signal, X represented the Cy3 signal, i 
represented one pixel in a spot and n was the number of pixels in the spot. 
 
Normalization 
Once an intensity ratio was determined for a particular spot, it had to be 
normalized to a standard in order to account for variations due to differences in exposure 
time, amount of target, amount of probe, dye incorporation, rate of photobleaching, 
hybridization conditions, imaging conditions, etc. Normalization was achieved by 
dividing all spot intensities on a slide by the average ratio of positive controls, which 
were spots designed to have the same intensity and ratio on all slides.  (Globin was 
hybridized using equal amounts of each color and served as the positive control for this 
groundtruth series.) When positive controls didn't have the expected ratio, we assumed 
the differences were due to the above variations, and we used the factor by which they 







In order to measure the effects of various analysis steps, we compared the 
computed intensity ratios against the known ratio of known probe quantities. As shown in 
Figure 2.3.4, the two were plotted such that the distance between the curves represented 
the error between measured and known quantities, with and without preprocessing. The 
curves were much closer together over a greater range of probe quantities with 
preprocessing. It was also possible to gauge the probe amounts at which the two curves 
diverge and to note that the computed intensity ratio was more accurate down to lower 
probe amounts following preprocessing. 
 
Error evaluation for various analysis methods and combinations 
In order to quantify the disparity among the curves for one gene, we calculated an 
error by summing the distance from measurement to the truth for all 10 dilutions in the 
series: 
      
Error = [ log(observed intensity ratio) - log(quantity ratio) ] 2Σ
10
n=1  
where intensity ratio was computed using results from one of the quantitation methods 
described earlier and the quantity ratio was computed using the known probe amounts. 
For the graphs in Figure 4, the error for quantitation type was 1.28 without preprocessing 
and 0.73 with preprocessing. These values are also shown in Table 2.3.2.  
Based on Table 2.3.2 error chart, preprocessing was most valuable when signal 
strength was low and when there was an intensity disparity between the two probe 




Figure 2.3.4.  The groundtruth (ratio of known probe amounts) for Rad52 was tracked among the 10 slides as shown by the (lower) 
green line.  The ratio of measured intensities is represented as the (upper) blue line.  The cumulative distance between these two lines 
provided an error measurement that enabled different methods to be applied and compared in a quantitative manner.
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aError was determined by measuring the cumulative distance between the truth (quantity ratio) and measured (observed intensity ratio) 
curves (e.g., Figure 2.3.4).
    Full preprocessing   No preprocessing, except alignment 
                          
    
Total 
intensity   Median   
Log 
geometric 
mean   
Total 




                          
Globin   0.05   0.07   0.07   4.34   0.07   0.07 
Dna-pkcs   0.33   0.36   0.35   0.27   0.29   0.29 
                          
Tp53   1.00   1.06   0.98   2.88   1.60   1.57 
Rad50   1.25   1.29   1.33   1.89   1.74   2.07 
Rad52   0.65   0.73   0.73   1.25   1.28   1.35 
Ku80   1.32   1.39   1.42   1.91   1.81   2.10 
                          
Tp53, Rad50, 
Rad52, and Ku80                         
Average error   1.06   1.12   1.12   1.98   1.61   1.77 




Dna-pkcs, did not benefit substantially from preprocessing. The other four genes, 
however, showed significantly larger improvements with preprocessing. This was 
primarily due to the color correction which accounted for spectral crosstalk by removing 
intensities from one color channel and adding them back to the appropriate color channel. 
For dim spot signals, this incremental change could be substantial, whereas bright spot 
signals were minimally affected. 
Also shown in Table 2.3.2 are the effects of utilizing different quantitation 
methods. As seen in the average error along the last row of the chart, the total intensity 
quantitation method could result in the lowest average error (1.06 with full 
preprocessing), but it could also give the highest average error (1.98 with no 
preprocessing, except alignment) when data was corrupted by debris or other noise. 
Therefore it was not a robust quantitation method. Instead, the median and the log 
geometric mean error values were more consistent with lower standard deviations and 
overall lower error than the total intensity method and all other methods evaluated (data 
not shown). 
Since all of the analyses used to generate the data for the chart were normalized 
via the Globin positive control spots, it stands to reason that the largest error occurred 
when the Globin control spot contained undetected debris, and the quantitative method of  
"total" included those values in the intensity measure for Globin (Table 2.3.2). Since that 
measurement was flawed, and since that value was subsequently used to normalize all of 
the gene intensity ratios, all computed ratios using that method were flawed.  
Just as these errors were generated for various combinations of preprocessing and 
quantitation parameters, similar values were generated for the other analysis steps. For 
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evaluation of background subtraction, we held constant the settings for preprocessing, 
segmentation, quantitation and normalization and only changed whether or not 
background was subtracted. For the genes of the dilution series, the average error 
improved from 1.41 to 1.12 when background was subtracted and the median or log 
geometric mean was used for quantitation. Further, almost all of the improvement was 
realized for the genes which had low probe amounts. As expected, the ratios for spots 
with strong intensity were least affected by background subtraction. 
 
2.3.6 Conclusions 
While there are numerous approaches to microarray analysis, accurate 
quantitation required system calibration. The methodology outlined in this paper can be 
used to calibrate any acquisition and analysis system and can be tailored and optimized 
for specific data and specific experiments for improved measurement accuracy. In order 
to calibrate and validate our system, we generated a dilution series with known quantities 
for the red and green hybridization probes. We used that groundtruth sample to evaluate 
the results of a number of computational techniques for preprocessing and analysis. 
Computed ratios were compared to the known groundtruth, and an error was calculated 
for each method. In order to obtain the least overall error for our groundtruth samples and 
our system, we found that: 
 
• preprocessing was superior to not preprocessing 
 





• spots were best segmented by combining a best circle fit with an intensity 
threshold 
 
• quantitation was most accurate when using the median or the log geometric 
mean 
 
• normalizing by a positive control was superior to not doing so. 
 
Preprocessing had the greatest impact on bringing the computed ratios closest to 
the groundtruth. For the gene with the lowest cumulative error across all analysis 
methods, Rad52, preprocessing enabled accurate quantitation of DNA probe to 0.05 ng 
(improved from a limit of 0.36 ng without preprocessing). Future efforts will establish 
whether this translates to the detectable amount for samples using cDNA or RNA probes 
and will also evaluate metrics for signal brightness and uniformity. 
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Differential Basal Expression of Genes Associated 
with Stress Response, Damage Control, and 




Tissues must be capable of efficiently recognizing and repairing various types of 
DNA damage in order to maintain genomic integrity and the overall health of an 
organism. However, differential DNA damage susceptibilities and cancer incidences have 
been observed among tissues, and the molecular mechanisms underlying tissue-specific 
differences are not well understood. The purpose of this research was to compare and 
contrast transcription profiles among healthy adult mouse tissues (testis, brain, liver, 
spleen and heart) using a 417 gene cDNA microarray enriched for genes involved in 
DNA damage recognition and repair processes. Several tissue-specific patterns of 
expression were identified through cluster analysis. With respect to specific biological 
pathways, we found that ~41% of the stress response genes, ~23% of the damage control 
genes and ~10% of DNA repair-associated genes were significantly differentially 
expressed among the tissues examined. In general, stress response genes exhibited the 
highest expression in liver and heart while DNA repair genes exhibited the highest 
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expression in testis. Damage control genes associated with cell cycle regulation often had 
the highest expression in testis. The finding that tissues differ in their basal expression of 
stress response, damage control and DNA repair-associated genes raises important 
questions regarding tissue-specific responses to endogenous and exogenous genotoxic 




Health maintenance requires that all mammalian tissues be capable of recognizing 
and repairing a variety of insults to genomic DNA. Yet, tissue-specific differences have 
been observed in the response to endogenous and exogenous genotoxic agents and cancer 
incidence. 
Several studies have reported differential tissue responses (ranging from 
modulations in gene expression to differences in the amount of damage induced) to a 
variety of DNA damaging agents. Recently, it has been suggested that transcriptional 
responses to ionizing radiation vary among cell lines derived from different tissue-types 
(Amundson et al., 1999). Valverde et al. showed that the extent of carcinogen-induced 
genotoxic damage also differs among tissues exposed to cadmium chloride (2000). 
Evaluation of single strand breakage and alkali-labile sites in various mouse tissues (e.g., 
lung, liver, kidney, brain, testis) suggested that a single exposure to cadmium induced 
relatively high amounts of DNA damage in brain and bone marrow, while the liver, testis, 
and kidney exhibited lower damage.  
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In addition to the observed differences in DNA damage produced following 
various environmental exposures, cancer incidence rates are also known to vary among 
tissues (American Cancer Society; http://www.cancer.org/eprise/main/docroot/stt/stt_0). 
The distribution of the approximately 1.3 million new cancer cases expected in the 
United States during 2002 varies significantly, ranging from a high of 1 in 6 new cases 
attributable to breast cancer to a low of 1 in 1070 new cases attributable to male genital 
cancers, excluding testicular and prostate cancers. Cancers of the brain/nervous system 
and liver/intrahepatic bile duct are expected to account for 1 in ~75 and 1 in ~77 new 
cases, respectively. However, soft tissue cancers (including heart) and testicular cancer 
only account for 1 in ~150 and 1 in ~170 cases, respectively. The molecular processes 
contributing to these tissue-specific differences in cancer rates are not well understood. 
Tissues may respond to DNA damaging conditions by activating signaling 
cascades involved in stress response (i.e., heat shock or oxidative stress depending on the 
type of exposure), regulating cell cycle progression, repairing DNA damage, and/or 
inducing apoptosis. Although many of the major genes in each of these biological 
pathways have been identified, information regarding their basal mRNA expression 
levels is limited. A better understanding of the in vivo baseline expression levels for these 
genes would provide insight on the cellular resources that are immediately available for 
responding to and processing DNA damage.  
Several studies have examined tissue-specific differences in the baseline 
expression of single genes or small numbers of genes associated with damage response 
and repair (Burns et al., 2001; Leasure et al., 2001; Pittman et al., 1998). In contrast, 
genome-scale technologies such as cDNA microarrays can provide a comprehensive 
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parallel evaluation of expression differences across large numbers of genes, biological 
pathways, and tissues. Although cDNA microarrays have been utilized to profile gene 
expression in tumor tissues (Alizadeh et al., 2001; DeRisi et al., 1996) as well as in 
tissues that have been exposed to DNA damaging agents, such as ionizing radiation 
(Amundson et al., 1999; Fornace et al., 1999), a microarray-based assessment of the 
differential basal expression of damage response genes among healthy mouse tissues has 
not yet been reported.  
The purpose of this research was to characterize and contrast the relative basal 
levels of gene expression among five tissues from healthy adult male mice (testes, brain, 
liver, spleen, and heart) using a cDNA microarray enriched for genes associated with 
DNA damage recognition and repair. After assessing the reproducibility and precision of 
our cDNA microarray technology, we (a) compared basal gene expression profiles among 
tissues, (b) characterized expression differences by biological pathway, and (c) validated 
cDNA microarray accuracy against northern blot results for selected genes. 
 
 
3.3 Materials and Methods 
Custom cDNA microarray generation 
Custom cDNA microarrays were generated to represent 417 genes involved in 
nucleotide excision repair, base excision repair, mismatch repair, homologous and non-
homologous recombination, stress response, apoptosis, cell cycle, transcription, 
translation, growth regulation, meiosis, spermatogenesis, and chromatin-remodeling. For 
each gene, one to four cDNA clones were obtained from either the I.M.A.G.E. 
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Consortium at LLNL or Research Genetics (Huntsville, AL). Several bacterial and 
lambda phage sequences served as controls. Clones were PCR-amplified with 5'-C6 
amino-modified vector-specific primers, purified on Qiagen purification columns 
(Qiagen Inc., Valencia, CA), ethanol precipitated, and resuspended in 0.1M sodium 
carbonate/bicarbonate (pH = 10.2) for spotting onto the array slides.   
Glass slides were cleaned for 30 min in 1:1 concentrated hydrochloric 
acid:methanol, soaked overnight in concentrated sulfuric acid, and washed 10 x 10 min in 
room temperature water and 10 min in boiling water. Slides were then submerged in 1% 
3-aminopropyltrimethoxysilane (Sigma, St. Louis, MO) / 95% acetone/ water for 2 min, 
washed 10 x 5 min in acetone, and heated at 110°C for 45 min (Guo et al., 1994).  Silane-
coated slides were submerged in 0.2% 1,4 phenylene diisothiocyanate (Sigma), 10% 
pyridine (Sigma) and dimethylformamide (Aldrich, Milwaukee, WI) for 2 hours, washed 
in methanol (2 x 10 min) and acetone (2 x 10 min), and air-dried. 608 clones were 
robotically arrayed (Norgren Systems, Palo Alto, CA) in duplicate with a 220 µm center-
to-center distance.   
 
RNA isolation and labeling  
Eight male B6C3F1 mice (Harlan Sprague Dawley, Indianapolis, IN) were 
euthanized by CO2(g) at 2 months of age. Mice were allowed food and water ad libitum 
and were not exposed to genotoxic agents. Testes from six mice were extracted and 
pooled for use as the reference tissue in each hybridization.  Heart, spleen, liver, testes 
and whole brain were extracted from each of the two remaining mice.  Tissues were 
stored at -80°C until RNA isolation. 
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Total RNA was isolated by homogenization (Omni Tissue Homogenizer, 
Warrenton, VA) in TRIzol Reagent (Life Technologies, Rockville, MD). RNA was 
ethanol precipitated twice, resuspended in RNase-free water (Sigma), and quantified 
using the GeneQuant spectrophotometer (Amersham Pharmacia Biotech, Piscataway, 
NJ). 25 µg of RNA was primed with 4 µg of 20mer oligo-dT (Life Technologies) and 
reverse transcribed at 42°C using Superscript II reverse transcriptase (Life Technologies) 
in the presence of unlabeled dUTPs (Amersham Pharmacia Biotech) and either Alexa 
Fluor 488-dUTPs (pooled testes reference; green fluorescence) or Alexa Fluor 546-
dUTPs  (test tissue; red fluorescence) from Molecular Probes, Inc. (Eugene, OR). For 
each hybridization, pooled testes and test tissue probes were co-purified on Qiagen 
columns (Qiagen, Inc.) and ethanol precipitated.   
 
Microarray hybridization  
Prepared slides were placed in 0.25% tryptone (Difco Laboratories, Detroit, MI) 
in water, agitated at 100 rpm for 1 hour, denatured 2 min. in 94-98°C water, dehydrated 
using an ice cold 70-85-100% ethanol series, and air dried. Probes were resuspended in 
2.75 µl water and added to 0.25 µL 10%SDS, 10 µg mouse cot-1 DNA (Life 
Technologies), 10 µg poly A+ (Amersham Pharmacia Biotech) and 10 µL  of 60% 
formamide / 3xSSC / 10% dextran sulfate. Hybridization mixtures were denatured at 
78°C for 6 min. and snap-cooled on ice. An in situ frame (Eppendorf, Westbury, NY) 
was used to confine the probe mixture over the arrayed area. Slides were hybridized 12 




Image capture and processing 
Image capture and processing was performed as described by Kegelmeyer et al. 
(2001). Briefly, images were acquired with a full-field white light imaging system. 
Arrays were exposed to bandpass-filtered excitation light from a Xenon source.  The 
resulting emitted light was bandpass-filtered and collected by a scientific-grade CCD 
camera (resolution = 0.015 mm/pixel). Custom algorithms, built within SCIL-Image 
(Delft, The Netherlands), corrected for CCD dark noise, spectral cross-talk, misaligned 
images and integration time variation. Additional processing algorithms determined the 
“segmentation mask” for each cDNA spot. The raw red and green intensities for all spots 
were computed by taking the geometric mean of all pixels within the segmentation mask 
that were greater than zero after background subtraction. Spots covered by debris were 
eliminated from all subsequent processing. 
 
Normalization and expression ratio calculations 
Logarithms were used to transform the raw red to green intensity ratio for each 
spot into red minus green intensity differences. This logarithmic transformation helped 
stabilize the variance. Logarithms to the base 2 were used for convenience in 
interpretation: a log-ratio of plus or minus one corresponds to a red to green ratio of 2:1 
or 1:2, respectively. 
Log-ratios were normalized using an intensity-dependent normalization similar to 
Yang et al. (2001). Two normalizations were performed in succession: (1) a 
normalization that adjusted the log-ratio based on the average of the log-transformed red 
and green intensities (called “A”) and (2) a subsequent normalization that adjusted the 
 
 84
log-ratio based on the Euclidean distance of the spot from the center of the array. This 
second normalization was performed to counter illumination differences between the 
center and edges of the array. Both normalizations used the "lowess" procedure in S-
PLUS (Venables and Ripley, 1999) to draw a smooth curve through the data while down-
weighting outliers that might affect the fit. The log-ratio for each spot was normalized by 
subtracting the value of the smooth curve at the “A” value (or Euclidean distance) 
associated with that spot. 
An expression ratio was then computed for each gene on a slide by averaging the 
normalized log-ratios for all cDNA target spots representing that gene.  The resulting 
ratios for each gene were then averaged across replicate hybridizations.  Log-ratios were 
then converted into fold-differences. 
 
Statistical analysis of expression differences among tissues 
For each gene, ten log-ratio measurements (two mice x five tissues) were 
combined into an F statistic to determine whether expression ratio measurements varied 
among tissues. The F statistic consisted of a ratio of a numerator (the variability of the 
average log-ratio measurements among tissues) to a denominator (the variability of 
measurements for a given tissue between mice). Higher variability among tissues than 
within a tissue indicated that the average log-ratios differed between tissues. The 
numerator was computed by summing twice the squared differences between individual 
tissue average log-ratios (averaged across the two observations for a tissue) and the 
overall average log-ratio, and dividing by four (the number of tissues minus one). The 
denominator was computed by summing the squared difference between each 
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measurement and the average of the two measurements for that tissue, and dividing by 
five (the number of measurements minus the number of tissues). Some F statistics were 
inflated by artificially low denominators (data not shown); therefore, the denominator 
was replaced by the maximum of the computed denominator for that gene and the median 
of the computed denominators across all genes. 
The significance of each F-ratio was assessed by re-sampling methods (Good, 
1994; Dudoit et al., in press). Briefly, if there were no expression differences among 
tissues, then the tissue label associated with each measurement would be considered 
irrelevant and could be permuted without affecting the random properties of the F 
statistic. An F statistic was computed for each possible assignment of the labels to 
measurements. The p value was then calculated as the proportion of the resulting F 
statistics that are at least as large as the statistic actually obtained. For a balanced 
experiment of five tissues and two mice per tissue, the number of distinct assignments is 
113,400. However, these assignments can be broken down into 945 distinct groups, each 
of size 120, in which the statistic has the same value. Hence, in this experimental design 
only 945 F statistics need to be evaluated for each gene, and the p value is one of 1/945, 
2/945, …, 945/945. 
Adjusted p values were calculated to account for the fact that 412 p values, one 
for each gene with a full complement of ten measurements, were calculated. The step-
down algorithm described by Dudoit et al., and based on Algorithm 4.1 of Westfall and 
Young (1993), was applied to adjust p values upward. 
Expression ratios for a gene were considered indistinguishable whenever the 
unadjusted p value exceeded 0.05 or the log-ratios differed by less than 2.6 times an 
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estimate of the residual standard deviation for that gene.  The number 2.6 corresponds to 
the threshold for Fisher’s LSD method of multiple comparisons, which simplifies to the 
value of the upper 0.25 tail of the t distribution with five degrees of freedom. 
 
Cluster analysis of gene expression 
 Expression trends were evaluated using CLUSFAVOR (CLUSter and Factor 
Analysis Using Varimax Orthogonal Rotation; Peterson, 2002). Briefly, log10 gene 
expression ratios were clustered using the centroid average Euclidean distance between 
joining nodes. The resulting dendograms identified groups of differentially expressed 
genes among tissues. 
 
Northern blot hybridization  
Expression ratios were verified for Araf, Catalase, Cdk2, Gadd153, Gpx1, Gstp2, 
Rad52, Stat4 and Tdg using Multiple Tissue Northern (MTN) Blots (CLONTECH 
Laboratories, Inc., Palo Alto, CA). Probes were generated by PCR-amplification of 
mouse QUICK-Clone cDNA (CLONTECH Laboratories, Inc.) using the following 
primer sequences: Araf fwd: 5'-ATCCGCTCCACATCTACTCC-3' and rev: 5'-
CTATCCCCAAACCCAAGAGG-3; Cas-1 fwd: 5'-CCGTTCGGTTCTCCACAGTC-3 
and rev: 5'-TGCGTTCTTAGGCTTCTCAG-3'; Cdk2 fwd: 5'-
TGCAGAGGGGTCCATCAAGC-3' and rev: 5'-AGGCCCAGGGTCAAGTCAGA-3'; 
Gadd153 fwd: 5'-GTCCCTGCCTTTCACCTTGG-3' and rev: 5'-
GGCGCTCGATTTCNTGCTTG-3’; Gpx1 fwd: 5'-CCACCGTGTATGCCTTCTCC-3' 
and rev: 5'-AGGCTATCCAAAAGGTGACA-3'; Gstp2 fwd: 5'-
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TGGAGACCTCACCCTTTACC-3' and rev: 5'-CCACTACTGTTTGCCATTGC-3'; 
Rad52 fwd: 5'-GTTACAATGGCTGGGCACAC-3' and rev: 5'-
CCCACATTTCAAGGTTCTCT-3'; Stat4 fwd:. 5'-ACTGGGAGTAAAGGAAACGAG-
3' and rev: 5'-GCACCAAGTGAGAAAGAGAGC-3'; and Tdg fwd: 5'-
GACCCGAGAGCAGGAAGAAG-3' and rev: 5'-CCCCGGACTCGTTACTCACC-3'. 
Primer specificity was confirmed using NCBI’s BLAST. Amplicon sizes were confirmed 
on a 2% agarose gel. PCR products were purified, labeled, hybridized, and visualized as 
described by Coleman et al. (2000). Briefly, 100 ng of each probe was [α-32P]dCTP-
labeled using the Megaprime DNA Labeling System (Amersham, Arlington Heights, IL). 
Hybridizations were performed according to manufacturer's instructions. Probes were 
visualized with the Storm 860 PhosphorImager (Molecular Dynamics, Sunnyvale, CA). 
Quantitation was performed using a gel documentation system (NucleoTech, San Mateo, 
CA). All blots were normalized to actin-ß. Normalized gene expression ratios were 
calculated by dividing each tissue measurement by the testis measurement. Ratio 




Normalization and expression ratio measurement variation 
The plot of the non-normalized average log intensity vs. log expression ratio for 
each cDNA target in the pooled testes vs. pooled testes hybridization (i.e., two separate 
aliquots from pooled testes reference labeled with either Alexa Fluor 488-dUTPs  or 
Alexa Fluor 546-dUTPs) showed a striking dependence on intensity (Figure 3.1A). After 





















Figure 3.1.  Intensity-based normalization of cDNA microarray data. Two aliquots from a pool of B6C3F1 testes were labeled with 
either Alexa Fluor 488 or Alexa Fluor 546 and co-hybridized onto the microarray. The average of the log of the red and green 
intensities (x-axis) vs. the log of the red:green ratio (y-axis) was plotted for each spot. The horizontal dashed line at a log-ratio of zero 
represents the expected ratio of 1. (A) The average log-intensity vs. log ratio for each cDNA spot on the array prior to normalization. 
The solid line represents the smooth curve drawn using the lowess procedure. (B) Data distribution following intensity-dependent 
normalization (see Materials and Methods section for details). 
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log-ratio of zero (Figure 3.1B), as expected, with little residual bias due to intensity. In 
replicate pooled testes vs. pooled testes hybridizations, >95% of the cDNA targets had 
log-ratios between –0.75 and +0.75, corresponding to ratios between 0.60 and 1.68. 
Because these normalization methods effectively minimized fluorophore- and intensity-
based biases, they were applied to each microarray hybridization in this study. 
To determine whether transcripts were similarly represented in the pooled testes 
sample and individual testis samples, expression ratio profiles for replicate individual 
testis vs. pooled testes hybridizations were analyzed. Gene expression ratios were not 
significantly different between the replicate hybridizations (data not shown); therefore, 
the replicate ratios for each gene were averaged (gray columns in Figure 3.2). These 
average gene expression ratios were similarly distributed around the expected value of 
1.0 with ~98% of all individual testis vs. pooled testes ratios between 0.60 and 1.68 (sum 
of all columns ≤1.7 in Figure 3.2). Because this ratio distribution was not significantly 
different from the pooled testes vs. pooled testes ratio distribution, pooled testes were 
used as the reference tissue in subsequent hybridizations.   
Animal-to-animal variation was assessed by analyzing the differences in gene 
expression ratios between replicate hybridizations of testis, spleen, brain or liver vs. 
pooled testes (Table 3.1). Average expression ratio differences at the 25th, 50th, 75th and 
95th percentiles were 0.06, 0.13, 0.24, and 0.62, respectively. These differences were not 
significantly different from those observed for the pooled testes vs. pooled testes 
hybridizations. The minor amount of variation between replicate animals allowed gene 
















Figure 3.2.  Distribution of normalized expression ratios for testes vs. testes 
hybridizations. The graph illustrates the percentage of genes (y-axis) with a given 
expression ratio (x-axis) following testes vs. testes hybridizations. Black columns 
represent the distribution of average expression ratios obtained from two independent 
hybridizations of pooled testes vs. pooled testes. Gray columns represent the distribution 
of average expression ratios obtained from two independent hybridizations of individual 
testis vs. pooled testes. Ratios that were higher in the Alexa Fluor 546-labeled pooled 
testes or individual testis samples are to the left of 1.0. Ratios that were higher in the 














































































aFor each gene, the absolute value of the difference in replicate hybridization expression 
ratio measurements was determined. Differences were rank-ordered from lowest to  
highest  and  were examined at the  25th,  50th,  75th,  and  95th percentiles.                     
 
bTwo hybridizations were  performed for individual mouse tissues  (testis, spleen liver, 
or brain) vs.  pooled testes.  Absolute differences were not calculated for heart because  
>50% of the  cDNA  targets were  irregularly shaped in one hybridization. 
 
cPooled testes vs. pooled testes hybridizations were used as an indicator  of technical 
variation. 
Table 3.1. Differences in the gene expression ratios from replicate independent 
                          
hybridizations. 
                          
                          
    Differences between replicate ratio measurementsa 
                          
Percentile   Tissues from individual miceb   
Pooled 
testesc 
                          
    Testis   Spleen   Brain   Liver   Average     
                          
25th   0.05   0.06   0.06   0.07   0.06   0.09 
                          
50th   0.10   0.12   0.13   0.16   0.13   0.17 
                          
75th   0.18   0.24   0.27   0.29   0.24   0.28 
                          




Comparison of gene expression profiles among healthy adult mouse tissues   
Based on the results above, gene expression ratios ≤ 0.68 or ≥1.68 were further 
evaluated for differential expression among tissues. Ratios ≤ 0.60 indicated higher 
expression in the testis, while ratios ≥ 1.68 indicated higher expression in brain, heart, 
liver or spleen.  Figure 3.3 summarizes the distribution of the 152 genes that were 
differentially expressed in at least one tissue-tissue comparison (brain, spleen, heart, or 
liver vs. testis).  See Appendix A for a complete list of the 152 genes showing differential 
expression among mouse tissues.  A subset of 105 genes showed significantly higher 
expression (unadjusted p values ≤ 0.05) in a single tissue (71 genes), in two tissues (23 
genes), in three tissues (7 genes) or in four tissues (4 genes).  Relatively higher baseline 
levels of gene expression were observed most often in heart (24 genes higher only in 
heart; 37 genes higher in heart and at least one other tissue) and testis (21 genes higher 
only in testis; 43 genes higher in testis and at least one other tissue).  
Genes with expression ratios outside of the 0.60 to 1.68 range were further 
analyzed for tissue-specific differences in expression using cluster analysis (Figure 3.4).  
When a vertical line was drawn through the cluster branch points so that the joining 
nodes to the immediate right of the line would group only ~10% of the genes into sub-
clusters of ≤ 5 genes, nine major (>5 genes) and seven minor (≤5 genes) sub-clusters 
were observed.  Among these sub-clusters, we identified groups of genes whose 
expression was specifically higher in either heart (sub-cluster I), brain (sub-cluster III), 
liver (sub-cluster V), spleen (sub-cluster X), or testis (sub-clusters VII, VIII, and XI).  
For example, Acrv1 and Sycp3, which are known to be involved in spermatogenesis and 



















Figure 3.3. Distribution of gene expression results among tissues. Genes with ratios ≤ 
0.60 are considered to be higher in testes. Genes with ratios ≥ 1.68 are considered to be 
higher in brain, liver, spleen, and/or heart. H = Heart, L = Liver, T = Testis, S = Spleen, B 
= Brain. *No ratio calculations were made for 1 or more replicate hybridizations because 








 0.60 to 1.68 range
6 genes with no ratio
calculations*
105 genes with
unadjusted p values Š 0.05
47 genes with
unadjusted p values > 0.05
Three Tissues
B & H & S
B & L & S
B & L & T
B & S & T



















































































































































































Brain     Liver    Heart    Spleen    Testis
 
Figure 3.4.  Cluster analysis of genes using 
CLUSFAVOR. Each column in the cluster represents 
one tissue (from left to right: brain, liver, heart, spleen, 
and testis). Each row represents one gene. Joining nodes 
to the immediate right of the orange vertical line 
determined the extent of each sub-cluster. The sixteen 
sub-clusters are indicated by Roman numerals I-XVI. 
Highlighted regions of the dendogram illustrate 
examples of genes that cluster together based on tissue-
specific elevated expression (e.g., top sub-cluster shows 
genes with elevated heart expression compared to other 
tissues). Graphs corresponding to each sub-cluster 
illustrate the mean log expression ratio for the sub-




genes with relatively higher expression in either two, three, or four tissues (e.g., Gstp2, 
which is involved in stress response, was higher in heart, brain, and liver than in spleen 
and testis). 
Genes with expression ratios outside of the 0.60 to 1.68 range were then grouped 
into one of eight biological pathways (Table 3.2). The stress response pathway had the 
greatest percentage of genes (55%) with differential expression while genes involved in 
DNA repair had the lowest percentage (20%) of differential expression. Approximately 
32% of the genes involved in damage control were differentially expressed among 
tissues.   
As shown in Table 3.3, the stress response genes were further subdivided, based 
on function, into oxidative stress or heat shock response. Oxidative stress genes were 
generally expressed highest in the heart (e.g., Sod3) and in the liver (e.g., Cas1), with the 
exception of heme-oxygenase 2 (Hmox2) which exhibited the highest expression in testis. 
Among the heat shock response genes, the Dnaj-related genes had higher expression in 
the testis, while the Hsp110-related gene Apg1b tended to have elevated expression in 
non-testis tissues. 
For genes involved in DNA repair, the highest levels of expression were generally 
observed in testis (e.g., Pol-b, Pcna and Mre11). However, a few genes exhibited higher 
expression in other tissues (i.e., Tdg and Mgmt were highly expressed in spleen and heart, 
respectively).  
Genes with functions related to damage control (i.e., apoptosis and cell cycle) 
exhibited differential expression among tissues as well. The cell cycle-related genes 







expressed genes a <6 6-10 11-25 >25
Chromatin-related 24 46 13 21 4 8
(4) (21) (0) (8)
Damage control 65 32 14 5 8 6
(6) (5) (6) (6)
DNA repair 51 20 12 4 2 2
(2) (4) (2) (2)
Growth regulation 80 36 16 5 11 4
(6) (5) (11) (4)
Meiosis /    
Spermatogenesis 20 45 30 5 5 5
(10) (0) (5) (5)
Stress response /     
Stress induced 22 55 14 5 9 27
(0) (5) (9) (27)
Transcription /     
Translation 58 41 14 10 12 5
(5) (9) (12) (5)
Miscellaneous 97 37 10 8 7 11
(0) (8) (7) (11)
Total 417 36 14 7 8 7
(4) (7) (7) (7)
aGenes with expression ratios outside of the 0.60 to 1.68 range in at least one tissue.
Table II. Distribution of F ratios for differentially expressed genes with respect 
to biological pathway.
F ratio b
bPercentage of genes in each F ratio category; Number in parentheses indicate the percentage of 






a Unadj.       
p value c
Testis Brain Liver Spleen Heart Num. Denom. Ratio b
Stress 
response
Adk1 GS 0.9 0.8 0.6 0.5* 0.7 0.19 0.09 2.1 0.204
Apg1b HS 1.1 1.8* 2.2* 1.5 2.5* 0.42 0.02 9.2^ 0.001
Dnaj HS 0.7 0.2* 0.2* 0.1* 0.2* 1.99 0.03 43.5^ 0.001
Dnajl1 HS 0.9 0.6 0.6 0.3* 0.5 0.94 0.02 20.7^ 0.001
Cas-1 OS 1.1 1.0 8.3* 1.2 1.4 3.26 0.10 31.3 0.017
Gadd153 OS 1.1 1.8 1.9 0.6 5.4* 2.79 0.10 28.6 0.003
Gpx1 OS 1.1 3.4* 4.2* 2.1* 26.5* 5.93 0.13 46.2 0.003
Gstp2 OS 1.1 4.0* 5.2* 0.9 18.0* 6.05 0.06 106.0 0.001
Hmox2 OS 0.8 0.6* 0.5* 0.3* 0.3* 0.82 0.05 15.1 0.001
Sod3 OS 1.2 2.6* 2.6* 0.8 8.8* 3.59 0.06 62.4 0.002
DNA repair
Pol- β BER 1.0 0.5* 0.3* 0.2* 0.2* 2.32 0.05 50.8^ 0.001
Tdg BER 1.3 1.9* 1.8* 4.4* 1.9* 0.88 0.01 19.3^ 0.001
Ung BER 0.9 0.5* 0.5 0.5* 0.3* 0.56 0.29 2.0 0.221
Mgmt DDR 1.1 1.4 1.6 1.1 2.8* 0.61 0.13 4.9 0.054
Mre11 DSBR 1.0 0.8 0.6 0.5* 0.7 0.32 0.02 7.0^ 0.001
Rad51B DSBR 1.3 1.1 2.0* 1.1 1.0 0.28 0.08 3.3 0.082
Rfc40 NER 0.9 0.6 0.5* 0.4* 0.5 0.40 0.11 3.8 0.100
Pcna NER 1.0 0.5* 0.4* 0.7 0.3* 1.02 0.14 7.3 0.017
Damage 
control
Bmp4 AP 1.1 1.5 1.8* 0.9 2.7* 0.75 0.04 16.4^ 0.001
Gap43 AP 1.1 2.5* 1.3 1.0 1.0 0.62 0.02 13.7^ 0.001
Gas2 AP 0.9 2.2* 3.0* 8.6* 3.7* 2.73 0.33 8.3 0.015
Naip2 AP 0.9 1.0 4.9* 0.7 0.9 2.53 0.12 20.5 0.074
Rip1 AP 1.1 3.6* 3.5* 1.0 19.4* 6.02 0.13 47.8 0.007
Smp30 AP 1.1 2.0* 10.5* 1.8* 2.7* 3.06 0.07 41.3 0.002
Tfar15 AP 0.9 1.1 0.9 0.7 0.5* 0.32 0.01 7.0^ 0.001
Mcl1 AP, CC 1.2 2.5* 4.3* 2.4* 9.4* 2.47 0.15 16.5 0.003
Btg1 CC 1.0 0.8 0.8 5.7* 0.4* 3.99 0.07 59.6 0.003
Cdc2 CC 1.0 0.6* 0.7 0.6 0.6 0.17 0.07 2.5 0.059
Cdc2a CC 1.0 0.7 0.6 0.6 0.5* 0.27 0.05 5.4 0.001
Cdc42 CC 1.2 2.9* 2.3* 2.9* 2.2* 0.54 0.05 10.2 0.002
Cdk2 CC 0.9 0.3* 0.5* 0.2* 0.2* 1.81 0.12 15.4 0.008
Paga CC 0.9 1.7 12.9* 1.3 2.7* 4.43 0.03 97.1^ 0.001
bF ratio = Numerator/Denominator (see Materials and Methods)
cUnadjusted p  values for the F ratios (see Materials and Methods)
*Replicate hybridizations had expression ratios Š 0.60 or  1.68.
^Denominator was replaced by the median denominator value (0.0456) before calculating the F ratio. 
Table III. Differentially expressed stress response, DNA repair and damage control genes.
F statistic
Ratio to pooled testes
aGS = Generalized Stress Response; OS = Oxidative Stress; HS = Heat-Shock; BER = Base Excision Repair; DDR 
= Direct Damage Reversal; DSBR = Double Strand Break Repair; NER = Nucleotide Excision Repair; AP = 




apoptosis tended to be more highly expressed in non-testis tissue (e.g., Smp30 in liver 
and Rip1 in heart). 
 
Northern blot confirmation of cDNA microarray results   
Expression ratios obtained from the cDNA microarrays were verified for nine 
genes using northern blots. These genes were selected across the following biological 
pathways: stress response (Cas1, Gstp2, Gadd153, Gpx1), DNA repair (Rad52, Tdg), 
damage recognition (Cdk2), growth regulation (Araf), and transcription/translation 
(Stat4). Although the specific expression ratios varied slightly between the microarrays 
and the multiple tissue northern blots, there was strong agreement overall between the 
relative rank-order of expression among tissues (Figure 3.5). For example, although the 
microarray-based ratio measurements for Gpx1 were consistently higher than the northern 
blot measurements, the relative rank-order of expression was very similar with the 
exception of heart, which had a much higher ratio than all of the other tissues according 
to the microarray. Additionally, both methods showed that the oxidative stress response 
gene Cas1 exhibited the highest levels of expression in the liver (microarray: 8.3-fold 
higher than testis; northern blot: 9.0-fold higher than testis) with similar levels of 
expression among the testes, spleen, and brain (microarray range: 1.0 to 1.4-fold; 
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B. Northern blot Microarray
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Figure 3.5. Comparison of northern blot and cDNA microarray results for 
selected genes.  Expression ratios were calculated as the value for the tissue of 
interest divided by the value for testis. Tissues were rank-ordered from highest 
to lowest expression on the northern blot. (H = Heart, L = Liver, T = Testis, S = 
Spleen, B = Brain.) Genes differing by ≤ 2-fold among tissues on the northern 
blot were considered to be similarly expressed (horizontal bar). Microarray-
based log expression ratios for each gene were also rank-ordered (highest to 
lowest). If the log-ratio difference between 2 tissues was < 2.6 x (square root of 
the residual standard deviation), the gene was similarly expressed (horizontal 
bar). (A) Northern blot images and northern blot vs. microarray results. (B)





cDNA microarray hybridizations revealed tissue-specific differences in the basal 
levels of transcript abundance for chromatin-related, damage recognition, DNA repair, 
growth regulation, meiosis, stress response, and transcription/translation genes.  Overall, 
152 of the 417 arrayed genes (36%) had expression ratios outside of the 0.60 to 1.68 
range, and 25% were significantly differentially expressed among healthy tissues. 
Experiments with split samples and replicate hybridizations demonstrated the 
precision and reproducibility of the microarray protocols used in this study. The generally 
strong agreement between the microarray and northern blot data demonstrated the 
accuracy of our findings.  
The unadjusted p-values used to assess the significance of differential gene 
expression among tissues were expected to be somewhat overly optimistic. With over 
400 genes being tested, we expected ~20 genes to appear significantly different at the 
0.05 level, even when no expression differences existed between tissues. However, after 
applying an extremely conservative indicator of differential expression (see Materials and 
Methods), only ~7% of the genes were still significantly differentially expressed 
(adjusted p ≤ 0.05) among tissues. In fact, when evaluated by their adjusted p-values, 
only genes with F ratios ≥ 25 were considered to be significantly different among tissues. 
The challenge for future microarray studies will be to develop statistical analyses 
methods that compromise between the overly conservative adjusted p-values and the 
overly permissive unadjusted p-values.  
Sixteen general patterns of differential tissue expression were observed following 
cluster analysis. Among the major sub-clusters, we identified genes that were similarly 
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expressed across tissues with the exception of higher expression in (a) one tissue (testis, 
heart, liver, brain, or spleen), (b) two tissues (heart and spleen), or (c) three tissues (brain, 
liver, and heart). We also identified minor sub-clusters of genes that had similar 
expression across tissues with the exception of higher expression in (a) two tissues (brain 
and testis), (b) three tissues (brain, liver, and heart or brain, heart, and spleen), or (c) four 
tissues (brain, liver, heart, and spleen or brain, heart, spleen, and testis). 
After assigning genes into one of eight biological pathways, we observed that the 
stress response genes showed the most variation in basal gene expression among tissues, 
DNA repair genes had the lowest variation among tissues, and damage control genes 
showed intermediate levels of variation. 
 
Stress response genes 
 Oxidative damage produced by reactive oxygen species (ROS) has been 
implicated in mutagenesis, inflammatory and autoimmune diseases, aging and cancer 
(Guyton et al., 1996; Lenzen et al., 1996; Loft and Poulsen, 2000; Li et al., 2001). ROS 
are continuously generated through the process of aerobic metabolism; however, the 
extent of ROS-related damage in cells depends upon the balance between ROS 
production, antioxidant scavenger capacity, and the efficiency of repair (Hollensworth et 
al., 2000; Loft and Poulsen, 2000).  
We found that higher expression of oxidative stress response genes was generally 
observed in liver, heart, and brain compared to spleen and testis (with the exception of 
Hmox2). Similar tissue-specific expression patterns have been reported for several of 
these oxidative stress-related genes, including catalase and glutathione peroxidase, 
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(Lenzen et al., 1996). These results, considered together with the observation that certain 
stress genes (e.g., Gadd153) have significantly higher basal expression levels in O2-
resistant versus control cell lines (Guyton et al., 1996), raise the question of whether 
these tissues may have differential responses to oxidative stress.  
Heat shock response provides protection against a variety of stress-inducing 
agents (including heat shock, oxidative stress, heavy metals, and inflammation) by either 
refolding or degrading damaged proteins (Jolly and Morimoto, 2000). We found that the 
differentially expressed heat shock response genes typically exhibited the highest 
expression in the testis, with the exception of Apg1b. Since up-regulation of heat shock 
gene expression occurs during stress and non-stress (e.g., cell cycle and differentiation) 
conditions (Jolly and Morimoto, 2000; Pirkkala et al., 2001), it is uncertain whether our 
finding may simply reflect variations in tissue physiology or tissue-specific variations in 
the ability to respond to stress stimuli. 
 
Damage control genes 
 In our study, genes involved in apoptosis and/or cell cycle regulation were 
categorized as damage control genes. Cells that have been damaged by various 
environmental exposures (e.g., ionizing radiation) may be removed by apoptosis, or 
programmed cell death. However, apoptosis is also critical for day-to-day health 
maintenance in the absence of exogenous exposures. It has been shown to play an 
important role in processes such as physiological cell turnover (Medh and Thompson, 
2000) and development (Meier et al., 2000). Our results indicate that the baseline 
expression of apoptosis-associated genes is usually highest in liver and heart and lowest 
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in testis and spleen. We found that Smp30 had significantly higher basal gene expression 
levels in the liver than the other tissues evaluated.  This finding correlates well with the 
suggestion by Fujita that SMP30 is essential for some of the highly differentiated 
functions of the liver (1999). Furthermore, we found that the differentially expressed 
genes function in different portions of the apoptotic pathway (e.g., initial signaling 
events, caspase substrates, etc.).  
 While the cell division cycle genes Cdc2 and Cdc2a and the cyclin dependent 
kinase gene Cdk2 exhibited the highest expression in testis (Table III), the remaining cell 
cycle-related genes exhibited higher expression in non-testis tissues even though some of 
them have similar functions. For example, both Cdk2 and Cdc42 are involved in 
progression through G1 into the S-phase of the cell cycle (Olson et al., 1995; Tsai et al., 
1993). Yet, we found that these genes have very different patterns of expression among 
tissues. 
 
DNA repair genes 
We found that genes involved in nearly every DNA repair pathway were 
differentially expressed among tissues and that testis generally exhibited the highest 
levels of expression. Genes involved in base excision repair (BER) tended to be more 
highly expressed in the testis, with the exception of Tdg which exhibited the highest 
levels of expression in the spleen and other somatic tissues.  These findings correlate well 
with the finding that BER activity initiated by uracil DNA glycosylase is highest in 
mixed testicular germ cell extracts (Intano et al., 2001). More specifically, Intano et al. 
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found that protein levels for polymerase β were much higher in mixed germ cells than in 
brain and liver. 
 We found that the direct damage reversal (DDR) enzyme Mgmt (or O6-
methylguanine-DNA methyltransferase), which is responsible for removing DNA lesions 
caused by alkylation, had the highest expression in heart. To our knowledge, this is the 
first report that Mgmt transcripts have higher abundance in the heart than in liver, brain, 
spleen and testis. 
Among the genes involved in double stranded DNA break repair, we found that 
Mre11 showed the highest expression in testis which complements the finding of 
Chamankhah et al. in human testis (1998). Our finding that Rad51B was most highly 
expressed in the liver contrasts the suggestion by Albala et al. who reported that the 
expression of this gene is highest in actively recombining tissues (1997).  However, it 
should also be noted liver was not among the tissues evaluated in the study by Albala et 
al.  
 Our results show that a few of the nucleotide excision repair (NER) genes 
represented on our cDNA microarray were differentially expressed among tissues. Genes 
encoding the p40 subunit of replication factor C (RFC) and Pcna exhibited the highest 
levels of expression in testis.  These results are particularly interesting because the p40 
subunit represents 1 of 5 RFC subunits required for Pcna-dependent DNA synthesis 
(Uhlmann et al. 1997).  
Although DNA repair genes showed the least variation in expression among all of 
the biological pathways surveyed, we found that genes involved in four out of five DNA 
repair pathways were differentially expressed among tissues. A possible explanation why 
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differential expression was not detected for more of the DNA repair genes represented on 
our microarray is that low signal intensities may have affected our ability to detect 
expression differences for certain genes. Other groups have also reported low transcript 
abundance for certain DNA repair genes under normal physiological conditions (e.g., 
Xrcc1, Walter et al., 1994).  
Our finding that transcriptional profiles for DNA repair genes vary among tissues 
may suggest that tissues have different DNA repair capacities. This suggestion is further 
supported by the finding that the induction of genotoxic damage, by chemicals such as 
acrylamide and acrylonitrile, may result in tissue-specific carcinogenic activity 
(Butterworth et al. 1992).  
  
Summary 
Through the use of cDNA microarray technology, this study takes an important 
step toward understanding global differences in gene expression among healthy adult 
tissues. Differences in basal gene expression levels among tissues may contribute to the 
observed differential tissue responses to DNA damaging agents such as cadmium, lead, 
ionizing radiation, etc. (Amundson et al. 1999; Fornace et al. 1999; Valverde et al. 2000; 
Valverde et al. 2002). By characterizing the differential basal expression of genes 
involved in DNA damage response, recognition, and repair processes among tissues, this 
research contributes to our understanding of tissue-specific responses to genotoxic agents 
and may also provide insight on the differential susceptibility to the onset and 
progression of cancer. 
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Future studies are needed to address the relative contributions of tissue 
microenvironments to differential basal expression levels among healthy tissues and to 
evaluate the involvement of these microenvironments in differential tissue responses to 
DNA damaging conditions. In addition, endeavors to identify groups of genes with 
coordinated expression (i.e., synexpression groups) and to assess transcript vs. protein 
abundance as well as post-transcriptional and post-translational differences among tissues 
will further enhance our understanding of variations in the response to and processing of 
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Mitotic and Meiotic Gene Expression Profiling of 




The purpose of this research was to characterize gene expression profiles for 
~10,000 genes as germ cells differentiated from spermatogonia into primary 
spermatocytes and to identify the genes and biological pathways associated with these 
periods in spermatogenesis.  Expression was characterized in the testes of prepubertal 
B6C3F1 mice during spermatogonial mitosis (postnatal day 7), at the onset of meiosis 
(postnatal day 9), and during the mid-pachytene stage of meiosis I (postnatal day 14).  
Approximately 550 genes were found to be differentially expressed across these time 
points, including 428 genes that exhibited differential expression between spermatogonial 
mitosis and the onset of meiosis (383 with relatively higher spermatogonial expression; 
45 genes with relatively higher preleptotene expression).  An additional 70 genes showed 
differential expression between early and mid-meiosis I (25 with higher pachytene 
expression; 35 with higher preleptotene expression).  The remaining 46 genes exhibited 
complex temporal expression patterns (differential expression during the mitosis to 
meiosis transition and also during meiosis I).  These results show that a genome-scale 
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approach for investigating gene expression during spermatogenesis allows the (a) 
characterization of temporal expression patterns for genes with known roles in germ cell 
differentiation, (b) identification of new spermatogenesis-related roles for genes with 
functions previously characterized in other biological pathways, and (c) discovery of 
novel pre-meiosis and meiosis-enriched genes.  These findings lay the foundation for 
understanding molecular mechanisms of the mitotic to meiotic transition and meiosis, 
genetic changes associated with male infertility, and susceptibility factors affecting the 




Spermatogenesis can be divided into three phases: proliferative (mitosis), meiotic, 
and post-meiotic.  Both the mitotic and meiotic phases occur within the seminiferous 
tubules of the testis.  Spermiogenesis begins in the seminiferous tubules, and final sperm 
maturation occurs in the epididymis.  The timing of germ cell progression through 
spermatogenesis has been well characterized in humans and rodents (Ham, 1974; Bellve 
et al., 1977). 
Male germ cell development begins in the fetal mouse at 8-8.5 days post-coitum 
(d.p.c.) when cells in the primitive ectoderm differentiate to form primordial germ cells 
(PGCs).  These PGCs, or prespermatogonia, divide and migrate to the genital ridge by 
13.5 d.p.c where they arrest in G1 of the mitotic cell cycle until after birth (Hogan et al., 
1986).  The first wave of spermatogenesis begins in the prepubertal mouse at postnatal 
(p.n.) day 5-6 with the initiation of spermatogonial stem cell mitosis (Bellve et al., 1977).  
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Mitotic divisions give rise to other spermatogonial stem cells and type A1 spermatogonia 
that will subsequently differentiate and mitotically divide to form A2-, A3-, A4-, 
Intermediate-, and B-type spermatogonia (Thomas et al., 1989).  On p.n. day 9, the first 
type B spermatogonia divide to form spermatocytes (meiotic cells).  Preleptotene 
spermatocytes undergo the last DNA replication (S phase) and enter the long prophase of 
meiosis I (Bellve et al., 1977).  During prophase I, the leptotene spermatocytes 
differentiate through zygotene (chromosome synapsis), pachytene (recombination and 
increased RNA synthesis), and diplotene (synaptonemal complex degeneration and RNA 
synthesis).  This prolonged prophase I lasts until p.n. day 18 when the primary 
spermatocytes undergo a reductional division to become secondary spermatocytes 
(Thomas et al. 1989).  The first and second meiotic divisions occur in rapid succession, 
forming the first round spermatids by p.n. day 20 (Bellve et al., 1977).  The process of 
spermiogenesis takes approximately 13.5 days (Gilbert, 1994).  It is estimated that a new 
wave of mouse spermatogenesis is initiated every 8.6 days (Oakberg, 1956); therefore, 
the second wave of spermatogenesis is initiated at approximately p.n. day 14-15 in the 
prepubertal mouse. 
The histophysiological characteristics of germ cell differentiation in the testis 
have been well documented (e.g., Bellve et al., 1977; Russell et al., 1990).  Germ cells 
remain connected by intercellular cytoplasmic bridges as they differentiate from the type 
A1 spermatogonial stage through the spermatid stage (Gilbert, 1994).  This syncytial 
organization is thought to promote synchronous male germ cell differentiation by 
allowing ions, molecules and gene products to be shared among cells (Braun et al., 1989; 
Gilbert, 1994).  A number of studies have shown that the expression of one or a small 
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number of genes across critical phases of germ cell development affects progression 
through mouse spermatogenesis.  For example,  Schrans-Stassen et al. showed that c-kit 
expression is a molecular marker for the transition of prespermatogonial cells into 
differentiating type A spermatogonial cells (1999).  Additionally, it has been suggested 
that the stage-specific expression of certain genes, such as topoisomerase II, may be 
required for progression through meiosis I (Cobb et al., 1997).  Recent advances in 
expression microarray technology provide an opportunity to develop a more complete 
understanding of the expression profiles of a large number of genes that contribute to the 
onset and progression of spermatogenesis. 
The objective of this research was to investigate the expression profiles of genes 
in the prepubertal mouse testis as germ cells differentiate through the mitotic and meiotic 
compartments during the first wave of spermatogenesis.  Random oligonucleotide 
microarrays containing ~10,000 annotated genes and unannotated sequences were used to 
identify clusters of genes that were differentially expressed (a) during the transition from 
spermatogonial mitosis to meiosis and (b) during early and mid-meiosis I (preleptotene 
vs. pachytene I). 
 
 
4.3 Materials and Methods 
Probe generation 
B6C3F1 male mice (Harlan Sprague Dawley, Indianapolis, IN) were kept on a 12 
hour light/dark cycle and were allowed food and water ad libitum.  Mice were euthanized 
by cervical dislocation at each of the following postnatal time points: spermatogonial 
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mitosis (day 7), onset of meiosis/preleptotene (day 9), mid-meiosis/pachytene (day 14), 
and adult mice (8 weeks).  Immediately following euthanization, testes were extracted 
from 4 - 6 mice per experimental time point, and microdissected under a dissection 
microscope to remove the tunica albuginea and isolate the seminiferous tubules.  The 
tubules were stored at –80ºC until RNA isolation was performed. 
Total RNA was isolated by homogenization (Omni Tissue Homogenizer, 
Warrenton, VA) in TRIzol Reagent (Life Technologies, Rockville, MD).  RNA was 
ethanol precipitated twice, resuspended in RNase-free water (Sigma, St. Louis, MO), and 
purified using RNeasy (Qiagen, Valencia, CA).  Purified RNA was quantitated using the 
GeneQuant spectrophotometer (Amersham Pharmacia Biotech, Piscataway, NJ).   
First and second strand cDNA synthesis was performed using a starting quantity 
of 8 µg of total RNA.  To synthesize first strand cDNA, RNA was primed with an HPLC 
purified T7-(dT)24 primer (final concentration: 100 pmol; Integrated DNA Technologies, 
Coralville, IA) and reverse transcribed at 42°C using Superscript II reverse transcriptase 
(Life Technologies) in the presence of unlabeled dNTPs (Amersham Pharmacia Biotech).  
Second strand synthesis was performed using DNA polymerase I (Life Technologies) and 
DNA ligase (Life Technologies) in the presence of RNase H (Life Technologies) to 
incorporate unlabeled dNTPs (Amersham Pharmacia Biotech).  The synthesized cDNA 
was purified using the QIAquick Purification Kit (Qiagen).  RNA was biotin-labeled 
during in vitro transcription reactions using the BioArray HighYield RNA Transcript 
Labeling Kit (Enzo Diagnostics, Inc., Farmingdale, NY).  The amplified, labeled RNA 
was then purified using the RNeasy Mini Kit (Qiagen).  Prior to hybridization, 
approximately 20 µg of labeled RNA was fragmented in a buffer comprised of 200 mM 
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tris-acetate (Sigma), 500 mM potassium acetate (Sigma), and 150 mM magnesium 
acetate (Sigma). 
 
Hybridization and image capture 
Two pools of independently prepared testes were hybridized per experimental 
group.  The fragmented labeled probe was hybridized to Affymetrix Murine Genome 
U74Av.1 microarrays (Affymetrix, Inc., Santa Clara, CA) according to manufacturer’s 
directions.  Briefly, the probe mixture for each hybridization was comprised of 5 µg 
fragmented probe, Affymetrix eukaryotic hybridization controls (BioB: 1.5 pmol; BioC: 5 
pmol; BioD: 25 pmol; cre: 100 pmol), 10 µg herring sperm DNA (Life Technologies), 50 
µg acetylated bovine serum albumin (Life Technologies), and the Affymetrix 
hybridization buffer (100 mM MES/1M sodium salt/20 mM EDTA/0.01% Tween 20).  
Hybridizations were performed for 16 hours at 45ºC in an Affymetrix hybridization oven 
set at 60 rpm.  The hybridized arrays were then washed and stained with streptavidin 
phycoerythrin (SAPE) on the Affymetrix Fluidics Station according to manufacturer’s 
directions (Affymetrix, Inc.).  Images were captured using the Agilent Gene Array laser 
scanner (Agilent Technologies, Palo Alto, CA). 
 
Data normalization and analysis 
To normalize the array data, a quantile normalization scheme was applied at the 
probe level (Irizarry et al., 2002) using an R statistical package that is publicly available 
at: http://biosun01.biostat.jhsph.edu/~ririzarr/Raffy.  Following normalization, all genes 
with MicroArray Suite 5.0 (Affymetrix, Inc.) detection p-values ≤ 0.005 (in at least one 
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hybridization) were selected for pairwise comparisons of gene expression between time 
points.  Using the replicate log2 intensity values obtained for each gene, a two-sample 
student’s t distribution was performed, assuming unequal variance (Dowdy and Wearden, 
1991), for each of the following comparisons: spermatogonial mitosis vs. onset of 
meiosis, onset of meiosis vs. mid-pachytene of MI, and mid-pachytene of MI vs. adult.  
Genes with t-test p-values ≤ 0.05 and expression ratios ≥ 1.8 were considered to be 
differentially expressed between time points and were further characterized according to 
their function in a given biological pathway. 
 
Cluster analysis of expression 
 Expression trends were characterized for all genes with a MicroArray Suite 5.0 
detection p-value ≤ 0.005 using the unsupervised hierarchical cluster analysis program 
CLUSFAVOR (CLUSter and Factor Analysis Using Varimax Orthogonal Rotation; 
Peterson, 2002).  Briefly, log10 gene expression intensities were clustered using the 
centroid average Euclidean distance between joining nodes. The resulting dendograms 
identified groups of genes that were differentially expressed between specific time points 
during the first wave of spermatogenesis in the prepubertal mouse and full 









Temporal Gene Expression During the First Wave of Mouse Spermatogenesis 
As shown in Figure 4.1, gene expression profiles were investigated in the 
seminiferous tubules obtained from prepubertal mice euthanized at times that correspond 
to when the most advanced cell types of the first wave of spermatogenesis were at the 
following: spermatogonial mitosis (p.n. day 7), onset of meiosis (preleptotene; p.n. day 
9), and mid-pachytene stage of meiosis I (MI; p.n. day 14).  Of approximately 10,000 
genes evaluated on the Affymetrix Murine U74Av.1 microarray, 3986 genes had 
significant signal intensities (Affymetrix MAS 5.0 detection p-value ≤ 0.005) at one or 
more experimental time points, indicating that they were expressed.  Of these, 544 genes 
(231 annotated genes and 313 unannotated sequences) exhibited significant temporal 
changes in expression (Student’s t-test p-value ≤0.05) in the prepubertal mouse testis, as 
further described below.  Among the 544 differentially expressed genes, 428 were 
differentially expressed between spermatogonial mitosis and preleptotene (but were not 
differentially expressed between preleptotene and pachytene), 70 were differentially 
expressed between preleptotene and pachytene (but were not differentially expressed 
between spermatogonial mitosis and preleptotene), and 46 exhibited complex patterns of 
expression (i.e., differential expression between spermatogonial mitosis and preleptotene 
and also between preleptotene and pachytene).  The temporally expressed annotated 
genes have a variety of biological functions, as shown in Tables 4.1 - 4.3 and Appendix 
B.  Therefore, each gene was also classified according to whether or not it had a 
















Meiotic Phase Post-Meiotic Phase
Testis Epididymis
Figure 4.1  Ge rm cell progression through  mouse  spermatogen esis.  Male germ cells differentiate through three  phas es: proliferative,
meiotic, and pos t-meiotic (left to right).  Th e proliferative phas e inc lude s the mitotic divisions  of sper matogon ial cells.  The meiotic
pha se includes the first and  second divisions of primary and  seconda ry spermatocy tes, resp ective ly.   The  post-meiotic phas e include s
the morphologica l tran sformation of the round haploid  spermatid into testicu lar spe rm, and  biochemical maturation of spe rm which






























































The genes that were differentially expressed between spermatogonial mitosis and 
the onset of meiosis may have important functions during the transition from mitosis to 
meiosis.  As shown in Figure 4.2, 187 of the 428 genes were annotated while the 
remaining 241 were unannotated sequences.  Among the 187 annotated genes, 14 
exhibited higher expression at the onset of meiosis, and the remaining 173 genes had 
higher expression during spermatogonial mitosis.  The expression data for these 187 
annotated genes is listed in Appendix B.  Specific roles in spermatogenesis were 
previously reported for only 37 (~20%) of the annotated genes (Appendix B).  Examples 
of the annotated genes that exhibited relatively higher expression levels during the onset 
of meiosis are listed in Table 4.1.  These genes may be important for the transition into 
the meiotic phase of spermatogenesis.  For example, Zfx which is important for cellular 
differentiation during spermatogenesis is expressed ~2.7-fold higher in preleptotene cells 
than in the mitotic cells (p = 0.05) and this higher level of expression is still observed in 
pachytene cells (p = 0.2; data not shown).  Examples of genes that exhibited relatively 
higher expression during spermatogonial mitosis are also listed in Table 4.1.  These genes 
may have important roles in spermatogonial mitosis; however, it is also possible that their 
decreased expression is necessary for the transition into meiosis.  For example, the cell 
cycle-related gene Plk1 had higher expression during mitosis than in preleptotene cells 
(~2.6-fold increase; p = 0.03) and the lower level of expression in preleptotene cells was 
still observed during pachytene I (p = 0.60; data not shown).  The 241 differentially 
expressed unannotated sequences (31 with higher preleptotene expression; 210 with 
higher mitotic expression), which may represent novel genes with roles in the mitosis to 
meiosis transition, are listed in Appendix C.
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    14 anno tated g enes
  
45 genes w ith h ighe r
preleptotene
exp ression    
    31 unanno tated sequenc es
      
      
428 differen tially
exp ressed genes      
      
      
    173 anno tated g enes
  
383 genes w ith
highe r mitotic
exp ression    
    210 unanno tated sequenc es
Figure 4.2.  Gene s that were differen tially exp ressed be tween  mitosis and the
onset of meiosis (but not  be tween  ea rly and mid-meios is).
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Table 4.1.  Examples of genes with differential expression between mitosis and the onset of meiosis. 
Ratio P-valuea
Genes with increased expression as germ cells progress from mitosis to the onset of meiosis
Ig germline H-chain gene V-region IgH (germline) Immune response M16724 6.8 0.001 Yes (Kerr and Burrows, 1991)
Zinc finger protein X-linked Zfx Cellular differentiation M32309 2.7 0.05 Yes (Luoh et al., 1997)
DNA methyltransferase Dnmt1 Transcription AF036008 1.7 0.01 Yes (Mertineit et al., 1998)
Methylmalonyl coenzyme A mutase Mut Metabolism X51941 11.9 0.04 No
Sprouty-4 Spry4 Signal transduction AB019280 5.6 0.02 No
Transactivating transcription factor 3 Sp3 Transcription AF062567 3.8 0.01 No
ADP-ribosyltransferase 5 Art5 Protein modification U60881 2.3 0.03 No
Cryptochrome 1 Cry1 Molecular clock AB000777 2.1 0.01 No
Genes with decreased expression as germ cells progress from mitosis to the onset of meiosis
Glutathione peroxidase 4 Gpx4 Stress response D87896 44.1 0.03 Yes (Giannattasio et al., 1997)
DEAD box polypeptide, Y chromosome Dby RNA helicase AJ007376 11.4 0.03 Yes (Mazeyrat et al., 2001)
Flap structure specific endonuclease 1 Fen1 DNA repair L26320 7.0 0.04 Yes (Harrington and Lieber, 1994)
Bcl2-associated X protein Bax Apoptosis L22472 6.4 0.01 Yes (Russell et al., 2002)
Breast cancer 2 Brca2 DNA repair U89652 3.5 0.02 Yes (Connor et al., 1997)
Polo-like kinase 1 Plk1 Cell cycle U73170 2.6 0.03 Yes (Matsubara et al., 1995)
RNA binding motif 3 Rbm3 Stress response AB016424 1.9 0.04 Yes (Danno et al., 2000)
Myeloid cell leukemia sequence 1 Mcl1 Apoptosis U35623 14.9 0.02 No
Thioredoxin Txn1 Stress response X77585 10.9 0.001 No
Cyclin F Ccnf Cell cycle Z47766 9.0 0.04 No
Programmed cell death 6 Pdcd6 Apoptosis U49112 4.4 0.01 No
DNA polymerase zeta catalytic subunit Rev3l DNA repair AF083464 2.8 0.02 No
aStudent's t-test p-values Š 0.05 indicate significant differences in expression across time points (see Materials and Methods)
bGenes with described roles in germ cell development or differentiation, meiosis, spermatogenesis, or fertilization 










 As shown in Figure 4.3, there were 70 genes that were differentially expressed 
between preleptotene and pachytene of meiosis I (25 with higher pachytene expression; 
35 with higher preleptotene expression).  Only 25 of the 70 genes were annotated, 
including 10 with known roles related to spermatogenesis (Table 4.2).  Nine of the 25 
annotated genes showed higher expression during pachytene I (e.g., the recombination-
associated gene Sycp1 was ~ 5.7-fold higher in pachytene compared to preleptotene; p = 
0.02).  The remaining 16 annotated genes exhibited higher expression during preleptotene 
(e.g., Zfp49 had ~3.8-fold higher expression in preleptotene compared to pachytene; p = 
0.01).  The expression of these genes may be important for spermatogonial mitosis and 
the onset of meiosis and/or their decreased expression may be necessary for progression 
through meiosis I.  The 45 unannotated sequences that were also differentially expressed 
during meiosis I (16 with higher pachytene expression; 29 with higher preleptotene 
expression; Figure 4.3) are listed in Appendix C. 
Forty-six genes (19 annotated and 27 unannotated) showed complex patterns of 
expression.  They were differentially expressed between spermatogonial mitosis and the 
onset of meiosis and also between the onset of meiosis and mid-meiosis I (Figure 4.4).  
As shown in Figure 4.4 and Table 4.3, three temporal patterns of expression were 
observed: (1) increased expression from mitosis to preleptotene and decreased expression 
from preleptotene to pachytene (1 annotated gene; 2 unannotated sequences); (2) 
decreased expression from mitosis to preleptotene and increased expression from 
preleptotene to pachytene (10 annotated genes; 15 unannotated sequences); and (c) 
continual decrease in expression from mitosis to preleptotene and from preleptotene to 
 
 127
Figure 4.3.  Gene s that were differentially exp ressed between  the onset of
meiosis and  mid-meiosis I (bu t not be tween  mitosis and prelep totene ).
    9 anno tated g enes
  
25 genes w ith h ighe r
pachy ten e exp ression    
    16 unanno tated sequenc es
      
      
70 differen tially
exp ressed genes      
      
      
    16 anno tated g enes
  
45 genes w ith h ighe r
preleptotene  expr ession    
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Table 4.2.  Genes with significant differential expression between the onset and middle of meiosis I. 
Ratio P-value a
Genes with increased expression as germ cells progress from the onset of meiosis to mid-meiosis I
Hematopoietic cell transcript HemT Cellular differentiation AJ242830 78.1 0.02 Yes (Xue et al., 1999)
Lipase, hormone sensitive Lipe Metabolism U69543 11.2 0.02 Yes (Chung et al., 2001)
Lactate dehydrogenase 3 Ldh3 Metabolism M17587 9.2 0.04 Yes (Kao et al., 1988)
Synaptonemal complex protein 1 Sycp1 Recombination D88539 5.7 0.02 Yes (Tureci et al., 1998)
Acid phosphatase 2, lysosomal Acp2 Signal transduction X57199 8.9 0.02 No
Ganglioside-induced differentiation  3 Gdap3 Unknown Y17852 3.9 0.04 No
Protein kinase inhibitor p58 Ipk Protein modification U28423 3.2 0.05 No
Glutamyl-tRNA synthetase Glut-tRNA 
synthetase
Biosynthesis X54327 2.4 0.01 No
House-keeping protein 1 Hkp1 Misc. M74555 2.2 0.02 No
Genes with decreased expression as germ cells progress from the onset of meiosis to mid-meiosis I
Hydroxysteroid (17-beta) dehydrogenase 3 Hsd17b3 Metabolism U66827 6.6 0.01 Yes (Sha et al., 1996)
Zinc finger protein 35 Zfp35 Cellular differentiation M36146 3.8 0.01 Yes (Cunliffe et al., 1990)
Integrin alpha 6 Itga6 Cell adhesion X69902 3.4 0.005 Yes (Husen et al., 1999)
Glutathione-S-transferase, alpha 1 Gsta1 Stress response L06047 2.9 0.01 Yes (Benbrahim-Tallaa et al., 2002)
Diazepam-binding inhibitor Dbi Metabolism X61431 2.7 0.01 Yes (Kolmer et al., 1997)
Zinc finger protein 49 Zfp49 Cellular differentiation AB013357 2.6 0.02 Yes (Cunliffe et al., 1990)
GA repeat binding protein, beta 1 Gabpb1 Transcription M74516 7.0 0.03 No
Tissue factor pathway inhibitor Tfpi Misc. AF004833 6.3 0.03 No
N-myristoyltransferase 2 Nmt2 Biosynthesis AF043327 5.1 0.04 No
Monocyte macrophage 19 Mmrp19 Immune response AB028863 4.9 0.001 No
Smoothened homolog Smoh Signal transduction AF089721 4.1 0.01 No
Prolyl oligopeptidase Prep Protein modification AB022053 3.6 0.001 No
Lysosomal-associated, transmembrane 4 Laptm4 Intercellular transport U34259 3.1 0.05 No
Fas-associated death domain Fadd Apoptosis U50406 2.8 0.03 No
Annexin III Anx3 Metabolism AJ001633 2.4 0.004 No
Ryanodine receptor 3 Ryr3 Signal transduction D38218 2.0 0.04 No
aStudent's t-test p-values Š 0.05 indicate significant differences in expression across time points (see Materials and Methods)
bGenes with described roles in germ cell development or differentiation, meiosis, spermatogenesis, or fertilization 
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Table 4.3.  Genes with complex patterns of differential expression from mitosis to mid-meiosis I. 
Ratiob P-valuec Ratiob P-valuec
Genes with described roles in germ 
cell development or differentiation, 
meiosis, spermatogenesis, or 
fertilization 
Degenerative spermatocyte homolog Mdes Meiosis Y08460 DD -7.5 0.01 -2.1 0.02 (Endo et al., 1997)
Growth arrest specific 6 Gas6 Growth regulation X59846 DD -7.3 0.04 -3.6 0.02 (Chan et al., 2000)
Ornithine decarboxylase antienzyme 2 Oaz2 Misc. D78643 DI -23.4 0.01 2.9 0.03 (Ivanov et al., 2000)
Secreted protein acidic and rich in cysteine Sparc Extracellular matrix X04017 DI -4.6 0.02 1.9 0.02 (Vernon and Sage, 1989)
Outer dense fiber 1 Odf1 Cytoskeletal element X79446 ID 4.8 0.01 2.3 0.04 (Burmester et al., 1996)
Genes with no known role in germ 
cell development or differentiation, 
meiosis, spermatogenesis, or 
fertilization 
Cardiac troponin T isoform A3b CtnTA3b Metabolism L47600 DD -11.6 0.02 -2.3 0.04
DEAD box polypeptide 4 Dbp4 RNA helicase D14859 DD -2.4 0.02 -1.8 0.04
Glutathione transferase mu 3 Gstm3 Stress response J03953 DD -2.1 0.02 -2.3 0.02
Inosine monophosphate dehydrogenase Impdh Biosynthesis M33934 DD -5.1 0.01 -2.6 0.02
Suppressor of cytokine signaling 2 Socs2 Growth regulation U88327 DD -4.5 0.01 -5.9 0.04
Transcytosis associated protein p115 Tap Intracellular transport AF096868 DD -2.6 0.01 -1.8 0.01
Adenylosuccinate synthetase Adss Biosynthesis L24554 DI -5.6 0.004 1.9 0.05
Cop9 complex subunit 6 Cops6 Protein modification AF071315 DI -32.8 0.01 3.3 0.01
Fibroblast secretory protein Fsp Growth regulation M70642 DI -12.2 0.02 1.6 0.01
Fibulin extracellular matrix glyroprotein Fbln1 Cell adhesion X70853 DI -6.9 0.001 5.1 0.002
Peroxisomal integral membrane protein 34 Pmp34 Intracellular transport AJ006341 DI -3.8 0.04 3.7 0.01
Spastin Spast Cytoskeletal element AJ246002 DI -7.4 0.03 5.2 0.04
TEA domain family member 4 Tead4 Transcription X94441 DI -2.7 0.03 3.8 0.05
Translocase of inner membrane 23 Tim23 Intracellular transport AB021122 DI -4.7 0.01 2.5 0.05
bFold difference in expression for preleptotene vs. spermatogonial mitosis or pachytene vs. preleptotene; Negative numbers indicate decreased expression as germ cells differentiate





aDD = Decreasesd expression from spermatogonial mitosis to preleptotene and decreased expression from preleptotene to pachytene; DI = Decreasesd expression from spermatogonial mitosis to preleptotene and 











pachytene (8 annotated genes; 10 unannotated sequences).  Only 5 of the 19 annotated 
genes have described roles related to germ cell development or progression through 
spermatogenesis.  The 27 unannotated sequences that have significant expression 
differences across all time points evaluated and, therefore, may be important for 
progression through the first wave of spermatogenesis are listed in Appendix C. 
 
Cluster Analysis of Temporal Gene Expression  
Unsupervised hierarchial cluster analysis was performed to identify clusters of 
genes with similar patterns of expression (CLUSFAVOR; Peterson 2002).  These similar 
expression patterns may indicate that these genes belong to common 
molecular/biochemical pathways.  All genes with significant differential expression were 
analyzed by cluster analysis.  Expression data for the adult mouse was also included in 
order to compare the onset and progression of meiosis in the prepubertal mouse with 
expression during full spermatogenesis.  Cluster analysis revealed the presence of 44 
major (≥ 4 genes) and 83 minor (< 4 genes) sub-clusters.  Examples of the major sub-
clusters, which contain both annotated genes and unannotated sequences, are shown in 
Figure 4.5.  Clusters were identified that contain genes which are highly expressed during 
spermatogonial mitosis (Figure 4.5 A).  It also identified groups of unannotated 
sequences that exhibit the highest or lowest expression levels at the onset of meiosis 
(Figure 4.5 B and C, respectively).  Groups of known genes and unannotated sequences 



































































































Figure 4.5.  Examples of gene sub-clusters obtained using CLUSFAVOR.  Each column 
in the sub-cluster represents one time point (from left to right: spermatogonial mitosis, 
preleptotene, pachytene I, and adult).  Each row represents one gene.  Graphs  
corresponding to each sub-cluster illustrate the mean log expression ratio for that sub-
cluster (± the standard deviation for that sub-cluster) at each time point. A.) Genes 
exhibiting relatively elevated expression during spermatogonial mitosis.  B.) Genes with 
slightly elevated expression in preleptotene. C.) Genes with decreased expression during  
preleptotene and similar (higher) expression at all other time points.  D.) Genes that have 
decreased expression during both meiosis I samplings (preleptotene and pachytene).  E.  




Spermatogenesis is a complex and highly synchronized differentiation process.  
During spermatogenesis, the expression of genes that encode proteins with key roles 
during specific periods of germ cell development is strictly regulated (Hecht, 1998; 
Grootegoed et al., 2000).  Temporal changes in gene expression as specific germ cell 
types appear during spermatogenesis have been reported for a small number of genes 
(e.g., Willison and Ashworth 1987; Thomas et al.,1989; Hecht 1998).  However, a global 
analysis of gene expression across critical timepoints during spermatogenesis (e.g., 
transition from mitosis to meiosis) is necessary to thoroughly understand germ cell 
progression through spermatogenesis and to identify genes that play critical roles in 
controlling the development and formation of mature germ cells.   
In the present study, random oligonucleotide microarrays were used to 
characterize temporal changes in gene expression in the prepubertal mouse testis as germ 
cells differentiated from spermatogonia to pachytene spermatocytes.  Differential gene 
expression was observed between every stage analyzed in this study.  This finding 
supports the suggestion that all stages of spermatogenesis are characterized by selective 
gene expression (Thomas et al. 1989).  Out of ~10,000 genes investigated, we identified 
544 genes (231 annotated genes and 313 unannotated sequences) that were differentially 
expressed during the transition from mitosis to meiosis and/or during meiosis I.  Among 
the 231 differentially expressed annotated genes, only 53 were known to have functions 
related to spermatogenesis.  Therefore, the remaining 178 annotated genes and 313 




Differential gene expression between spermatogonial mitosis and the onset of meiosis 
 Approximately 79% of the genes (428 out of 544) showed differential expression 
during the mitotic to meiotic transition.  As shown in Figure 4.2, the majority of these 
genes showed a decrease in expression as spermatogonia committed to meiosis.  Among 
the annotated genes with decreased expression were several apoptosis-related genes such 
as Bax, Mcl1 and Pdcd6 (Table 4.1).  Apoptosis plays a key role during spermatogenesis 
to regulate sperm production. During the first wave of spermatogenesis in particular, an 
early wave of apoptosis, which is necessary for the development of functional 
spermatogenesis, is coincident with a temporarily high expression of Bax (Rodriguez et al 
1997). Recent data indicate that Bax promotes cell death specifically in type A 
spermatogonia (Russell et al 2002).  Therefore, the reduced expression of Bax as 
spermatogonia move to meiosis is in agreement with the known involvement of Bax in 
regulating sperm production. 
Several genes associated with DNA repair and stress response were also shown to 
decrease in expression as cells proceeded from mitosis to meiosis (Table 4.1). 
Differential expression of DNA repair and stress response genes among the various 
spermatogenic phases has been reported in the rat, and it has been suggested that such 
differential expression contributes to the selective susceptibilities of germ cells to stress 
(Aguilar-Mahecha et al., 2001). The present results show that a similar trend is present in 
the mouse. 
 Only 45 of the 428 differentially expressed annotated genes and unannotated 
sequences genes showed higher expression in meiotic cells with respect to mitotic cells.  
Their higher expression suggest an important role in meiosis for these genes. The limited 
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number of genes that was detected as having higher expression in preleptotene cells is 
probably related to the fact that the Affymetrix Murine U74Av.1 microarray used in this 
study is highly enriched for genes with functions in somatic tissues.  
 
Differential gene expression between the onset of meiosis and mid-meiosis I 
 As shown in Figure 4.3, there was also a trend toward down-regulated gene 
expression as cells proceeded through meiosis.  Of the 70 genes that were differentially 
expressed during meiosis I, approximately 2/3 had relatively higher expression at the 
onset of meiosis compared to mid-meiosis.  Among the 25 annotated genes and 
unannotated sequences with higher expression during pachytene I, we identified Sycp1 
which exhibited a 5.7-fold increase in expression.  Sycp1 is an integral component of the 
synaptonemal complex which is assembled during pachytene I (Tureci et al 1998).  
 
Complex temporal patterns of gene expression 
Forty-six genes had a complex pattern of expression across the periods of 
spermatogenesis evaluated in this study (Table 4.3).  Further analysis of the temporal 
patterns of expression for these genes may provide clues to their function.  For example, 
genes with increased expression as spermatogonia differentiate into preleptotene 
spermatocytes and decreased expression as the preleptotene spermatocytes differentiate 
into pachytene I spermatocytes, (i.e., Odf increased 4.8-fold and subsequently decreased 
~2.3-fold), may have roles in the onset of meiosis.  Genes with decreased expression 
from mitosis to preleptotene followed by increased expressed from preleptotene to 
pachytene, (e.g., Spast decreased ~7.1-fold and then increased ~5.2-fold), may represent 
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genes whose repression is necessary for the transition from mitosis to meiosis.  Genes 
whose expression decreased between spermatogonial mitosis and preleptotene and then 
decreased further from preleptotene to pachytene, (e.g., Mdes expression decreased by 
~7.7-fold from spermatogonial mitosis to preleptotene and decreased ~2.1-fold from 
preleptotene to pachytene I), may be mitosis-associated genes.  
 
Cluster analysis of gene expression 
Cluster analysis has found widespread use in functional genomics studies for 
classifying genes based on gene expression levels from cDNA microarrays.  Several 
clustering methods have been developed for analyzing gene expression data (Eisen et al 
1998; Sneath and Sokol, 1973; Peterson, 2002).  We used hierarchical cluster analysis to 
identify groups of genes (sub-clusters) that shared identical expression patterns across the 
various spermatogenic periods (Figure 4.5).  A total of 44 major (≥ 4 genes) and 83 minor 
(< 4 genes) sub-clusters were identified.  Genes within each group may have similar 
cellular functions.  For example, four of the known genes in sub-cluster A in Figure 4.5 
(Nrp, Cask, Anx6 and Mdes) encode for plasma membrane-associated proteins suggesting 
that they may all be part of the cellular modification processes associated with 
spermatogonial proliferation and differentiation.  Genes belonging to the same cluster can 
also be used to search for common regulatory elements that may be responsible for their 
coordinated expression (Werner, 2001).  This approach has been successfully used in 






By characterizing the temporal coordination of gene expression in the prepubertal 
testis as germ cells differentiate from spermatogonia to pachytene spermatocytes, this 
research has identified ~550 genes whose function may be associated with male germ cell 
differentiation.  Characterizing the function of these genes will greatly expand our 
understanding of the molecular mechanisms associated with the onset and progression of 
spermatogenesis.  The prepubertal mouse model utilized in this study provides a unique 
method for future investigations of (a) the molecular basis of male infertility (e.g., 
meiotic arrest in mutant mice) and (b) the genetic causes of adverse reproductive 
outcomes following paternal exposure to various genotoxic agents (e.g., acrylamide, 




Special thanks to Dorreyah Schahin-Reed for her assistance with the testis 
extractions and Shea Gardner for normalizing the Affymetrix data.  Work was performed 
under the auspices of the US DOE by the University of California, LLNL under contract 
W-7405-ENG-48 with support from NIH ES09117-02; NIEHS Superfund P42ES04705; 
the Low Dose Radiation Research Program, Biological and Environmental Research 
(BER), U.S. DOE grant KP110202; the University of California and  






Adamali, H. I., Somani, I. H., Huang, J. Q., Gravel, R. A., Trasler, J. M., and Hermo, L.  
(1999a).  II. Characterization and development of the regional- and cellular- specific 
abnormalities in the epididymis of mice with beta- hexosaminidase A deficiency.  J. 
Androl. 20, 803-24. 
 
Adamali, H. I., Somani, I. H., Huang, J. Q., Mahuran, D., Gravel, R. A., Trasler, J. M., 
and Hermo, L.  (1999b).  I. Abnormalities in cells of the testis, efferent ducts, and 
epididymis in juvenile and adult mice with beta-hexosaminidase A and B deficiency.  J. 
Androl. 20, 779-802. 
 
Aguilar-Mahecha, A., Hales, B. F., and Robaire, B.  (2001).  Expression of stress 
response genes in germ cells during spermatogenesis.  Biol. Reprod. 65, 119-127. 
 
Bellve, A.R., Cavicchia, J.C., Millette, C.F., O’Brien, D.A., Bhatnagar, Y.M., and Dym, 
M.  (1977).  Spermatogenic cells of the prepuberal mouse: isolation and morphological 
characterization.  J. Cell Biol. 74, 68-85. 
 
Benbrahim-Tallaa, L., Tabone, E., Tosser-Klopp, G., Hatey, F., and Benahmed, M.  
(2002).  Glutathione S-transferase alpha expressed in porcine Sertoli cells is under the 




Bernard, P., Maure, J. F., and Javerzat, J. P.  (2001).  Fission yeast Bub1 is essential in 
setting up the meiotic pattern of chromosome segregation.  Nat. Cell. Biol. 3, 522-6. 
 
Bo, J. and Wensink, P. C.  (1989).  The promoter region of the Drosophila alpha 2-
tubulin gene directs testicular and neural specific expression.  Development 106, 581-7. 
 
Braun, R.E., Behringer, R.R., Peschon, J.J., Brinster, R.L., and Palmiter, R.D.  (1989).  
Genetically haploid spermatids are phenotypically diploid.  Nature 337, 373-6. 
 
Broceno, C., Ruiz, P., Reina, M., Vilaro, S., and Pons, G.  (1995).  The muscle-specific 
phosphoglycerate mutase gene is specifically expressed in testis during spermatogenesis.  
Eur. J. Biochem. 227, 629-35. 
 
Bucci, L. R., Brock, W. A., Goldknopf, I. L., and Meistrich, M. L.  (1984).  
Characterization of high mobility group protein levels during spermatogenesis in the rat.  
J. Biol. Chem. 259, 8840-6. 
 
Burmester, S. and Hoyer-Fender, S.  (1996).  Transcription and translation of the outer 
dense fiber gene (Odf1) during spermiogenesis in the rat. A study by in situ analyses and 




Cai, L., Chen, S., Evans, T., Deng, D. X., Mukherjee, K., and Chakrabarti, S.  (2000).  
Apoptotic germ-cell death and testicular damage in experimental diabetes: prevention by 
endothelin antagonism.  Urol. Res. 28, 342-7. 
 
Castellano, L. E., Martinez-Cadena, G., Lopez-Godinez, J., Obregon, A., and Garcia-
Soto, J.  (1997).  Subcellular localization of the GTP-binding protein Rho in the sea 
urchin sperm.  Eur. J. Cell Biol. 74, 329-35. 
 
Chan, M. C., Mather, J. P., McCray, G. and Lee, W. M.  (2000).  Identification and 
regulation of receptor tyrosine kinases Rse and Mer and their ligand Gas6 in testicular 
somatic cells.  J. Androl. 21, 291-302. 
 
Chung, S., Wang, S. P., Pan, L., Mitchell, G., Trasler, J., and Hermo, L.  (2001).  
Infertility and testicular defects in hormone-sensitive lipase-deficient mice.  
Endocrinology 142, 4272-81. 
 
Cobb, J., Reddy, R.K., Park, C., and Handel, M.A.  (1997).  Analysis of expression and 
function of topoisomerase I and II during meiosis in male mice.  Mol. Reprod. Dev. 46, 
489-98. 
 
Connor, F., Bertwistle, D., Mee, P. J., Ross, G. M., Swift, S., Grigorieva, E., Tybulewicz, 
V. L., and Ashworth, A.  (1997).  Tumorigenesis and a DNA repair defect in mice with a 




Cunliffe, V., Koopman, P., McLaren, A., and Trowsdale, J.  (1990).  A mouse zinc finger 
gene which is transiently expressed during spermatogenesis.  EMBO J. 9, 197-205. 
 
Cunningham, D.B., Segretain, D., Arnaud, D., Rogner, U.C., and Avner, P.  (1998).  The 
mouse Tsx gene is expressed in Sertoli cells of the adukt testis and transiently in 
premeiotic germ cells during puberty.  Dev. Biol. 15, 345-60. 
 
Danno, S., Itoh, K., Matsuda, T., and Fujita, J.  (2000).  Decreased expression of mouse 
Rbm3, a cold-shock protein, in Sertoli cells of cryptorchid testis.  Am. J. Pathol. 156, 
1685-92. 
 
Desseyn, J. L., Burton, K. A., and McKnight, G. S.  (2000).  Expression of a 
nonmyristylated variant of the catalytic subunit of protein kinase A during male germ-cell 
development.  Proc. Natl. Acad. Sci. USA 97, 6433-8. 
 
Di Agostino, S., Rossi, P., Geremia, R., and Sette, C.  (2002).  The MAPK pathway 
triggers activation of Nek2 during chromosome condensation in mouse spermatocytes.  
Development 129, 1715-27. 
 
Dowdy, S. and Wearden, S. (1991).  Student’s t distribution.  Statistics for Research.  2nd 




Edelmann, L., Stankiewicz, P., Spiteri, E., Pandita, R. K., Shaffer, L., Lupski, J. R., and 
Morrow, B. E.  (2001).  Two functional copies of the DGCR6 gene are present on human 
chromosome 22q11 due to a duplication of an ancestral locus.  Genome Res 11, 208-17. 
 
Eisen, M. B., Spellman, P. T., Brown, P. O., and Botstein, D.  (1998).  Cluster analysis 
and display of genome-wide expression patterns.  Proc. Natl. Acad. Sci. USA 95, 14863-
14868. 
 
Endo, K., Matsuda, Y., and Kobayashi, S.  (1997).  Mdes, a mouse homolog of the 
Drosophila degenerative spermatocyte gene is expressed during mouse spermatogenesis. 
Dev. Growth Differ. 39, 399-403. 
 
Fouquet, J., Kann, M., Soues, S., and Melki, R.  (2000).  ARP1 in Golgi organisation and 
attachment of manchette microtubules to the nucleus during mammalian 
spermatogenesis.  J. Cell Sci. 113, 877-86. 
 
Fulcher, K. D., Welch, J. E., Klapper, D. G., O'Brien, D. A., and Eddy, E. M.  (1995).  
Identification of a unique mu-class glutathione S-transferase in mouse spermatogenic 
cells.  Mol. Reprod. Dev. 42, 415-24. 
 
Futcher, B.  (2000).  Microarrays and cell cycle transcription in yeast.  Curr. Opin. Cell 




Giannattasio, A., Girotti, M., Williams, K., Hall, L., and Bellastella, A.  (1997).  Puberty 
influences expression of phospholipid hydroperoxide glutathione peroxidase (GPX4) in 
rat testis: probable hypophysis regulation of the enzyme in male reproductive tract.  J. 
Endocrinol. Invest. 20, 439-44. 
 
Gilbert, S.F.  (1994).  The saga of the germ line.  Developmental Biology.  4th Ed.  
Sunderland:Sinauer Associates, Inc.  pp. 798-801. 
 
Grootegoed, J. A., Siep, M., and Baarends, W. M.  (2000).  Molecular and cellular 
mechanisms in spermatogenesis.  Baill. Clin. Endocrin. Metab. 14, 331-343. 
 
Ham, A.W.  (1974).  The male reproductive system.  Histology. 7th Ed.  Philadelphia: 
J.B. Lippincott Company, pp. 900-35. 
 
Hansis, C., Jahner, D., Spiess, A. N., Boettcher, K., and Ivell, R.  (1998).  The gene for 
the Alzheimer-associated beta-amyloid-binding protein (ERAB) is differentially 
expressed in the testicular Leydig cells of the azoospermic by w/w(v) mouse.  Eur. J. 
Biochem. 258, 53-60. 
 
Harrington, J. J. and Lieber, M. R.  (1994).  The characterization of a mammalian DNA 




Hogan, B., Costantini, F., and Lacy, E.  (1986).  Summary of mouse development.  
Manipulating the Mouse Embryo: A Laboratory Manual.  New York: Cold Spring Harbor 
Laboratory.  pp. 19-27. 
 
Husen, B., Giebel, J., and Rune, G.  (1999).  Expression of the integrin subunits alpha 5, 
alpha 6 and beta 1 in the testes of the common marmoset.  Int. J. Androl. 22, 374-84. 
 
Irizarry, R.A., Hobbs, B., Collin, F., Beazer-Barclay, Y.D., Antonellis, K.J., Scherf, U., 
and Speed, T.P.  (2002).  Exploration, normalization, and summaries of high density 
oligonucleotide array probe level data.  Submitted to: Biostatistics and available at: 
http://biosun01.biostat.jhsph.edu/~ririzarr/papers/index.html. 
 
Ivanov, I. P., Rohrwasser, A., Terreros, D. A., Gesteland, R. F., and Atkins, J. F.  (2000).  
Discovery of a spermatogenesis stage-specific ornithine decarboxylase antizyme: 
antizyme 3.  Proc. Natl. Acad. Sci. USA 97, 4808-13. 
 
Jelinsky, S. A., Estep, P., Church, G. M., and Samson, L. D.  (2000).  Regulatory 
networks revealed by transcriptional profiling of damaged Saccharomyces cerevisiae 
cells: Rpn4 links base excision repair with proteasomes.  Mol. Cell. Biol. 20, 8157-67. 
 
Kanai, Y., Kanai-Azuma, M., Tajima, Y., Birk, O. S., Hayashi, Y., and Sanai, Y.  (2000).  
Identification of a stromal cell type characterized by the secretion of a soluble integrin-




Kao, F. T., Wu, K. C., Law, M. L., Hartz, J. A., and Lau, Y. F.  (1988).  Assignment of 
human gene encoding testis-specific lactate dehydrogenase C to chromosome 11, region 
p14.3-p15.5.  Somat. Cell Mol. Genet. 14, 515-8. 
 
Kerr, W. G. and Burrows, P. D.  (1991).  Stage-specific transcription of germline IgH C 
gamma and C alpha regions during human B cell differentiation.  Int. Immunol. 3, 1059-
65. 
 
Kilpatrick, D. L., Zinn, S. A., Fitzgerald, M., Higuchi, H., Sabol, S. L., and Meyerhardt, 
J.  (1990).  Transcription of the rat and mouse proenkephalin genes is initiated at distinct 
sites in spermatogenic and somatic cells.  Mol. Cell. Biol. 10, 3717-26. 
 
Kim, E., Waters, S. H., Hake, L. E., and Hecht, N. B.  (1989).  Identification and 
developmental expression of a smooth-muscle gamma- actin in postmeiotic male germ 
cells of mice.  Mol. Cell. Biol. 9, 1875-81. 
 
Kolmer, M., Pelto-Huikko, M., Parvinen, M., Hoog, C., and Alho, H.  (1997).  The 
transcriptional and translational control of diazepam binding inhibitor expression in rat 




Komada, M., McLean, D. J., Griswold, M. D., Russell, L. D., and Soriano, P.  (2000).  E-
MAP-115, encoding a microtubule-associated protein, is a retinoic acid-inducible gene 
required for spermatogenesis.  Genes Dev. 14, 1332-42. 
 
Kurth, B. E., Klotz, K., Flickinger, C. J., and Herr, J. C.  (1991).  Localization of sperm 
antigen SP-10 during the six stages of the cycle of the seminiferous epithelium in man.  
Biol. Reprod. 44, 814-21. 
 
Le Douarin, B., Nielsen, A. L., Garnier, J. M., Ichinose, H., Jeanmougin, F., Losson, R., 
and Chambon, P.  (1996).  A possible involvement of TIF1 alpha and TIF1 beta in the 
epigenetic control of transcription by nuclear receptors.  EMBO J. 15, 6701-15. 
 
Lindner, K., Gregan, J., Montgomery, S., and Kearsey, S. E.  (2002).  Essential role of 
MCM proteins in premeiotic DNA replication.  Mol. Biol. Cell 13, 435-44. 
 
Luoh, S. W., Bain, P. A., Polakiewicz, R. D., Goodheart, M. L., Gardner, H., Jaenisch, 
R., and Page, D. C.  (1997).  Zfx mutation results in small animal size and reduced germ 
cell number in male and female mice.  Development 124, 2275-84. 
 
Manandhar, G., Moreno, R. D., Simerly, C., Toshimori, K., and Schatten, G.  (2000).  
Contractile apparatus of the normal and abortive cytokinetic cells during mouse male 




Matsubara, N., Yanagisawa, M., Nishimune, Y., Obinata, M., and Matsui, Y.  (1995).  
Murine polo like kinase 1 gene is expressed in meiotic testicular germ cells and oocytes.  
Mol. Reprod. Dev. 41, 407-15. 
 
Matsumoto, M., Kurata, S., Fujimoto, H., and Hoshi, M.  (1993).  Haploid specific 
activations of protamine 1 and hsc70t genes in mouse spermatogenesis.  Biochim. 
Biophys. Acta 1174, 274-8. 
 
Mazeyrat, S., Saut, N., Grigoriev, V., Mahadevaiah, S. K., Ojarikre, O. A., Rattigan, A., 
Bishop, C., Eicher, E. M., Mitchell, M. J., and Burgoyne, P. S.  (2001).  A Y-encoded 
subunit of the translation initiation factor Eif2 is essential for mouse spermatogenesis.  
Nat. Genet. 29, 49-53. 
 
Mertineit, C., Yoder, J. A., Taketo, T., Laird, D. W., Trasler, J. M., and Bestor, T. H.  
(1998).  Sex-specific exons control DNA methyltransferase in mammalian germ cells.  
Development 125, 889-97. 
 
Mulholland, D. J., Dedhar, S., and Vogl, A. W. (2001).  Rat seminiferous epithelium 
contains a unique junction (Ectoplasmic specialization) with signaling properties both of 
cell/cell and cell/matrix junctions.  Biol. Reprod. 64, 396-407. 
 
Oakberg, E.F.  (1956).  Duration of spermatogenesis in the mouse and timing of stages of 




Pei, L.  (1999).  Pituitary tumor-transforming gene protein associates with ribosomal 
protein S10 and a novel human homologue of DnaJ in testicular cells.  J. Biol. Chem. 
274, 3151-8. 
 
Peterson, L.E.  (2002).  Factor analysis of cluster-specific gene expression levels from 
cDNA microarrays.  Comput. Methods Programs Biomed.  In press. 
 
Ramalho-Santos, J. and Moreno, R. D.  (2001).  Targeting and fusion proteins during 
mammalian spermiogenesis.  Biol. Res. 34, 147-52. 
 
Rodriguez, I., Ody, C., Araki, K., Garcia, I., and Vassalli, P.  (1997).  An early and 
massive wave of germinal cell apoptosis is required for the development of functional 
spermatogenesis.  EMBO J. 16, 2262-2270. 
 
Roscoe, W. A., Barr, K. J., Mhawi, A. A., Pomerantz, D. K., and Kidder, G. M.  (2001).  
Failure of spermatogenesis in mice lacking connexin43.  Biol. Reprod. 65, 829-38. 
 
Russell, D. L. and Kim, K. H.  (1996).  Expression of triosephosphate isomerase 
transcripts in rat testis: evidence for retinol regulation and a novel germ cell transcript.  




Russell, L. D., Chiarini-Garcia, H., Korsmeyer, S. J., and Knudson, C. M.  (2002).  Bax-
dependent spermatogonia apoptosis is required for testicular development and 
spermatogenesis.  Biol. Reprod. 66, 950-8. 
 
Russell, L., Ettlin, R., Sinha-Hikim, A., and Clegg, E.  (1990).  Mammalian 
spermatogenesis.  Histological and Histopathological Evaluation of the Testis.  
Illinois:Cache River Press.  pp. 1-58. 
 
Schrans-Stassen, B.H., van de Kant, H.J., de Rooij, D.G., and van Pelt, A.M.  (1999).  
Differential expression of c-kit in mouse undifferentiated and differentiating type A 
spermatogonia.  Endocrinology 140, 5894-900. 
 
Sha, J., Baker, P., and O'Shaughnessy, P. J.  (1996).  Both reductive forms of 17 beta-
hydroxysteroid dehydrogenase (types 1 and 3) are expressed during development in the 
mouse testis.  Biochem. Biophys. Res. Commun. 222, 90-4. 
 
Shih, D. M. and Kleene, K. C.  (1992).  A study by in situ hybridization of the stage of 
appearance and disappearance of the transition protein 2 and the mitochondrial capsule 
seleno-protein mRNAs during spermatogenesis in the mouse.  Mol. Reprod. Dev. 33, 
222-7. 
 





Tanaka, K., Tamura, H., Tanaka, H., Katoh, M., Futamata, Y., Seki, N., Nishimune, Y., 
and Hara, T.  (2002).  Spermatogonia-dependent expression of testicular genes in mice.  
Dev. Biol. 246, 466-79. 
 
Thomas, K.H., Wilkie, T.M., Tomashefsky, P., Bellve, A.R., and Simon, M.I.  (1989).  
Differential gene expression during mouse spermatogenesis.  Biol. Reprod. 41, 729-39. 
 
Tosaka, Y., Tanaka, H., Yano, Y., Masai, K., Nozaki, M., Yomogida, K., Otani, S., 
Nojima, H., and Nishimune, Y.  (2000).  Identification and characterization of testis 
specific ornithine decarboxylase antizyme (OAZ-t) gene: expression in haploid germ 
cells and polyamine-induced frameshifting.  Genes Cells 5, 265-76. 
 
Tsuruta, J. K., O'Brien, D. A., and Griswold, M. D.  (1993).  Sertoli cell and germ cell 
cystatin C: stage-dependent expression of two distinct messenger ribonucleic acid 
transcripts in rat testes.  Biol. Reprod. 49, 1045-54. 
 
Tureci, O., Sahin, U., Zwick, C., Koslowski, M., Seitz, G., and Pfreundschuh, M.  (1998).  
Identification of a meiosis-specific protein as a member of the class of cancer/testis 
antigens.  Proc. Natl. Acad. Sci. USA 95, 5211-6. 
 
Vernon, R. B. and Sage, H.  (1989).  The calcium-binding protein SPARC is secreted by 




Wakayama, T., Ohashi, K., Mizuno, K., and Iseki, S.  (2001).  Cloning and 
characterization of a novel mouse immunoglobulin superfamily gene expressed in early 
spermatogenic cells.  Mol. Reprod. Dev. 60, 158-64. 
 
Welch, J. E., Schatte, E. C., O'Brien, D. A., and Eddy, E. M.  (1992).  Expression of a 
glyceraldehyde 3-phosphate dehydrogenase gene specific to mouse spermatogenic cells.  
Biol. Reprod. 46, 869-78. 
 
Werner, T.  (2001).  Target gene identification from expression array data by promoter 
analysis.  Biomol. Eng. 17, 87-94. 
 
Wine, R. N. and Chapin, R. E.  (1999).  Adhesion and signaling proteins spatiotemporally 
associated with spermiation in the rat.  J. Androl. 20, 198-213. 
 
Xue, H., O'Neill, D., Wang, X., Wolgemuth, D. J., and Bank, A.  (1999).  HemT-3, an 














Characterizing variations in gene expression is essential for thoroughly 
understanding the molecular events associated with diverse biological functions 
including: normal cell and tissue physiology, tissue response to DNA damaging 
conditions, susceptibility to genetic disease, and cellular differentiation during 
development.  The large and continuing increase in genome sequence information has 
facilitated the development of expression microarrays for analyzing the differential 
expression of hundreds to thousands of genes in parallel.  The goal of this research was to 
use expression microarray technology to (a) understand the natural tissue variation in 
stress response and DNA repair-associated gene expression and (b) characterize 
differential gene expression during male germ cell differentiation from mitotic to meiotic 
cells and discover new candidate genes associated with the onset and progression of 
spermatogenesis. 
To address these issues, this research utilized two separate approaches.  Custom 
cDNA microarrays comprised of genes selected a priori were used to characterize the 
variation in gene expression among tissues, and random oligonucleotide microarrays 
were used to discover new genes associated with early male germ cell differentiation.  
First, cDNA microarray hybridization and image analysis techniques were optimized 
(Chapter 2).  A custom cDNA microarray was built to detect the differential basal 
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expression of 417 genes associated with chromatin remodeling, damage control, DNA 
repair, growth regulation, meiosis, stress response, transcription, and translation among 
adult mouse tissues (testis, brain, liver, spleen, and heart).  Approximately 25% of the 
arrayed genes were differentially expressed among healthy tissues.  Genes associated 
with stress response showed the most variation among tissues, while DNA repair genes 
showed the least variation.  Damage control genes showed intermediate variation 
(Chapter 3).  These findings identify candidate stress response, DNA repair, and damage 
control genes whose variation in expression among tissues may contribute to tissue-
specific differences in the response to DNA damage and in genetic disease susceptibility. 
A random oligonucleotide microarray was then utilized to identify genes whose 
expression profile changed as germ cells differentiated from spermatogonia into primary 
spermatocytes during the first wave of spermatogenesis (Chapter 4).  Expression profiling 
of the prepubertal mouse testis characterized the temporal modulations in gene 
expression that underlie cellular differentiation during spermatogenesis.  Specifically, 
differential expression was observed for 231 annotated genes and 313 unannotated 
sequences (544 total).  Spermatogenesis-related roles were previously reported for only 
53 of these 231 annotated genes (~23%).  Thus, this research has identified potential 
spermatogenesis-related functions for 178 annotated genes and 313 unannotated 
sequences that had not been previously associated with male germ cell development.  The 
identification of ~500 new candidate genes associated with the onset and progression of 
spermatogenesis opens the door to a better understanding of the molecular events 
controlling male germ cell development. 
The findings of this dissertation research suggest that future work is needed to (a) 
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link tissue-specific variations in gene expression with genetic disease phenotypes, (b) 
characterize the specific functions of candidate genes associated with germ cell 
progression through spermatogenesis, (c) identify groups of genes with coordinated 
expression (i.e., syn-expression groups), (d) assess differences in transcript vs. protein 
abundance, and (e) investigate the relative contributions of tissue microenvironments to 







































Symbols, names, biological pathways, I.M.A.G.E. clone IDs, and cDNA microarray data 


























Gene Symbol Gene Name Pathways (General) I.M.A.G.E. ID
P 
valuec
Testis Spleen Heart Liver Brain Num. Denom. Ratio
14-3-3 gamma 14-3-3 gamma Growth regulation 636783 0.95 0.66 0.74 0.60 0.78 0.13 0.16 0.8 1.00
14-3-3 tau 14-3-3 tau Growth regulation 849982 1.00 0.66 0.43 0.54 1.43 0.95 *0.03870 20.9 0.12
Acetyltransferase Acetyltransferase Chromatin related 577211 0.89 0.47 0.89 1.66 0.66 0.92 0.10 9.3 0.20
Acrv1 Acrosomal vesicle protein 1 Other 515873 0.65 0.15 0.20 0.34 0.28 1.27 0.10 12.8 0.13
Actb Actin, beta Housekeeping 992475, 989387 1.13 2.86 2.06 0.69 0.66 1.78 0.20 8.8 0.22
Adk1 Adenylate kinase isozyme 1 Stress response/ Stress inducible 602526 0.92 0.52 0.73 0.65 0.77 0.19 0.09 2.1 0.98
Apg-1b Apg-1b Stress response/ Stress induced 901984 1.11 1.49 2.48 2.18 1.81 0.42 *0.02340 9.2 0.21
B2m Beta-2 microglobulin Growth regulation 596438 1.06 9.90 2.68 5.87 1.79 3.36 0.24 13.8 0.12
Bmp4 Bone morphogenetic protein 4 Damage recognition, cell cycle, apoptosis
888656, 865694, 
873328 1.08 0.92 2.68 1.82 1.53 0.75 *0.04070 16.4 0.12
Bp-h5 Brain protein h5 Other 876821 1.33 0.58 6.52 12.30 2.13 6.23 *0.03120 137.0 0.00
Btg1 B-cell translocation gene 1 Damage recognition, cell cycle, apoptosis 634804 0.99 5.66 0.41 0.83 0.81 3.99 0.07 59.6 0.01
Cas1 Catalase 1 Stress response/ Stress induced 573840 1.10 1.23 1.43 8.28 0.98 3.26 0.10 31.3 0.03
Ctnnb1 Catenin, beta 1 Transcription/ Translation 777028 1.00 1.86 2.47 1.46 1.73 0.46 0.05 10.1 0.18
Cdc2 Cell division cycle 2 Damage recognition, cell cycle, apoptosis 375194, 763260 0.96 0.60 0.60 0.71 0.60 0.17 0.07 2.5 0.91
Cdc2a Cell division cycle  2a Damage recognition, cell cycle, apoptosis 582109 1.04 0.64 0.54 0.59 0.69 0.27 0.05 5.4 0.52
Cdc42 Cell division cycle 42 Damage recognition, cell cycle, apoptosis 977455 1.19 2.88 2.15 2.28 2.86 0.54 0.05 10.2 0.18
Cdk2 Cyclin dependent kinase 2 Damage recognition, cell cycle, apoptosis 876724 0.93 0.19 0.20 0.46 0.33 1.81 0.12 15.4 0.12
Pki Camp-dependent protein kinase inhibitor Growth regulation 514418 0.66 0.18 0.19 0.25 0.28 1.11 0.06 18.2 0.12
Clu Clusterin Other 617298 0.87 1.44 0.87 2.04 1.09 0.55 0.11 4.8 0.58
Crem CAMP responsive element modulator Growth regulation 917671 0.76 0.25 0.33 0.50 0.57 0.80 0.36 2.2 0.96
Crem-like CAMP responsive element modulator-like Growth regulation 917671 0.85 0.18 0.26 0.30 0.38 1.39 0.13 10.6 0.17
Cut3 Cut3 Chromatin related 643940 0.79 0.23 0.22 0.87 0.50 1.83 0.18 9.9 0.19
Ccnf Cyclin-F Damage recognition, cell cycle, apoptosis 888861 0.99 0.95 2.20 1.03 0.87 0.59 0.78 0.8 1.00
Ck17 Cytokeratin-17 Housekeeping 975849 0.86 1.25 2.42 1.16 1.20 0.60 0.34 1.8 1.00
Dapk1 DAP-kinase related protein 1 Other 403602 1.06 1.68 1.05 2.46 1.13 0.58 0.12 4.9 0.58
Dby DEAD/H box polypeptide, Y chromosome Meiosis/ Spermatogenesis 573643 1.04 1.51 1.43 1.33 1.69 0.14 *0.01640 3.0 0.83
Dnaj Dnaj Stress response/ Stress inducible 602316, 602961 0.67 0.11 0.16 0.17 0.20 1.99 *0.03350 43.5 0.01
Dnaj-like Dnaj-like Stress response/ Stress inducible 514436 0.93 0.25 0.47 0.61 0.57 0.94 *0.01690 20.7 0.12
E2f1 E2f transcription factor 1 Transcription/ Translation 605037 0.87 0.94 2.24 0.93 1.17 0.64 *0.00859 13.9 0.12
E2f3 E2f transcription factor 3 Transcription/ Translation 539249 1.02 0.46 0.48 0.54 0.78 0.49 0.08 6.2 0.38
Faf1 Fas(TNFRSF6)-associated factor 1 Damage recognition, cell cycle, apoptosis 574610 0.91 0.55 0.81 0.85 0.77 0.16 *0.01930 3.4 0.75
Fbr-MuSV Finkel-Biskis-Reilly murine sarcoma virus Other 805511 0.87 2.88 0.67 1.61 1.07 1.37 0.05 28.4 0.03
Figf C-fos induced growth factor Transcription/ Translation 614347 1.18 1.01 0.48 1.32 1.09 0.66 0.56 1.2 1.00
Gadd153 Growth arrest and DNA damage inducible 153 Stress response/ Stress inducible 903718 1.07 0.59 5.44 1.88 1.77 2.79 0.10 28.6 0.03
Gap43 Growth accentuating protein 43 Damage recognition, cell cycle, apoptosis 479228 1.06 1.02 1.02 1.26 2.52 0.62 *0.01960 13.7 0.12
Gas2 Growth arrest specific 2 Damage recognition, cell cycle, apoptosis 520303 0.92 8.57 3.70 3.01 2.20 2.73 0.33 8.3 0.23
Gli Glioma-associated oncogene homolog Transcription/ Translation 386514 1.08 1.09 0.73 0.60 0.65 0.33 0.14 2.5 0.91
Gpx1 Glutathione peroxidase 1 Stress response/ Stress induced 861820 1.10 2.09 26.50 4.15 3.38 5.93 0.13 46.2 0.01
Grp78 Glucose regulated protein, 78 kDa Stress response/ Stress inducible 935093 0.89 0.96 1.17 1.88 0.82 0.46 0.12 3.8 0.70
Gstp2 Glutathione S-transferase, pi 2 Stress response/ Stress inducible 864333 1.13 0.95 18.00 5.18 3.95 6.05 0.06 106.0 0.00
Hdac1 Histone deacetylase 1 Chromatin related 641105 1.02 0.94 0.53 0.63 0.80 0.32 0.05 6.0 0.41
Histone-1 Histone-1 Chromatin related 493091 1.28 2.58 2.31 1.41 1.63 0.39 0.23 1.7 1.00
Histone-H1.1 Histone-H1.1 Chromatin related 483515 0.84 2.63 0.74 1.34 1.00 1.06 0.12 8.9 0.22
Ratio to Pooled Testis F Statistic b




Gene Symbol Gene Name Pathways (General) I.M.A.G.E. ID
P 
valuec
Testis Spleen Heart Liver Brain Num. Denom. Ratio
Histone-H3.3A Histone-H3.3A Chromatin related 961662 0.97 0.49 0.39 0.26 0.44 0.95 0.14 6.9 0.33
Histone-H4 Histone-H4 Chromatin related 493223 0.97 1.73 14.80 4.43 9.97 5.47 0.09 60.6 0.01
Hk1 Hexokinase 1 Growth regulation 973936 0.65 1.38 0.27 0.81 0.79 1.46 0.07 19.5 0.12
Hmox2 Heme oxygenase 2 Stress response/ Stress induced 602116 0.82 0.33 0.28 0.54 0.63 0.82 0.05 15.1 0.12
hnRNP-A2 heterogenous nuclear ribonucleoprotein A2/B1 Transcription/ Translation 721779 1.52 1.71 1.18 1.21 1.51 0.11 0.11 1.0 1.00
hnRP-A1 heterogenous nuclear ribonucleoprotein A1 Transcription/ Translation 386370 1.14 3.66 1.55 1.11 0.93 1.24 0.09 14.2 0.12
hTAFII18-like PolII transcription factor TFIID chain hTAFII18 Transcription/ Translation 523974 0.78 0.42 0.70 0.76 0.89 0.36 0.07 4.9 0.58
Idb2 Inhibitor of DNA binding 2 Transcription/ Translation 608134 0.88 1.19 1.95 1.39 1.46 0.36 *0.02120 7.8 0.24
Jun v-jun sarcoma virus 17 oncogene Growth regulation 975691 0.80 1.61 3.24 1.10 1.24 1.16 1.11 1.0 1.00
Keratin-like Keratin-like Housekeeping
975676, 975855, 
608390, 608109 1.08 1.58 2.71 2.06 1.49 0.50 *0.02260 11.0 0.15
Kif1a Kinesin heavy chain member 1A Growth regulation 492514 1.12 15.90 4.84 2.76 1.95 4.26 0.45 9.5 0.19
Kif1b Kinesin heavy chain member 1B Growth regulation 560049 1.08 1.83 1.51 1.49 1.03 0.25 *0.00513 5.5 0.50
Kif2 Kinesin heavy chain member 2 Growth regulation 602145 0.94 0.34 0.90 1.08 1.06 0.97 *0.03390 21.2 0.11
Kif3b Kinesin family member 3b Growth regulation 1108812 1.08 0.76 0.48 0.52 0.75 0.44 0.06 7.8 0.24
Kinesin-2-related Kinesin-2-related Growth regulation 990126 0.71 0.95 0.53 0.75 0.85 0.21 0.06 3.7 0.70
Krag Kras oncogene-associated gene Growth regulation 484140 1.06 2.80 1.34 2.14 1.13 0.75 0.10 7.8 0.24
Kras2 Kirsten rat sarcoma oncogene 2 Growth regulation 572995 1.04 1.17 3.84 1.24 1.31 1.18 2.31 0.5 1.00
Krt1-10 Keratin complex 1, acidic, gene 10 Housekeeping 976351 0.93 0.37 0.26 0.41 0.48 0.90 0.42 2.1 0.96
Krt1-13 Keratin complex 1, acidic, gene 13 Housekeeping 521007 1.11 2.37 2.88 1.28 0.95 1.00 *0.03720 21.9 0.11
Lama2 Laminin, alpha 2 Other 493133 1.45 8.51 5.90 2.14 1.89 2.49 0.07 37.2 0.01
Lama4 Laminin, alpha 4 Other 584781 1.10 0.87 15.40 2.67 3.27 5.36 *0.00823 118.0 0.00
Mak Male germ cell associated kinase Growth regulation 602281 0.94 0.16 0.19 0.24 0.27 2.06 *0.02610 45.2 0.01
Mapk2 Mitogen activated protein kinase 2 Growth regulation
749454, 439956, 
554209 1.07 0.91 0.79 2.05 0.90 0.59 *0.02690 12.9 0.13
Mcl1 Myeloid cell leukemia sequence 1 Damage recognition, cell cycle, apoptosis 493170 1.20 2.38 9.42 4.32 2.46 2.47 0.15 16.5 0.12
Mea1-like Male enhanced antigen 1-like Other 315756 0.64 0.40 0.40 0.56 0.82 0.40 *0.01120 8.8 0.22
Mea1 Male enhanced antigen 1 Other 608800 1.01 0.11 0.18 0.20 0.21 2.89 0.18 16.1 0.12
Meg1 Meiosis expressed gene 1 Other 514389 0.75 0.11 0.11 0.18 0.22 2.52 *0.04480 55.3 0.01
Map2k1 Mitogen activated protein kinase kinase 1 Meiosis/ Spermatogenesis 616850 1.17 2.03 1.50 1.24 1.37 0.19 *0.03230 4.2 0.58
Map3k1 Mitogen activated protein kinase kinase kinase 1 Growth regulation 875311 0.90 0.25 0.49 0.44 0.43 0.89 0.16 5.5 0.51
Mgmt 0-6-methylguanine-DNA methyltransferase DNA repair (direct reversal) 493108 1.12 1.11 2.83 1.56 1.38 0.61 0.13 4.9 0.58
Mig-2 Mitogen inducible gene 2 Meiosis/ Spermatogenesis 988186 1.24 1.07 5.50 18.40 3.14 5.67 0.88 6.4 0.38
Mkk7 Mitogen-activated protein kinase kinase 7 Growth regulation 821017 0.96 1.87 1.60 1.63 4.90 1.48 *0.00408 32.4 0.02
Mlc2 Myosin light chain 2 Housekeeping 556208, 604573 1.04 0.96 2.91 0.94 1.11 0.95 *0.04520 20.8 0.12
Mns1 Meiosis-specific nuclear structural protein 1 Meiosis/ Spermatogenesis 538140 1.11 0.23 0.36 0.27 0.37 1.58 0.32 5.0 0.58
Kzf2 Kruppel zinc finger protein 2 Other 789990 1.11 0.56 0.70 0.51 0.87 0.42 *0.00970 9.2 0.20
RbAp48 Retinoblastoma-binding protein Other 660074 0.77 1.93 0.57 0.95 0.66 0.96 0.15 6.5 0.38
Mre11b Meiotic recombination 11 homolog b DNA Repair (RR-Non-Homologous end joining)524361 0.96 0.46 0.74 0.62 0.77 0.32 *0.02260 7.0 0.32
Msk2 Mitogen- and stress-activated protein kinase-2 Growth regulation 873975 1.03 1.42 1.73 1.26 0.99 0.22 0.10 2.2 0.96
Mt2 Metallothionein 2 Other 963382 0.80 0.26 0.24 0.34 1.11 1.99 0.07 27.9 0.03
Mybl2 Myeloblastosis oncogene-like 2 Growth regulation 532188 1.02 0.54 0.69 0.84 0.69 0.24 *0.03350 5.3 0.54
Myla Myosin light chain, alkali Housekeeping 586078 0.94 1.24 5.22 1.32 1.21 1.94 0.07 27.2 0.05




Gene Symbol Gene Name Pathways (General) I.M.A.G.E. ID
P 
valuec
Testis Spleen Heart Liver Brain Num. Denom. Ratio
Naip1 Neuronal apoptosis inhibitory protein 1 Damage recognition, cell cycle, apoptosis 864370 0.73 1.23 2.38 1.01 1.15 0.78 1.43 0.5 1.00
Naip2 Neuronal apoptosis inhibitory protein 2 Damage recognition, cell cycle, apoptosis 737787 0.93 0.73 0.89 4.93 0.99 2.53 0.12 20.5 0.12
Odf1 Outer dense fiber of sperm tails 1 Other 603127 0.86 0.40 0.50 0.63 0.51 0.35 0.23 1.5 1.00
p18 p18 Transcription/ Translation 474080 0.90 0.31 0.50 0.49 0.65 0.65 0.14 4.6 0.58
p40 p40 DNA repair (NER) 931450 0.90 0.38 0.53 0.54 0.62 0.40 0.11 3.8 0.70
p52 p52 DNA repair (NER) 443359 1.15 0.82 0.60 0.92 0.80 0.24 0.05 5.0 0.58
Pabp PolyA binding protein Transcription/ Translation 891504, 977971 0.70 0.54 0.33 0.29 0.37 0.55 *0.04060 12.1 0.15
Pabp (testis) PolyA binding protein (testis-enriched isoform) Transcription/ Translation 516680 0.67 0.29 0.15 0.26 0.21 1.32 0.20 6.5 0.38
Paga Proliferation-associated gene A Damage recognition, cell cycle, apoptosis 617734 0.93 1.31 2.67 12.90 1.68 4.43 *0.03300 97.1 0.00
Pcna Proliferating cell nuclear antigen DNA repair (NER) 907695 1.04 0.72 0.31 0.37 0.48 1.02 0.14 7.3 0.28
Pcsk2 Proprotein convertase subtilisin/kexin type 2 Other 477515 0.91 1.18 0.56 0.83 0.59 0.41 0.05 8.1 0.23
Pctk3 PCTAIRE-motif protein kinase 3 Damage recognition, cell cycle, apoptosis 579416 1.07 1.35 1.08 1.42 2.34 0.42 0.14 2.9 0.87
Pgk1 Phosphoglycerate kinase 1 Growth regulation 822652 0.98 0.74 2.47 1.70 1.68 0.97 0.06 15.8 0.12
Phb Prohibitin Other 584178 0.94 0.47 1.42 1.07 0.66 0.78 0.06 13.0 0.13
Pkcq Protein kinase C, theta Growth regulation 582973 0.86 0.59 0.99 0.83 1.06 0.21 0.07 3.0 0.84
Pla2g2c Phospholipase A2, group IIC Housekeeping 513783 1.13 1.52 21.00 6.50 5.30 5.83 *0.02490 128.0 0.00
Pol-β DNA polymerase beta DNA repair (BER) 918389 1.00 0.17 0.18 0.26 0.46 2.32 *0.04520 50.8 0.01
Mapk1 Mitogen activated protein kinase 1 Growth regulation 736825, 634946 1.21 1.64 1.65 1.26 2.72 0.44 0.10 4.2 0.60
Prkmk1 Prkmk1 Growth regulation 585802 0.87 1.67 1.22 1.76 2.23 0.55 0.06 8.8 0.22
Prm1 Protamine 1 Meiosis/ Spermatogenesis 918252 0.41 0.17 0.18 0.16 0.13 0.79 0.29 2.7 0.87
Prm2 Protamine 2 Meiosis/ Spermatogenesis 917852 0.94 0.36 0.33 0.61 0.53 0.75 0.06 12.1 0.15
Prm3 Protamine 3 Meiosis/ Spermatogenesis 907309 1.11 2.16 1.42 0.88 1.01 0.52 0.31 1.7 1.00
Prp22 Pre-mRNA splicing factor RNA helicase Transcription/ Translation 604173 1.05 1.10 0.29 0.42 0.45 1.45 0.18 8.2 0.23
Ptgds Prostaglandin D2 synthase Other 571621 1.46 1.31 16.70 5.93 4.98 4.68 0.09 54.4 0.01
Rad51-ap1 Rad51 associated protein 1 DNA repair related 849369 1.13 0.80 2.23 1.06 0.96 0.64 0.86 0.7 1.00
Rad51b Rad51b DNA repair (Recombinational repair-Homologous)
1225890, 
1246004 1.33 1.13 1.04 1.97 1.11 0.28 0.08 3.3 0.77
Rara Retinoic acid receptor, alpha Other 475996 1.02 0.74 0.74 0.61 0.48 0.32 *0.02520 7.1 0.31
Rbm3 RNA binding motif protein 3 Transcription/ Translation 872105 1.16 1.78 14.40 6.90 3.07 4.30 *0.04340 94.2 0.00
Rec2 RecA-like protein Other 1246004 0.87 1.45 0.91 2.94 1.44 1.00 0.06 17.6 0.12
Req Requiem Damage recognition, cell cycle, apoptosis 573346 1.03 0.95 3.30 0.70 0.75 1.66 1.14 1.5 1.00
Rip1 Ral-interacting protein 1 Damage recognition, cell cycle, apoptosis 849333 1.11 0.98 19.40 3.52 3.59 6.02 0.13 47.8 0.01
RNA pol transcrip. 
reg. med.
RNA polymerase transcriptional regulation 
mediator Transcription/ Translation 635118 0.95 0.68 0.53 0.67 0.98 0.28 0.07 4.2 0.58
Rxrb Retinoid X receptor beta Other 493651 1.27 4.79 6.07 1.92 1.65 1.98 0.70 2.8 0.87
Rxrg Retinoid X receptor gamma Other 479866 1.03 3.51 3.16 1.54 1.07 1.43 *0.00852 31.4 0.03
Smp30 Senescence marker protein-30 Damage recognition, cell cycle, apoptosis 521164, 747954 1.07 1.82 2.72 10.50 1.97 3.06 0.07 41.3 0.01
Snf2l
SWI/SNF-related, matrix associated, actin 
dependent regulator of chromatin, subfamily a, 
member 1 Transcription/ Translation 960224 0.98 0.73 3.64 0.92 1.15 1.65 *0.02490 36.3 0.01
Snf5l
SWI/SNF-related, matrix associated, actin 
dependent regulator of chromatin, subfamily b, 
member 1 Transcription/ Translation 580874 1.08 0.91 0.90 2.51 0.94 0.80 *0.00704 17.5 0.12
Snrpn Small nuclear ribonucleoprotein N Transcription/ Translation 977306 1.01 0.72 0.68 0.84 2.36 1.07 0.05 19.5 0.12
Sod1 Superoxide dismutase 1 Stress response/ Stress induced 762216 0.98 0.59 0.63 1.06 0.64 0.32 0.14 2.3 0.93
Sod3 Superoxide dismutase 3 Stress response/ Stress induced 776821 1.16 0.78 8.78 2.57 2.58 3.59 0.06 62.4 0.01
Ratio to Pooled Testis F Statistic b
 
 159
Gene Symbol Gene Name Pathways (General) I.M.A.G.E. ID
P 
valuec
Testis Spleen Heart Liver Brain Num. Denom. Ratio
Sox6 SRY-box containing gene 6 Transcription/ Translation 1068053 1.11 0.95 4.38 2.21 1.74 1.54 0.05 31.1 0.03
Srm Spermidine-synthase Other 582569 0.89 1.09 0.88 0.90 2.04 0.54 0.13 4.3 0.58
Spnr Spermatid perinuclear RNA-binding protein Transcription/ Translation 764543 0.87 0.34 0.30 0.40 0.78 0.99 0.07 14.8 0.12
Stat3 Signal transducer and activator of transcription 3 Growth regulation 975718 0.97 0.76 1.85 0.66 0.58 0.88 0.64 1.4 1.00
Stat4 Signal transducer and activator of transcription 4 Transcription/ Translation 577343 0.77 0.19 0.18 0.98 0.34 2.55 0.19 13.5 0.12
Sycp3 Synaptonemal complex protein 3 Chromatin related
874980, 
1230236 0.92 0.19 0.18 0.26 0.27 1.81 0.07 25.8 0.06
Tak1 TGF-beta-activated kinase Growth regulation 865301 0.96 0.92 2.24 0.91 0.81 0.71 0.86 0.8 1.00
Tb4y Thymosin, beta 4, Y chromosome Meiosis/ Spermatogenesis 273224, 325197 0.93 7.43 3.07 0.88 5.26 4.01 0.09 43.8 0.01
Tbp TATA box binding protein Transcription/ Translation 573420 0.99 0.61 0.61 0.60 0.70 0.19 0.15 1.3 1.00
Tctex2 T-complex testis-expressed 2 Meiosis/ Spermatogenesis 514791, 515753 0.65 0.34 0.20 0.15 0.22 1.36 0.27 5.0 0.58
Tdgb
T:G mismatch-specific thymine-DNA 
glycosylase DNA repair (BER) 990644 1.25 4.37 1.87 1.80 1.89 0.88 *0.00642 19.3 0.12
Tenr Testis nuclear RNA-binding protein Transcription/ Translation 602129 0.93 0.39 0.86 1.14 1.09 0.80 0.14 5.8 0.46
Testin-2 Testin-2 Other 917479 0.90 0.35 0.91 0.48 0.45 0.78 0.21 3.8 0.70
Pdcd10 Programmed cell death 10 Damage recognition, cell cycle, apoptosis 822588 0.90 0.71 0.54 0.88 1.11 0.32 *0.01190 7.0 0.32
TIFII-B Transcription initiation factor IIB Transcription/ Translation 315324 0.98 0.77 0.55 0.61 0.87 0.24 *0.04490 5.2 0.55
Timp2 Tissue inhibitor of metalloproteinase 2 Adhesion/ Extracellular matrix 535104 1.47 1.62 1.82 1.18 1.22 0.14 0.11 1.4 1.00
Tk1 Thymidine kinase 1 Other 556061 0.97 0.99 3.93 0.90 1.14 1.60 *0.01860 35.0 0.01
Tnp1 Transition protein 1 Chromatin related 602551 0.58 0.16 0.18 0.17 0.15 1.37 0.11 12.1 0.15
Top1 Topoisomerase (DNA) I Chromatin related 873675 0.94 1.36 2.89 1.07 1.21 0.80 0.39 2.1 0.98
Top2b Topoisomerase (DNA) II beta Chromatin related 652824 0.95 1.62 2.27 1.04 1.47 0.52 0.14 3.6 0.70
Tssk2 Testis specific serine kinase 2 Growth regulation 602020 0.93 0.14 0.22 0.28 0.26 2.00 0.12 16.6 0.12
Tuba2 Tubulin alpha 2 Housekeeping 919504 1.10 1.42 0.89 0.60 1.10 0.43 *0.04300 9.4 0.20
Ube2b Ubiquitin-conjugating enzyme E2B Other 577631 0.98 0.50 1.22 0.73 0.64 0.52 0.09 6.0 0.40
Ube3a Ubiquitin conjugating enzyme E3A Other 538653 0.93 0.38 0.52 0.60 0.91 0.59 0.13 4.5 0.58
Ung Uracil-DNA glycosylase DNA repair (BER)
355462, 406824, 
931428 0.92 0.50 0.33 0.49 0.53 0.56 0.29 2.0 0.99
Vegf Vascular endothelial growth factor Damage recognition, cell cycle, apoptosis 988133 1.03 1.19 0.39 1.23 1.20 1.03 0.66 1.6 1.00
Wnt10b Wingless related MMTV integration site 10b Growth regulation 439485 1.10 0.33 0.23 0.23 1.47 3.28 0.07 47.5 0.01
Zfp105 Zinc finger protein 105 Damage recognition, cell cycle, apoptosis 536078 1.23 1.06 2.38 1.04 1.45 0.48 0.20 2.4 0.92
aData for the 152 genes with expression ratios Š0.60 or 1.68 in one or more tissues
bDenominators with an asterisk were replaced by the median of the denominators (0.0456) before calculating the ratio
cPermuation p value






















All annotated genes showing significant differences in expression during the transition 






























Genes with increased expression as germ cells progress from mitosis to the onset of meiosis
Seleno-protein Sep Misc. M88463 9.8 0.04 Yes (Shih and Kleene, 1992)
Ig germline H-chain gene V-region IgH (germline) Immune response M16724 6.8 0.001 Yes (Kerr and Burrows, 1991)
Immunosuperfamily protein Bl2 Igsf4 Immune response AF061260 4.0 0.04 Yes (Wakayama et al., 2001)
Zinc finger protein X-linked Zfx Cellular differentiation M32309 2.7 0.05 Yes (Luoh et al., 1997)
Adipocyte-specific protein adipoQ AdipoQ Unknown U49915 37.0 0.02 No
Glioblastoma amplified sequence Gbas Unknown AJ001261 22.2 0.002 No
Methylmalonyl coenzyme A mutase Mut Metabolism X51941 11.9 0.04 No
Sprouty-4 Spry4 Signal transduction AB019280 5.6 0.02 No
Short stature homeobox 2 Shox2 Transcription U66918 4.1 0.04 No
Transactivating transcription factor 3 Sp3 Transcription AF062567 3.8 0.01 No
Histone H2a(A), H2a(B), and H2b H2A-B Chromatin-related U62673 2.8 0.03 No
ADP-ribosyltransferase 5 Art5 Protein modification U60881 2.3 0.03 No
Cryptochrome 1 Cry1 Molecular clock AB000777 2.1 0.01 No
Intracisternal A-particle type IIB Iap2 Growth regulation X16672 2.1 0.03 No
Genes with decreased expression as germ cells progress from mitosis to the onset of meiosis
DiGeorge syndrome critical region 6 Dgcr6 Unknown AF021031 143.8 0.02 Yes (Edelmann et al., 2001)
Glutathione peroxidase 4 Gpx4 Stress response D87896 44.1 0.03 Yes (Giannattasio et al., 1997)
Budding inhibited by benzimidazoles 1 Bub1 Cell cycle AF002823 22.6 0.02 Yes (Bernard et al., 2001)
Hydroxysteroid (17-beta) dehydrogenase 10 Hsd17b10 Metabolism U96116 20.4 0.002 Yes (Hansis et al., 1998)
High mobility group 1 Hmgb1 Cellular differentiation U00431 20.2 0.0003 Yes (Bucci et al., 1984)
Hexosaminidase A Hexa Metabolism U05837 20.1 0.02 Yes (Adamali et al., 1999a,b)
Integrin linked kinase Ilk Signal transduction U94479 15.7 0.05 Yes (Mulholland et al., 2001)
Actin-related protein 2/3 1A Arpc1a Cytoskeletal element AB024984 13.2 0.01 Yes (Fouquet et al., 2000)
Glutathione s-transferase, MU Gstm5 Cytoskeletal element U24428 13.0 0.02 Yes (Fulcher et al., 1995)
DEAD box polypeptide, Y chromosome Dby RNA helicase AJ007376 11.4 0.03 Yes (Mazeyrat et al., 2001)





All annotated genes showing significant differences in expression between spermatogonial mitosis and preleptotene 








Genes with decreased expression as germ cells progress from mitosis to the onset of meiosis (continued)
Milk fat globule-EGF factor 8 Mfge8 Cell adhesion M38337 9.5 0.002 Yes (Kanai et al., 2000)
Acrosomal vesicle protein 1 Acvp1 Fertilization U31992 8.9 0.02 Yes (Kurth et al., 1991)
NIMA-related expressed kinase 2 Nek2 Cell cycle AF013166 8.8 0.004 Yes (Di Agostino et al., 2002)
Endothelin 1 Edn1 Signal transduction U35233 7.7 0.01 Yes (Cai et al., 2000)
Cystatin 3 Cst3 Cellular differentiation U10098 7.6 0.02 Yes (Tsuruta et al., 1993)
Flap structure specific endonuclease 1 Fen1 DNA repair L26320 7.0 0.04 Yes (Harrington and Lieber, 1994)
Triosephosphate isomerase Tpi Metabolism L31777 6.7 0.03 Yes (Russell and Kim, 1996)
Bcl2-associated X protein Bax Apoptosis L22472 6.4 0.01 Yes (Russell et al., 2002)
Catenin alpha 1 Catna1 Cell adhesion X59990 4.8 0.01 Yes (Wine and Chapin, 1999)
Phosphoglycerate mutase muscle-specific Pgam-m Metabolism AF029843 4.6 0.05 Yes (Broceno et al., 1995)
Tubulin alpha 2 Tuba2 Cytoskeletal element M28727 4.2 0.01 Yes (Bo and Wensink, 1989)
Mcm2 Mcm2 DNA replication D86725 3.9 0.02 Yes (Lindner et al., 2002)
TIF1 beta Tif1b Transcription X99644 3.6 0.04 Yes (Le Douarin et al., 1996)
Breast cancer 2 Brca2 DNA repair U89652 3.5 0.02 Yes (Connor et al., 1997)
Mictrotubule-associated protein 7 Mtap7 Cytoskeletal element Y15197 3.0 0.02 Yes (Komada et al., 2000)
Rab7 Rab7 Intracellular transport Y13361 2.7 0.03 Yes (Ramalho-Santos and Moreno, 2001)
Polo-like kinase 1 Plk1 Cell cycle U73170 2.6 0.03 Yes (Matsubara et al., 1995)
RhoB Arhb Cytoskeletal element X99963 2.4 0.002 Yes (Castellano et al., 1997)
Preproenkephalin related Penk-rs Signal transduction M55181 2.0 0.02 Yes (Kilpatrick et al., 1990)
Heat shock cognate 70 (testis) Hsc70t Stress response AF109905 2.0 0.02 Yes (Matsumoto et al., 1993)
RNA binding motif 3 Rbm3 Stress response AB016424 1.9 0.04 Yes (Danno et al., 2000)
Actin, gamma 2 Actg2 Cytoskeletal element U20365 1.8 0.05 Yes (Kim et al., 1989)
Peroxiredoxin protein 2 Prdx2 Stress response AF093853 1752.9 0.03 No
LIM protein-1 Lhx1 Transcription D88792 105.0 0.02 No
TPR-containing, SH2-binding phosphoprotein Tsbp Misc. L49502 66.9 0.02 No
Calponin 2 Cnn2 Cytoskeletal element Z19543 43.1 0.01 No
Isocitrate dehydrogenase 3 (NAD+) Idh3 Metabolism U68564 41.9 0.02 No
Dynactin 3 Dctn3 Cytoskeletal element AF098508 39.0 0.01 No
Diacylglycerol acyltransferase Dgat Metabolism AF078752 36.3 0.004 No
RNA binding protein regulatory subunit Dj1 Growth regulation AB015652 34.7 0.05 No
Rab6/rab5-associated protein Rabac1 Intracellular transport L40934 33.2 0.002 No
SRY-box containing gene 18 Sox18 Transcription L35032 32.9 0.04 No
Peptidylprolyl isomerase B Ppib Protein modification X58990 27.3 0.05 No












Genes with decreased expression as germ cells progress from mitosis to the onset of meiosis (continued)
Ubiquitin c-terminal hydrolase related Uchrp Protein modification D84096 24.3 0.03 No
Viral envelope like protein (G7e) G7e Unknown U69488 23.0 0.05 No
RNA polymerase I associated factor Paf53 Transcription D14336 22.5 0.05 No
Centromere protein A Cenp-a Chromatin-related AF012710 22.2 0.04 No
Thioredoxin reductase 1 Txnrd1 Stress response AB027565 20.8 0.01 No
Serine protease inhibitor 4 Serpine2 Misc. X70296 20.7 0.02 No
Alpha-actinin-2 associated LIM protein Alp Cytoskeletal element AF002283 20.0 0.04 No
Tuberous sclerosis 2 Tsc2 Growth regulation U39818 19.6 0.02 No
Baf53a Baf53a Chromatin-related AF041476 18.7 0.05 No
NIK-related kinase Nrk Signal transduction AB020741 18.2 0.05 No
Adaptor protein complex gamma Ap1g1 Intracellular transport X54424 17.6 0.04 No
Cell surface antigen AA4 AA4 Unknown AF081789 15.8 0.04 No
P35b P35b Immune response X53619 15.8 0.04 No
ClpP protease ClpP Protein modification AJ005253 15.0 0.03 No
 X chromosome-linked phosphoglycerate kinase Pgk1 Metabolism M15668 14.9 0.01 No
Elongation factor 2 Eef2 Biosynthesis M76131 14.9 0.04 No
Myeloid cell leukemia sequence 1 Mcl1 Apoptosis U35623 14.9 0.02 No
Ribosomal protein L8 Rpl8 Biosynthesis U67771 14.8 0.004 No
Dynactin 1 Dctn1 Cytoskeletal element U60312 14.4 0.04 No
Mitogen activated protein kinase kinase 5 Map2k5 Signal transduction AB019374 14.2 0.01 No
Anti-corynebacterium kutscheri Ack Immune response AF037260 13.5 0.04 No
Solute carrier 20, member 1 Slc20a1 Intercellular transport M73696 13.3 0.02 No
Transaldolase Taldol Metabolism U67611 13.3 0.01 No
N-myristoyltransferase 1 Nmt1 Protein modification AF043326 13.1 0.05 No
Mini chromosome maintenance deficient 4 Mcmd4 Cell cycle D26089 13.0 0.01 No
Seb4 Seb4l Post-transcriptional reg. X75316 12.8 0.04 No
Ferredoxin-NADP reductase Fdxr Metabolism D49920 12.3 0.05 No
Annexin VI, p68 Anx6 Metabolism X13460 11.9 0.05 No
Rab24 Rab24 Unknown Z22819 11.8 0.04 No
Kryn Kryn Unknown D89677 11.8 0.02 No
Histidyl-tRNA synthetase Hars Biosynthesis U39473 11.8 0.01 No
SKD3 Skd3 Intercellular transport U09874 11.0 0.003 No
Retinal S-antigen Sag Misc. M24086 11.0 0.05 No
Thioredoxin Txn1 Stress response X77585 10.9 0.001 No
Sec22b Sec22l1 Intracellular transport U91538 10.3 0.02 No












Genes with decreased expression as germ cells progress from mitosis to the onset of meiosis (continued)
Alcohol dehydrogenase-B2 Adhb2 Metabolism M84147 9.5 0.01 No
Ubiquitin-like enzyme 1a Uble1a Protein modification AB024303 9.5 0.01 No
Transcription factor S-II SII Transcription M18209 9.3 0.01 No
Histone 1-0 H1fo Chromatin-related M29260 9.3 0.02 No
Cyclin F Ccnf Cell cycle Z47766 9.0 0.04 No
Calcium/calmodulin serine protein kinase Cask Signal transduction Y17138 8.9 0.04 No
Glutaredoxin Glrx1 Metabolism AB013137 8.8 0.01 No
WSB-1 Wsb Unknown AF033186 8.1 0.05 No
Neuropilin Nrp Cell adhesion D50086 8.0 0.02 No
Procollagen, type XVIII, alpha 1 Col18a1 Cell adhesion L22545 7.8 0.01 No
Ribosomal protein L29 Rpl29 Biosynthesis X05021 7.6 0.03 No
CMP-N-acetylneuraminic acid synthetase Cmas Biosynthesis AJ006215 7.5 0.04 No
Phosphatidylserine synthase-1 Ptdss1 Biosynthesis AF042731 7.4 0.04 No
Chloride channel protein 3 Clcn3 Intracellular transport AF029347 6.8 0.03 No
NfiX1-protein Nfix Transcription Y07688 6.5 0.05 No
Lumican Lum Extracellular matrix AF013262 6.4 0.05 No
Kinesin heavy chain member 2 Kif2 Intracellular transport D12644 6.4 0.04 No
Glycerol-3-phosphate dehydrogenase G3pd Metabolism D50430 6.3 0.02 No
Catechol-O-methyltransferase Comt Metabolism AF076156 6.3 0.02 No
S100 calcium-binding protein A13 S100a13 Misc. X99921 6.2 0.01 No
Cleft lip and palate transmembrane 1 Clptm1 Intracellular transport D67067 6.1 0.003 No
Hemoglobin, beta adult major chain Hbb Misc. J00413 6.1 0.01 No
Cdc6-related protein Cdc6p Cell cycle AJ223087 5.8 0.03 No
TFIIH, 62 kD subunit Gtf2h1 Transcription AJ002366 5.7 0.01 No
H2A histone, member X H2afx Chromatin-related Z35401 5.5 0.02 No
MHC class III region RD RD Unknown AF109906 5.5 0.01 No
Transcription factor 21 Tf21 Transcription factor AF035717 5.4 0.01 No
Golgi autoantigen subfamily a4 Golga4 Growth regulation AF051357 5.4 0.04 No
Wingless-related MMTV integration site 6 Wnt6 Signal transduction M89800 5.3 0.02 No
DNA polymerase alpha 1 Pola1 DNA replication D13543 5.2 0.03 No
Polyubiquitin TI-225 Ti-225 Protein modification D50527 4.9 0.004 No
Ribosomal protein S16 Rps16 Biosynthesis M11408 4.9 0.002 No
ATP binding cassette D3 Abcd3 Biosynthesis L28836 4.8 0.02 No
Unc-119 Unc119h Misc. AF030169 4.6 0.02 No
Acid beta glucosidase Gba Metabolism M24119 4.5 0.02 No












Genes with decreased expression as germ cells progress from mitosis to the onset of meiosis (continued)
Programmed cell death 6 Pdcd6 Apoptosis U49112 4.4 0.01 No
Discoidin domain receptor 1 Ddr1 Signal transduction L57509 4.4 0.004 No
Complement component 1 inhibitor C1inh Misc. AF010254 4.4 0.01 No
Defender against Apoptotic Death Dad1 Apoptosis U81052 4.3 0.01 No
Annexin 1 Anxa1 Growth regulation M69260 4.2 0.001 No
Tubulin, beta Tbb Cytoskeletal element X04663 4.2 0.02 No
Ribosomal protein S2 Rps2 Biosynthesis M20632 4.2 0.01 No
Lantibiotic synthetase component C Lancl1 Signal transduction Y16518 4.2 0.04 No
Sialyltransferase 10 Siat10 Metabolism D28941 4.1 0.003 No
Siva Siva Apoptosis AF033115 4.1 0.01 No
Pur-alpha Pura Transcription U02098 3.8 0.03 No
Phosphatidylinositol 4-phosphate 5-kinase I-beta Pip5k1b Signal transduction D86177 3.8 0.02 No
Activin receptor (ActR IIB) AcvrIIb Signal transduction M84120 3.8 0.01 No
Acidic ribosomal phosophoprotein PO Arbp Biosynthesis X15267 3.8 0.03 No
Ndr1 related protein 3 Ndr3 Cellular differentiation AB033922 3.7 0.03 No
Calpain small subunit Capn4 Protein modification AF058298 3.7 0.04 No
G protein beta 2 Gbeta2 Signal transduction U34960 3.6 0.01 No
Cystatin B Cstb Apoptosis U59807 3.5 0.05 No
CD1d1 antigen Cd1d1 Immune response M63695 3.4 0.02 No
Protein tyrosine phosphatase epsilon Ptpe Signal transduction D83484 3.4 0.03 No
Ribosomal protein L28 Rpl28 Biosynthesis X74856 3.4 0.001 No
Trans-golgi network protein 1 Ttgn1 Intracellular transport D50031 3.3 0.05 No
Mitochondrial ribosomal protein S31 Mrps31 Biosynthesis Z46966 3.2 0.02 No
Poliovirus receptor homolog Plvr Signal transduction D26107 3.2 0.04 No
Ndr1 related protein Ndr2 Cellular differentiation AB033921 3.1 0.05 No
Fibroblast growth factor inducible 13 Fgf13 Signal transduction U42383 3.1 0.05 No
Dia Dia Cytoskeletal element Y15910 3.1 0.05 No
Rab9 Rab9 Intracellular transport AB027290 3.1 0.05 No
Sara Sara Intracellular transport L20294 3.0 0.01 No
E46 E46 Unknown X61506 2.9 0.02 No
Carnitine palmitoyltransferase 1 Cpt1 Metabolism AF017175 2.9 0.01 No
Sin3B Sin3b Transcription AF038848 2.9 0.03 No
Signal peptidase complex 18 Spc18 Intracellular transport AB025405 2.9 0.02 No
Ribosomal protein S3 Rps3 Biosynthesis X76772 2.9 0.01 No
Enoyl coenzyme A hydratase 1 Ech1 Metabolism AF030343 2.8 0.01 No











Genes with decreased expression as germ cells progress from mitosis to the onset of meiosis (continued)
DEAD box polypeptide 6 Ddx6 RNA helicase AF038995 2.7 0.01 No
Nucleolin Ncl Transcription X07699 2.7 0.001 No
Ribosomal protein S8 Rps8 Biosynthesis X73829 2.6 0.001 No
Metallothionein 1 Mt1 Stress response V00835 2.6 0.05 No
CD98 antigen Cd98 Immune response AB017189 2.6 0.02 No
Actin, alpha 2, smooth muscle Acta2 Cytoskeletal element X13297 2.5 0.004 No
Calnexin Canx Protein modification L18888 2.5 0.04 No
Ribosomal protein S6 kinase 3 Rps6ka2 Biosynthesis AJ131021 2.4 0.03 No
JTB Jtb Misc. AB016490 2.4 0.03 No
Bat-4 Bat4 Unknown L76155 2.4 0.02 No
Ribosomal protein S4, X-linked Rps4x Biosynthesis M73436 2.3 0.001 No
Cyclin T1 Ccnt1 Cell cycle AF095640 2.1 0.02 No
Ribosomal protein L19 Rpl19 Biosynthesis M62952 2.1 0.03 No
Procollagen, type VI, alpha 1 Col6a1 Cell adhesion X66405 2.1 0.03 No
Lymphocyte antigen 6 locus E Ly6e Immune response U47737 2.1 0.03 No
Golgi autoantigen a5 Golga5 Growth regulation AB016784 2.0 0.03 No
Ornithine decarboxylase antizyme Oaz1 Metabolism U52823 2.0 0.005 No
Dystroglycan 1 Dag1 Cytoskeletal element U43512 1.9 0.04 No
Antigen identified by monoclonal antibodies 4F2 4F2 Unknown X14309 1.9 0.01 No
CD-1 cardiac troponin I Tnni3 Cytoskeletal element U09181 1.8 0.03 No
aStudent's t-test p-values Š 0.05 indicate significant differences in expression across time points (see Materials and Methods in Chapter 4)
bGenes with described roles in germ cell development or differentiation, meiosis, spermatogenesis, or fertilization 
Fold-difference in 


























Unannotated sequences with significant expression differences during the first wave of 
























Ratio a P-valueb Ratio a P-valueb
C81612 185.0 0.04 AW125224 -1.9 0.05
AW123801 63.1 0.03 AI835883 -2.0 0.03
AI451558 45.4 0.05 AI847904 -2.0 0.01
C79052 36.6 0.04 AW124711 -2.0 0.05
AI451008 34.5 0.04 AI839770 -2.1 0.05
AI853703 26.8 0.02 AI463490 -2.1 0.03
AI837621 18.3 0.02 AI552528 -2.1 0.05
AW048038 18.1 0.001 AI854432 -2.2 0.05
AI324972 14.1 0.02 AW122284 -2.3 0.003
C80919 11.0 0.02 AA388099 -2.3 0.02
AI197161 10.3 0.01 AI842095 -2.3 0.01
AI183202 7.7 0.03 AI841629 -2.4 0.05
AW121930 5.6 0.04 AW061222 -2.4 0.02
AI843895 5.3 0.03 AI847269 -2.5 0.03
AF045953 5.1 0.02 AI854771 -2.5 0.03
AI846484 4.7 0.01 AW123032 -2.5 0.05
AW046194 3.9 0.01 AI854624 -2.5 0.05
AA986782 3.6 0.02 AI255450 -2.5 0.01
AA266298 3.0 0.0004 AA822413 -2.6 0.01
AI842066 2.8 0.04 AW049194 -2.6 0.03
AW125669 2.6 0.02 AI843895 -2.6 0.04
AI842066 2.6 0.05 AA760073 -2.6 0.04
C76063 2.5 0.004 AI843655 -2.7 0.04
AW048944 2.5 0.05 AA879764 -2.7 0.04
AI892206 2.4 0.01 AW123953 -2.7 0.04
AW047476 2.4 0.04 AW050353 -2.8 0.03
AA684456 2.4 0.01 AW122615 -2.8 0.04
AW124681 2.3 0.04 AI843655 -2.8 0.05
AW124735 2.1 0.02 AI852808 -2.8 0.04
C77386 2.0 0.04 AI851539 -2.9 0.04
AI842259 1.9 0.01 AI843682 -3.0 0.02
AI843417 -1.8 0.05 AI844853 -3.0 0.05
AW125739 -1.8 0.03 AI847904 -3.0 0.02
L29441 -1.8 0.03 AA895984 -3.1 0.02
AI647612 -1.8 0.05 AI851218 -3.1 0.05
AW121892 -1.8 0.02 AI851046 -3.1 0.03
AI462105 -1.9 0.02 AA919208 -3.2 0.01
bStudent's t-test p-values Š 0.05 indicate significant differences in expression across time points





Preleptotene / Spermatogonial 
Mitosis
Unannotated sequences showing differential expression between  spermatogonial mitosis and 
preleptotene
Complete list of unnannotated sequences with differential expression during 









Ratio a P-valueb Ratio a P-valueb
AI845182 -3.2 0.03 AA655199 -4.7 0.02
AW050086 -3.2 0.03 AA675468 -4.8 0.02
AA688938 -3.3 0.02 AW046443 -4.8 0.01
AI846628 -3.3 0.03 AI836686 -4.9 0.03
AW048038 -3.3 0.05 AA612483 -4.9 0.004
AW045665 -3.3 0.04 AI844011 -4.9 0.01
AI851237 -3.3 0.02 AW050305 -4.9 0.01
AI839988 -3.3 0.05 AI845882 -5.0 0.02
AI852340 -3.4 0.04 AA596710 -5.0 0.05
AW124044 -3.4 0.04 AI846127 -5.0 0.03
AI854043 -3.4 0.02 AA165759 -5.1 0.05
AW048272 -3.5 0.01 AI845580 -5.1 0.01
AW124187 -3.5 0.03 AW045481 -5.3 0.03
C88243 -3.7 0.01 AI842524 -5.4 0.02
AI852457 -3.7 0.04 AI851356 -5.5 0.001
AA967263 -3.8 0.02 AI853331 -5.5 0.04
AW227778 -3.8 0.03 AI843586 -5.6 0.02
AI840579 -3.8 0.01 AW125634 -5.6 0.004
AI843679 -3.9 0.02 AW121930 -5.7 0.04
AW046793 -3.9 0.01 AW122551 -5.7 0.004
AI840267 -3.9 0.04 AI850356 -5.7 0.05
AI843709 -3.9 0.002 AI851160 -5.9 0.01
AW061255 -3.9 0.05 AW050133 -5.9 0.01
AA709672 -4.0 0.01 AI846078 -5.9 0.02
AI843335 -4.0 0.01 AC002397 -6.2 0.002
AA122714 -4.1 0.03 AI838398 -6.4 0.05
AI853269 -4.1 0.02 AI854771 -6.4 0.01
AW047926 -4.1 0.02 AI849180 -6.4 0.05
AW122935 -4.2 0.01 AW124933 -6.4 0.01
AI851542 -4.2 0.05 AW046273 -6.4 0.002
AI848471 -4.3 0.04 AA615161 -6.5 0.05
AI851441 -4.3 0.01 AW210320 -6.6 0.02
AI841629 -4.4 0.02 AW121162 -6.6 0.03
AW124778 -4.4 0.02 AI853331 -6.9 0.04
AI846396 -4.4 0.02 AI414051 -7.2 0.001
AW123802 -4.4 0.04 AA823653 -7.3 0.03
AA693125 -4.4 0.03 AW124920 -7.4 0.01
AW048347 -4.4 0.04 AW125420 -7.4 0.04
AI849271 -4.4 0.004 AI846078 -7.5 0.05
AI153693 -4.5 0.01 AW124582 -7.5 0.02
AA285446 -4.5 0.05 AA879709 -8.0 0.01
AA755260 -4.6 0.04 AW045481 -8.0 0.03
AA690091 -4.6 0.02 AW045710 -8.1 0.01
AW124194 -4.6 0.01 AI847926 -8.1 0.05











aFold difference in expression for preleptotene vs. spermatogonial mitosis; Negative numbers indicate decreased expression as 
germ cells differentiate





Ratio a P-valueb Ratio a P-valueb
AW060819 -8.3 0.001 C80836 -16.6 0.02
AI844089 -8.6 0.03 AI152779 -16.6 0.04
AI839286 -8.7 0.001 AW212479 -16.8 0.01
AA796831 -8.8 0.05 AI839681 -18.1 0.03
AW121136 -8.8 0.02 AW122530 -18.1 0.03
AI838398 -8.9 0.01 AI845581 -18.2 0.002
L29441 -8.9 0.04 AW124401 -19.6 0.01
AI838053 -9.0 0.01 AA866668 -19.9 0.01
AW259199 -9.1 0.04 AW050287 -21.3 0.04
AI838915 -9.2 0.01 AI647493 -22.6 0.05
AW121767 -9.2 0.01 AW125224 -24.1 0.04
AI788543 -9.4 0.02 U38981 -24.6 0.01
AI845593 -9.6 0.05 AI835592 -27.2 0.02
AI847314 -10.0 0.003 AA615100 -27.2 0.002
AI847564 -10.2 0.05 AW120691 -30.6 0.04
AV380793 -10.3 0.04 AI853173 -31.9 0.04
AA517835 -10.8 0.02 AI115399 -34.0 0.01
AI843709 -10.8 0.05 AW125649 -34.4 0.04
AA657164 -11.1 0.04 AW227345 -34.8 0.01
AI845165 -11.3 0.02 AI843884 -35.7 0.01
AI006319 -11.5 0.04 AW060257 -37.1 0.04
AW123952 -11.6 0.01 AA285446 -37.7 0.05
AW123801 -11.7 0.05 AW060324 -38.3 0.02
AA388099 -12.5 0.05 AA693246 -39.3 0.01
AW123880 -12.6 0.04 AI846708 -41.3 0.04
AI644179 -12.8 0.02 AW046496 -43.5 0.03
AI747444 -12.8 0.05 AW049122 -44.0 0.003
AA624336 -13.1 0.01 AW120683 -46.1 0.0004
AI849620 -13.3 0.03 AW046038 -59.5 0.05
AA657164 -13.4 0.04 AW120986 -60.0 0.05
AA940430 -13.5 0.03 AI843074 -67.7 0.02
AW120557 -13.6 0.001 AW061222 -75.1 0.003
AW047012 -14.2 0.01 AI846773 -82.4 0.03
AW213777 -14.6 0.05 AW124874 -104.4 0.05
AW124735 -14.7 0.01 AI847972 -107.3 0.02
AI849280 -14.7 0.03 AI844737 -108.8 0.04
AI842095 -15.4 0.01 AI843401 -132.2 0.02
AI060709 -15.7 0.03 AW120739 -132.9 0.04
AW125880 -16.1 0.05 AI843417 -146.5 0.004
AI847056 -16.2 0.03
bStudent's t-test p-values Š 0.05 indicate significant differences in expression across time points
Unannotated sequences showing differential expression between  spermatogonial mitosis and 
preleptotene (continued)





Preleptotene / Spermatogonial 







Ratio a P-valueb Ratio a P-valueb
AI852571 34.8 0.04 AW125043 -5.4 0.03
AW124239 7.0 0.04 AI006228 -6.7 0.05
AW060971 6.5 0.04 AI850793 -8.7 0.04
AI842544 6.2 0.04 AW046661 -11.4 0.05
AI120844 5.9 0.04 AI851220 -12.1 0.01
AA921481 5.0 0.01 AI195392 -14.8 0.05
AW120890 4.5 0.002 AA763918 -24.5 0.03






























bStudent's t-test p-values Š 0.05 indicate significant differences in expression across time points




Pachytene / Preleptotene Pachytene / PreleptoteneGenBank 
Accession 
ID







Ratio a P-valueb Ratio a P-valueb
AI848888 6.4 0.02 -5.0 0.02 ID
AW047237 3.7 0.04 -8.5 0.04 ID
AI854214 -1.8 0.05 -2.6 0.05 DD
AI854144 -2.4 0.04 -1.8 0.01 DD
AI837369 -2.4 0.02 2.1 0.03 DI
AI836082 -2.9 0.03 -2.2 0.02 DD
AI849082 -3.0 0.02 3.0 0.01 DI
AW124044 -3.0 0.02 2.5 0.03 DI
AI848968 -3.1 0.005 2.3 0.01 DI
AW122609 -3.4 0.01 -3.2 0.04 DD
AW049326 -3.4 0.001 2.2 0.05 DI
AI847054 -3.7 0.04 -4.2 0.02 DD
AW125431 -4.1 0.03 -1.8 0.03 DD
AW049897 -4.5 0.02 4.8 0.01 DI
AI415065 -4.8 0.001 1.8 0.01 DI
AI840458 -5.2 0.03 2.3 0.05 DI
AI850953 -5.5 0.03 1.9 0.02 DI
AW060843 -6.2 0.04 1.7 0.05 DI
AI843650 -6.7 0.01 -2.8 0.02 DD
AI844549 -6.8 0.04 2.2 0.05 DI
AI837302 -13.3 0.04 -3.0 0.01 DD
AW047625 -20.60 0.01 3.2 0.04 DI
AI467390 -23.50 0.02 -3.8 0.03 DD
AW213883 -28.40 0.002 -2.2 0.05 DD
AA794350 -39.60 0.02 9.6 0.001 DI
AW046708 -46.50 0.002 5.8 0.01 DI
AI836446 -81.20 0.001 2.4 0.03 DI
bStudent's t-test p-values Š 0.05 indicate significant differences in expression across time points
Unannotated sequences with differential expression between spermatogonial 
mitosis and preleptotene and also between preleptotene and pachytene
cDD = Decreasesd expression from spermatogonial mitosis to preleptotene and decreased expression 
from preleptotene to pachytene; DI = Decreasesd expression from spermatogonial mitosis to 
preleptotene and increased expression from preleptotene to pachytene; ID = Increasesd expression from 








aFold difference in expression for preleptotene vs. spermatogonial mitosis and pachytene vs. 


















































Website Name URL Website Description
National Center for Biotechnology Information (NCBI) http://www.ncbi.nlm.nih.gov/ Public databases for biological research
PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi Searchable scientific publication database
Entrez Nucleotide Query http://www.ncbi.nlm.nih.gov/Entrez/nucleotide.html Searchable nucleotide sequence database
UniGene http://www.ncbi.nlm.nih.gov/UniGene/ Searchable non-redundant gene cluster database
Basic Local Alignment Search Tool (BLAST) http://www.ncbi.nlm.nih.gov/BLAST/ Compares DNA and/or protein sequences
CloneRanger https://www.resgen.com/resources/apps/cloneranger/index.php3 Searchable cDNA clone database
I.M.A.G.E. Consortium at LLNL http://image.llnl.gov/ Searchable cDNA clone database
Large-Scale Gene Expression & Microarray Resources http://industry.ebi.ac.uk/~alan/MicroArray/ Non-commercial microarray-related resources
Affymetrix http://www.affymetrix.com/index.affx Commercial GeneChip resource
Mouse Genome Informatics: Gene Expression http://www.informatics.jax.org/menus/expression_menu.shtml Searchable gene expression databases
Human Gene Nomenclature Database http://www.gene.ucl.ac.uk/cgi-bin/nomenclature/searchgenes.pl Searchable database for obtaining gene symbols
Spidey http://www.ncbi.nlm.nih.gov/IEB/Research/Ostell/Spidey/ Aligns mRNA and genomic sequences
BLAST 2 Sequences http://www.ncbi.nlm.nih.gov/gorf/bl2.html Aligns 2 user-selected nucleotide sequences against each other
CLUSFAVOR http://mbcr.bcm.tmc.edu/genepi/home.html Unsupervised hierarchial cluster and principal component analyses
MicroArray Explorer http://www.lecb.ncifcrf.gov/MAExplorer/
Analyzes the expression of individual genes and gene families; 
Compares expression patterns; Provides access to other genomic 
databases
Gene Microarray Pathway Profiler (GenMAPP) http://www.genMAPP.org/ Maps gene expression data to biological pathways
Gene Ontology Project http://www.geneontology.org Searchable database of molecular functions, biological processes, and cellular components that are similar across organisms
Genomatix PromoterInspector http://www.genomatix.de/cgi-bin/promoterinspector/promoterinspector.pl Predicts promoter regions in mammalian genomic sequences
Methods for Affymetrix Oligonucleotide Arrays http://biosun01.biostat.jhsph.edu/~ririzarr/Raffy Interactive Affymetrix oligonucleotide array data analysis
National Library of Medicine Gateway Search http://gateway.nlm.nih.gov/gw/Cmd Simultaneously searches multiple databases at the U.S. National Library of Medicine
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